Go to the Table of Contents
90331
Table 1.47A – Inhalant Use in Lifetime, Past Year, and Past Month among Persons Aged 26 or Older, by Demographic Characteristics: Numbers in Thousands, 2007 and 2008
Demographic Characteristic Lifetime
(2007)
Lifetime
(2008)
Past Year
(2007)
Past Year
(2008)
Past Month
(2007)
Past Month
(2008)
*Low precision; no estimate reported.
a Difference between estimate and 2008 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2008 estimate is statistically significant at the 0.01 level.
1 The Other Employment category includes retired persons, disabled persons, homemakers, students, or other persons not in the labor force.
Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2007 and 2008.
TOTAL 16,365 16,555 560 536 191 268
GENDER            
Male 10,836 10,938 453 447 154 229
Female 5,529 5,618 107 89 37 39
HISPANIC ORIGIN AND RACE            
Not Hispanic or Latino 15,062 15,048 489 503 145 247
White 13,682 13,531 446 424 140 204
Black or African American 652 799 26 11 * 11
American Indian or Alaska Native 117 71 * 2 1 *
Native Hawaiian or Other Pacific Islander * * * * * *
Asian 314 236 * 60 * 25
Two or More Races 250 394 7 6 3 6
Hispanic or Latino 1,304 1,508 71 33 47 21
EDUCATION            
< High School 1,805 1,734 63 29 53 19
High School Graduate 4,069 4,180 107 181 30 30
Some College 4,709 4,840 117 142 38 94
College Graduate 5,782 5,801 273 185 71 125
CURRENT EMPLOYMENT            
Full-Time 11,612 11,439 413 345 104 210
Part-Time 1,764 1,939 100 103 73 12
Unemployed 526 734 11 50 3 21
Other1 2,463 2,444 37 38 11 25
90331
Table 1.47B – Inhalant Use in Lifetime, Past Year, and Past Month among Persons Aged 26 or Older, by Demographic Characteristics: Percentages, 2007 and 2008
Demographic Characteristic Lifetime
(2007)
Lifetime
(2008)
Past Year
(2007)
Past Year
(2008)
Past Month
(2007)
Past Month
(2008)
*Low precision; no estimate reported.
a Difference between estimate and 2008 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2008 estimate is statistically significant at the 0.01 level.
1 The Other Employment category includes retired persons, disabled persons, homemakers, students, or other persons not in the labor force.
Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2007 and 2008.
TOTAL 8.6 8.6 0.3 0.3 0.1 0.1
GENDER            
Male 11.9 11.9 0.5 0.5 0.2 0.2
Female 5.6 5.6 0.1 0.1 0.0 0.0
HISPANIC ORIGIN AND RACE            
Not Hispanic or Latino 9.1 9.0 0.3 0.3 0.1 0.1
White 10.2 10.1 0.3 0.3 0.1 0.2
Black or African American 3.1 3.8 0.1 0.1 * 0.1
American Indian or Alaska Native 12.5 9.1 * 0.3 0.1 *
Native Hawaiian or Other Pacific Islander * * * * * *
Asian 3.9 2.8 * 0.7 * 0.3
Two or More Races 13.3 18.8 0.4 0.3 0.2 0.3
Hispanic or Latino 5.5 6.1 0.3 0.1 0.2 0.1
EDUCATION            
< High School 6.0 5.9 0.2 0.1 0.2 0.1
High School Graduate 7.1 7.1 0.2 0.3 0.1 0.1
Some College 10.1 10.4 0.3 0.3 0.1 0.2
College Graduate 10.3 10.0 0.5 0.3 0.1 0.2
CURRENT EMPLOYMENT            
Full-Time 10.9 10.7 0.4 0.3 0.1 0.2
Part-Time 8.4 8.9 0.5 0.5 0.3 0.1
Unemployed 11.7 12.4 0.2 0.8 0.1 0.4
Other1 4.2 4.3 0.1 0.1 0.0 0.0
90331
Table 1.48A – Inhalant Use in Lifetime, Past Year, and Past Month among Persons Aged 18 or Older, by Demographic Characteristics: Numbers in Thousands, 2007 and 2008
Demographic Characteristic Lifetime
(2007)
Lifetime
(2008)
Past Year
(2007)
Past Year
(2008)
Past Month
(2007)
Past Month
(2008)
*Low precision; no estimate reported.
a Difference between estimate and 2008 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2008 estimate is statistically significant at the 0.01 level.
1 The Other Employment category includes retired persons, disabled persons, homemakers, students, or other persons not in the labor force.
Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2007 and 2008.
TOTAL 20,055 19,967 1,086 1,069 321 372
GENDER            
Male 13,065 12,957 832 799 235 301
Female 6,990 7,010 254 270 86 71
HISPANIC ORIGIN AND RACE            
Not Hispanic or Latino 18,233 17,956 930 959 247 327
White 16,547 16,166 847 831 223 274
Black or African American 797 945 44 31 9 13
American Indian or Alaska Native 142 89 * 5 1 0
Native Hawaiian or Other Pacific Islander * 24 0 * 0 *
Asian 383 296 13a 74 11 30
Two or More Races 308 436 15 14 3 6
Hispanic or Latino 1,822 2,011 156 110 74 45
EDUCATION            
< High School 2,570 2,354 195a 111 84 31
High School Graduate 5,242 5,335 305 384 91 78
Some College 5,960 6,006 281 350 70 127
College Graduate 6,283 6,271 306 224 77 135
CURRENT EMPLOYMENT            
Full-Time 13,538 13,109 625 542 167 250
Part-Time 2,644 2,823 241 278 98 51
Unemployed 836 1,062 59a 123 17 39
Other1 3,037 2,973 161 126 38 32
90331
Table 1.48B – Inhalant Use in Lifetime, Past Year, and Past Month among Persons Aged 18 or Older, by Demographic Characteristics: Percentages, 2007 and 2008
Demographic Characteristic Lifetime
(2007)
Lifetime
(2008)
Past Year
(2007)
Past Year
(2008)
Past Month
(2007)
Past Month
(2008)
*Low precision; no estimate reported.
a Difference between estimate and 2008 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2008 estimate is statistically significant at the 0.01 level.
1 The Other Employment category includes retired persons, disabled persons, homemakers, students, or other persons not in the labor force.
Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2007 and 2008.
TOTAL 9.0 8.9 0.5 0.5 0.1 0.2
GENDER            
Male 12.2 11.9 0.8 0.7 0.2 0.3
Female 6.1 6.0 0.2 0.2 0.1 0.1
HISPANIC ORIGIN AND RACE            
Not Hispanic or Latino 9.4 9.2 0.5 0.5 0.1 0.2
White 10.7 10.4 0.5 0.5 0.1 0.2
Black or African American 3.1 3.7 0.2 0.1 0.0 0.1
American Indian or Alaska Native 12.9 9.3 * 0.6 0.1 0.0
Native Hawaiian or Other Pacific Islander * 3.0 0.1 * 0.1 *
Asian 4.0 3.0 0.1a 0.8 0.1 0.3
Two or More Races 13.3 17.4 0.6 0.6 0.1 0.3
Hispanic or Latino 6.2 6.6 0.5 0.4 0.2 0.1
EDUCATION            
< High School 7.1 6.7 0.5 0.3 0.2 0.1
High School Graduate 7.7 7.6 0.4 0.5 0.1 0.1
Some College 10.4 10.5 0.5 0.6 0.1 0.2
College Graduate 10.4 10.0 0.5 0.4 0.1 0.2
CURRENT EMPLOYMENT            
Full-Time 11.1 10.7 0.5 0.4 0.1 0.2
Part-Time 9.0 9.3 0.8 0.9 0.3 0.2
Unemployed 11.8 11.8 0.8 1.4 0.2 0.4
Other1 4.7 4.7 0.2 0.2 0.1 0.1
90331
Table 1.49A – Nonmedical Use of Prescription-Type Psychotherapeutics in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Demographic Characteristics: Numbers in Thousands, 2007 and 2008
Demographic Characteristic Lifetime
(2007)
Lifetime
(2008)
Past Year
(2007)
Past Year
(2008)
Past Month
(2007)
Past Month
(2008)
*Low precision; no estimate reported.
NOTE: Nonmedical use of prescription-type psychotherapeutics includes the nonmedical use of pain relievers, tranquilizers, stimulants, or sedatives and does not include over-the-counter drugs.
NOTE: Estimates in this table include data from methamphetamine items added in 2005 and 2006 and are not comparable with estimates presented in NSDUH reports prior to the 2007 National Findings report. See Section B.4.8 in Appendix B of the Results from the 2008 National Survey on Drug Use and Health: National Findings.
a Difference between estimate and 2008 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2008 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2007 and 2008.
TOTAL 50,415 51,970 16,280a 15,166 6,895a 6,224
AGE            
12-17 2,949 2,772 2,034 1,913 829a 710
18-25 9,790 9,626 4,913 4,868 1,949 1,943
26 or Older 37,676 39,572 9,334a 8,385 4,117 3,571
GENDER            
Male 26,442 27,179 8,674b 7,673 3,907b 3,096
Female 23,973 24,791 7,606 7,493 2,988 3,128
HISPANIC ORIGIN AND RACE            
Not Hispanic or Latino 45,206 46,474 14,359 13,430 6,119 5,597
White 39,597 40,053 12,193 11,452 5,114 4,821
Black or African American 3,514a 4,103 1,399 1,276 632 539
American Indian or Alaska Native 285 * 103 78 58 33
Native Hawaiian or Other Pacific Islander * * * * * 15
Asian 937 1,015 317 323 161 108
Two or More Races 713 803 285 209 112 81
Hispanic or Latino 5,210 5,496 1,921 1,736 776 627
90331
Table 1.49B – Nonmedical Use of Prescription-Type Psychotherapeutics in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Demographic Characteristics: Percentages, 2007 and 2008
Demographic Characteristic Lifetime
(2007)
Lifetime
(2008)
Past Year
(2007)
Past Year
(2008)
Past Month
(2007)
Past Month
(2008)
*Low precision; no estimate reported.
NOTE: Nonmedical use of prescription-type psychotherapeutics includes the nonmedical use of pain relievers, tranquilizers, stimulants, or sedatives and does not include over-the-counter drugs.
NOTE: Estimates in this table include data from methamphetamine items added in 2005 and 2006 and are not comparable with estimates presented in NSDUH reports prior to the 2007 National Findings report. See Section B.4.8 in Appendix B of the Results from the 2008 National Survey on Drug Use and Health: National Findings.
a Difference between estimate and 2008 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2008 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2007 and 2008.
TOTAL 20.3 20.8 6.6a 6.1 2.8a 2.5
AGE            
12-17 11.7 11.1 8.1 7.7 3.3a 2.9
18-25 29.9 29.2 15.0 14.8 6.0 5.9
26 or Older 19.8 20.6 4.9a 4.4 2.2 1.9
GENDER            
Male 22.0 22.4 7.2b 6.3 3.2b 2.6
Female 18.8 19.3 6.0 5.8 2.3 2.4
HISPANIC ORIGIN AND RACE            
Not Hispanic or Latino 21.2 21.6 6.7a 6.3 2.9 2.6
White 23.4 23.6 7.2 6.8 3.0 2.8
Black or African American 12.0 13.9 4.8 4.3 2.2 1.8
American Indian or Alaska Native 22.5 * 8.1 7.2 4.5 3.0
Native Hawaiian or Other Pacific Islander * * * * * 1.7
Asian 8.8 9.4 3.0 3.0 1.5 1.0
Two or More Races 26.1 26.6 10.4 6.9 4.1 2.7
Hispanic or Latino 15.2 15.7 5.6 5.0 2.3 1.8
90331
Table 1.50A – Nonmedical Use of Prescription-Type Psychotherapeutics in Lifetime, Past Year, and Past Month among Persons Aged 12 to 17, by Demographic Characteristics: Numbers in Thousands, 2007 and 2008
Demographic Characteristic Lifetime
(2007)
Lifetime
(2008)
Past Year
(2007)
Past Year
(2008)
Past Month
(2007)
Past Month
(2008)
*Low precision; no estimate reported.
NOTE: Nonmedical use of prescription-type psychotherapeutics includes the nonmedical use of pain relievers, tranquilizers, stimulants, or sedatives and does not include over-the-counter drugs.
NOTE: Estimates in this table include data from methamphetamine items added in 2005 and 2006 and are not comparable with estimates presented in NSDUH reports prior to the 2007 National Findings report. See Section B.4.8 in Appendix B of the Results from the 2008 National Survey on Drug Use and Health: National Findings.
a Difference between estimate and 2008 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2008 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2007 and 2008.
TOTAL 2,949 2,772 2,034 1,913 829a 710
GENDER            
Male 1,436a 1,255 970 863 391a 312
Female 1,513 1,517 1,064 1,050 438 398
HISPANIC ORIGIN AND RACE            
Not Hispanic or Latino 2,447 2,305 1,708 1,595 702a 605
White 1,914 1,809 1,358 1,270 537 490
Black or African American 388 312 251 201 120a 79
American Indian or Alaska Native 28 22 * 15 * 5
Native Hawaiian or Other Pacific Islander * * * * * *
Asian 65 80 45 47 14 7
Two or More Races 45 67 27a 51 13 21
Hispanic or Latino 502 466 326 318 127 106
GENDER/RACE/HISPANIC ORIGIN            
Male, White, Not Hispanic 924a 809 639 564 259 223
Female, White, Not Hispanic 990 1,000 718 706 278 267
Male, Black, Not Hispanic 191 165 107 101 49 32
Female, Black, Not Hispanic 197 147 145a 100 71 47
Male, Hispanic 244 217 171 153 59 41
Female, Hispanic 258 249 154 165 68 65
90331
Table 1.50B – Nonmedical Use of Prescription-Type Psychotherapeutics in Lifetime, Past Year, and Past Month among Persons Aged 12 to 17, by Demographic Characteristics: Percentages, 2007 and 2008
Demographic Characteristic Lifetime
(2007)
Lifetime
(2008)
Past Year
(2007)
Past Year
(2008)
Past Month
(2007)
Past Month
(2008)
*Low precision; no estimate reported.
NOTE: Nonmedical use of prescription-type psychotherapeutics includes the nonmedical use of pain relievers, tranquilizers, stimulants, or sedatives and does not include over-the-counter drugs.
NOTE: Estimates in this table include data from methamphetamine items added in 2005 and 2006 and are not comparable with estimates presented in NSDUH reports prior to the 2007 National Findings report. See Section B.4.8 in Appendix B of the Results from the 2008 National Survey on Drug Use and Health: National Findings.
a Difference between estimate and 2008 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2008 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2007 and 2008.
TOTAL 11.7 11.1 8.1 7.7 3.3a 2.9
GENDER            
Male 11.1a 9.9 7.5 6.8 3.0a 2.5
Female 12.3 12.4 8.6 8.6 3.5 3.3
HISPANIC ORIGIN AND RACE            
Not Hispanic or Latino 11.9 11.4 8.3 7.9 3.4 3.0
White 12.7 12.3 9.0 8.6 3.6 3.3
Black or African American 10.1 8.3 6.5 5.3 3.1a 2.1
American Indian or Alaska Native 17.0 16.3 * 11.3 * 4.0
Native Hawaiian or Other Pacific Islander * * * * * *
Asian 6.4 8.3 4.4 4.8 1.4 0.7
Two or More Races 10.7 13.3 6.5 10.2 3.2 4.2
Hispanic or Latino 10.8 9.9 7.0 6.7 2.7 2.2
GENDER/RACE/HISPANIC ORIGIN            
Male, White, Not Hispanic 12.0 10.8 8.3 7.5 3.4 3.0
Female, White, Not Hispanic 13.5 14.0 9.8 9.9 3.8 3.7
Male, Black, Not Hispanic 9.8 8.7 5.5 5.3 2.5 1.7
Female, Black, Not Hispanic 10.3 7.8 7.6a 5.3 3.7 2.5
Male, Hispanic 10.2 9.0 7.2 6.4 2.5 1.7
Female, Hispanic 11.3 10.8 6.8 7.1 3.0 2.8
90331
Table 1.51A – Nonmedical Use of Prescription-Type Psychotherapeutics in Lifetime, Past Year, and Past Month among Persons Aged 18 to 25, by Demographic Characteristics: Numbers in Thousands, 2007 and 2008
Demographic Characteristic Lifetime
(2007)
Lifetime
(2008)
Past Year
(2007)
Past Year
(2008)
Past Month
(2007)
Past Month
(2008)
*Low precision; no estimate reported.
NOTE: Nonmedical use of prescription-type psychotherapeutics includes the nonmedical use of pain relievers, tranquilizers, stimulants, or sedatives and does not include over-the-counter drugs.
NOTE: Estimates in this table include data from methamphetamine items added in 2005 and 2006 and are not comparable with estimates presented in NSDUH reports prior to the 2007 National Findings report. See Section B.4.8 in Appendix B of the Results from the 2008 National Survey on Drug Use and Health: National Findings.
a Difference between estimate and 2008 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2008 estimate is statistically significant at the 0.01 level.
1 The Other Employment category includes retired persons, disabled persons, homemakers, students, or other persons not in the labor force.
Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2007 and 2008.
TOTAL 9,790 9,626 4,913 4,868 1,949 1,943
GENDER            
Male 5,188 5,110 2,679 2,623 1,073 1,038
Female 4,602 4,516 2,234 2,244 877 905
HISPANIC ORIGIN AND RACE            
Not Hispanic or Latino 8,423 8,272 4,247 4,253 1,742 1,737
White 7,246 7,027 3,658 3,592 1,479 1,463
Black or African American 733 753 367 413 156 183
American Indian or Alaska Native * 64 * 30 * 10
Native Hawaiian or Other Pacific Islander 25 * 12 * 4 4
Asian 194 249 72 117 38 46
Two or More Races 164 147 99 76 41 32
Hispanic or Latino 1,367 1,354 666 614 207 206
EDUCATION            
< High School 1,942 1,786 1,051 943 482 401
High School Graduate 3,295 3,236 1,706 1,687 683 723
Some College 3,304 3,253 1,680 1,675 602 613
College Graduate 1,248 1,351 477 562 182 206
CURRENT EMPLOYMENT            
Full-Time 4,914 4,763 2,311 2,255 896 917
Part-Time 2,359 2,274 1,241 1,162 511 445
Unemployed 829a 1,002 465 553 191 215
Other1 1,689 1,587 896 898 351 366
90331
Table 1.51B – Nonmedical Use of Prescription-Type Psychotherapeutics in Lifetime, Past Year, and Past Month among Persons Aged 18 to 25, by Demographic Characteristics: Percentages, 2007 and 2008
Demographic Characteristic Lifetime
(2007)
Lifetime
(2008)
Past Year
(2007)
Past Year
(2008)
Past Month
(2007)
Past Month
(2008)
*Low precision; no estimate reported.
NOTE: Nonmedical use of prescription-type psychotherapeutics includes the nonmedical use of pain relievers, tranquilizers, stimulants, or sedatives and does not include over-the-counter drugs.
NOTE: Estimates in this table include data from methamphetamine items added in 2005 and 2006 and are not comparable with estimates presented in NSDUH reports prior to the 2007 National Findings report. See Section B.4.8 in Appendix B of the Results from the 2008 National Survey on Drug Use and Health: National Findings.
a Difference between estimate and 2008 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2008 estimate is statistically significant at the 0.01 level.
1 The Other Employment category includes retired persons, disabled persons, homemakers, students, or other persons not in the labor force.
Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2007 and 2008.
TOTAL 29.9 29.2 15.0 14.8 6.0 5.9
GENDER            
Male 31.5 30.8 16.3 15.8 6.5 6.3
Female 28.3 27.6 13.7 13.7 5.4 5.5
HISPANIC ORIGIN AND RACE            
Not Hispanic or Latino 31.3 30.5 15.8 15.7 6.5 6.4
White 35.8 34.6 18.1 17.7 7.3 7.2
Black or African American 16.2 16.2 8.1 8.9 3.5 3.9
American Indian or Alaska Native * 37.0 * 17.2 * 5.9
Native Hawaiian or Other Pacific Islander 18.5 * 8.8 * 2.7 3.3
Asian 13.4 16.7 5.0 7.8 2.6 3.0
Two or More Races 37.1 35.8 22.4 18.4 9.3 7.7
Hispanic or Latino 23.6 23.4 11.5 10.6 3.6 3.6
EDUCATION            
< High School 31.2 30.3 16.9 16.0 7.8 6.8
High School Graduate 29.6 27.9 15.3 14.5 6.1 6.2
Some College 30.1 30.0 15.3 15.4 5.5 5.6
College Graduate 28.3 29.5 10.8 12.3 4.1 4.5
CURRENT EMPLOYMENT            
Full-Time 32.1 31.8 15.1 15.1 5.8 6.1
Part-Time 28.0 26.6 14.7 13.6 6.1 5.2
Unemployed 31.7 32.8 17.8 18.1 7.3 7.0
Other1 26.5 25.0 14.1 14.1 5.5 5.8
90331
Table 1.52A – Nonmedical Use of Prescription-Type Psychotherapeutics in Lifetime, Past Year, and Past Month among Persons Aged 26 or Older, by Demographic Characteristics: Numbers in Thousands, 2007 and 2008
Demographic Characteristic Lifetime
(2007)
Lifetime
(2008)
Past Year
(2007)
Past Year
(2008)
Past Month
(2007)
Past Month
(2008)
*Low precision; no estimate reported.
NOTE: Nonmedical use of prescription-type psychotherapeutics includes the nonmedical use of pain relievers, tranquilizers, stimulants, or sedatives and does not include over-the-counter drugs.
NOTE: Estimates in this table include data from methamphetamine items added in 2005 and 2006 and are not comparable with estimates presented in NSDUH reports prior to the 2007 National Findings report. See Section B.4.8 in Appendix B of the Results from the 2008 National Survey on Drug Use and Health: National Findings.
a Difference between estimate and 2008 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2008 estimate is statistically significant at the 0.01 level.
1 The Other Employment category includes retired persons, disabled persons, homemakers, students, or other persons not in the labor force.
Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2007 and 2008.
TOTAL 37,676 39,572 9,334a 8,385 4,117 3,571
GENDER            
Male 19,819 20,813 5,025a 4,186 2,444b 1,746
Female 17,858 18,758 4,308 4,199 1,673 1,825
HISPANIC ORIGIN AND RACE            
Not Hispanic or Latino 34,336 35,896 8,404 7,582 3,675 3,255
White 30,437 31,216 7,178 6,590 3,098 2,868
Black or African American 2,394a 3,039 780 661 356 277
American Indian or Alaska Native 196 * 43 33 20 17
Native Hawaiian or Other Pacific Islander * * * * * *
Asian 678 686 200 159 109 56
Two or More Races 504 589 159 82 57 28
Hispanic or Latino 3,340 3,676 930 803 442 315
EDUCATION            
< High School 4,498 4,868 1,522 1,223 864a 540
High School Graduate 10,733a 11,871 2,656 2,589 1,240 1,072
Some College 10,909 11,162 2,791 2,489 1,141 1,248
College Graduate 11,536 11,671 2,364 2,084 872 711
CURRENT EMPLOYMENT            
Full-Time 24,874 25,761 5,845 5,303 2,576a 2,079
Part-Time 4,487 5,138 1,233 969 524 364
Unemployed 1,224a 1,650 403 585 203 264
Other1 7,092 7,023 1,853 1,528 814 864
90331
Table 1.52B – Nonmedical Use of Prescription-Type Psychotherapeutics in Lifetime, Past Year, and Past Month among Persons Aged 26 or Older, by Demographic Characteristics: Percentages, 2007 and 2008
Demographic Characteristic Lifetime
(2007)
Lifetime
(2008)
Past Year
(2007)
Past Year
(2008)
Past Month
(2007)
Past Month
(2008)
*Low precision; no estimate reported.
NOTE: Nonmedical use of prescription-type psychotherapeutics includes the nonmedical use of pain relievers, tranquilizers, stimulants, or sedatives and does not include over-the-counter drugs.
NOTE: Estimates in this table include data from methamphetamine items added in 2005 and 2006 and are not comparable with estimates presented in NSDUH reports prior to the 2007 National Findings report. See Section B.4.8 in Appendix B of the Results from the 2008 National Survey on Drug Use and Health: National Findings.
a Difference between estimate and 2008 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2008 estimate is statistically significant at the 0.01 level.
1 The Other Employment category includes retired persons, disabled persons, homemakers, students, or other persons not in the labor force.
Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2007 and 2008.
TOTAL 19.8 20.6 4.9a 4.4 2.2 1.9
GENDER            
Male 21.8 22.6 5.5b 4.6 2.7b 1.9
Female 18.0 18.8 4.4 4.2 1.7 1.8
HISPANIC ORIGIN AND RACE            
Not Hispanic or Latino 20.7 21.4 5.1a 4.5 2.2 1.9
White 22.8 23.2 5.4 4.9 2.3 2.1
Black or African American 11.5a 14.4 3.7 3.1 1.7 1.3
American Indian or Alaska Native 21.0 * 4.6 4.2 2.1 2.2
Native Hawaiian or Other Pacific Islander * * * * * *
Asian 8.3 8.2 2.5 1.9 1.3 0.7
Two or More Races 26.9 28.0 8.5 3.9 3.1 1.3
Hispanic or Latino 14.0 15.0 3.9 3.3 1.9 1.3
EDUCATION            
< High School 14.9 16.7 5.1 4.2 2.9a 1.9
High School Graduate 18.8 20.3 4.7 4.4 2.2 1.8
Some College 23.5 24.1 6.0 5.4 2.5 2.7
College Graduate 20.5 20.2 4.2 3.6 1.6 1.2
CURRENT EMPLOYMENT            
Full-Time 23.4 24.0 5.5 4.9 2.4a 1.9
Part-Time 21.3 23.7 5.8 4.5 2.5 1.7
Unemployed 27.3 27.8 9.0 9.9 4.5 4.5
Other1 12.2 12.3 3.2 2.7 1.4 1.5
90331
Table 1.53A – Nonmedical Use of Prescription-Type Psychotherapeutics in Lifetime, Past Year, and Past Month among Persons Aged 18 or Older, by Demographic Characteristics: Numbers in Thousands, 2007 and 2008
Demographic Characteristic Lifetime
(2007)
Lifetime
(2008)
Past Year
(2007)
Past Year
(2008)
Past Month
(2007)
Past Month
(2008)
*Low precision; no estimate reported.
NOTE: Nonmedical use of prescription-type psychotherapeutics includes the nonmedical use of pain relievers, tranquilizers, stimulants, or sedatives and does not include over-the-counter drugs.
NOTE: Estimates in this table include data from methamphetamine items added in 2005 and 2006 and are not comparable with estimates presented in NSDUH reports prior to the 2007 National Findings report. See Section B.4.8 in Appendix B of the Results from the 2008 National Survey on Drug Use and Health: National Findings.
a Difference between estimate and 2008 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2008 estimate is statistically significant at the 0.01 level.
1 The Other Employment category includes retired persons, disabled persons, homemakers, students, or other persons not in the labor force.
Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2007 and 2008.
TOTAL 47,467 49,198 14,246 13,253 6,066 5,514
GENDER            
Male 25,007 25,924 7,704a 6,810 3,516b 2,784
Female 22,460 23,274 6,543 6,443 2,550 2,730
HISPANIC ORIGIN AND RACE            
Not Hispanic or Latino 42,759 44,168 12,651 11,835 5,417 4,992
White 37,683 38,244 10,835 10,183 4,577 4,331
Black or African American 3,127a 3,791 1,147 1,074 512 459
American Indian or Alaska Native 257 * 82 62 44 27
Native Hawaiian or Other Pacific Islander * * * * * 13
Asian 873 935 272 276 147 101
Two or More Races 668 736 258 158 99 60
Hispanic or Latino 4,708 5,030 1,596 1,418 649 522
EDUCATION            
< High School 6,440 6,654 2,573a 2,166 1,346b 942
High School Graduate 14,028 15,107 4,362 4,276 1,923 1,795
Some College 14,213 14,415 4,471 4,164 1,743 1,861
College Graduate 12,784 13,022 2,841 2,646 1,054 917
CURRENT EMPLOYMENT            
Full-Time 29,788 30,524 8,155 7,558 3,472 2,997
Part-Time 6,846 7,412 2,474 2,131 1,035 809
Unemployed 2,052b 2,652 868a 1,138 394 479
Other1 8,780 8,610 2,749 2,426 1,165 1,229
90331
Table 1.53B – Nonmedical Use of Prescription-Type Psychotherapeutics in Lifetime, Past Year, and Past Month among Persons Aged 18 or Older, by Demographic Characteristics: Percentages, 2007 and 2008
Demographic Characteristic Lifetime
(2007)
Lifetime
(2008)
Past Year
(2007)
Past Year
(2008)
Past Month
(2007)
Past Month
(2008)
*Low precision; no estimate reported.
NOTE: Nonmedical use of prescription-type psychotherapeutics includes the nonmedical use of pain relievers, tranquilizers, stimulants, or sedatives and does not include over-the-counter drugs.
NOTE: Estimates in this table include data from methamphetamine items added in 2005 and 2006 and are not comparable with estimates presented in NSDUH reports prior to the 2007 National Findings report. See Section B.4.8 in Appendix B of the Results from the 2008 National Survey on Drug Use and Health: National Findings.
a Difference between estimate and 2008 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2008 estimate is statistically significant at the 0.01 level.
1 The Other Employment category includes retired persons, disabled persons, homemakers, students, or other persons not in the labor force.
Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2007 and 2008.
TOTAL 21.3 21.9 6.4a 5.9 2.7 2.5
GENDER            
Male 23.3 23.9 7.2b 6.3 3.3b 2.6
Female 19.5 20.0 5.7 5.5 2.2 2.3
HISPANIC ORIGIN AND RACE            
Not Hispanic or Latino 22.2 22.7 6.6 6.1 2.8 2.6
White 24.5 24.7 7.0 6.6 3.0 2.8
Black or African American 12.3a 14.7 4.5 4.2 2.0 1.8
American Indian or Alaska Native 23.3 * 7.4 6.6 4.0 2.9
Native Hawaiian or Other Pacific Islander * * * * * 1.7
Asian 9.1 9.5 2.8 2.8 1.5 1.0
Two or More Races 28.8 29.3 11.1a 6.3 4.3 2.4
Hispanic or Latino 15.9 16.6 5.4 4.7 2.2 1.7
EDUCATION            
< High School 17.7 19.0 7.1 6.2 3.7a 2.7
High School Graduate 20.6 21.5 6.4 6.1 2.8 2.6
Some College 24.7 25.2 7.8 7.3 3.0 3.3
College Graduate 21.1 20.8 4.7 4.2 1.7 1.5
CURRENT EMPLOYMENT            
Full-Time 24.5 25.0 6.7 6.2 2.9 2.5
Part-Time 23.2 24.5 8.4a 7.0 3.5a 2.7
Unemployed 28.9 29.5 12.2 12.7 5.5 5.3
Other1 13.6 13.6 4.3 3.8 1.8 1.9
90331
Table 1.54A – Nonmedical Use of Pain Relievers in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Demographic Characteristics: Numbers in Thousands, 2007 and 2008
Demographic Characteristic Lifetime
(2007)
Lifetime
(2008)
Past Year
(2007)
Past Year
(2008)
Past Month
(2007)
Past Month
(2008)
*Low precision; no estimate reported.
a Difference between estimate and 2008 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2008 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2007 and 2008.
TOTAL 33,060a 34,861 12,466 11,885 5,174 4,747
AGE            
12-17 2,452 2,346 1,681 1,608 669a 567
18-25 8,128 8,042 3,970 3,941 1,517 1,502
26 or Older 22,481a 24,473 6,815 6,336 2,987 2,678
GENDER            
Male 18,092 18,913 6,890 6,373 3,067b 2,469
Female 14,968 15,948 5,576 5,513 2,107 2,278
HISPANIC ORIGIN AND RACE            
Not Hispanic or Latino 29,380a 30,915 10,947 10,506 4,565 4,249
White 25,293 26,455 9,154 8,788 3,723 3,556
Black or African American 2,655 2,999 1,189 1,141 546 483
American Indian or Alaska Native 191 144 82 62 53 27
Native Hawaiian or Other Pacific Islander 79 137 41 * * 12
Asian 635 698 261 273 136 99
Two or More Races 527 482 220 155 85 73
Hispanic or Latino 3,680 3,946 1,519 1,379 609 497
90331
Table 1.54B – Nonmedical Use of Pain Relievers in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Demographic Characteristics: Percentages, 2007 and 2008
Demographic Characteristic Lifetime
(2007)
Lifetime
(2008)
Past Year
(2007)
Past Year
(2008)
Past Month
(2007)
Past Month
(2008)
*Low precision; no estimate reported.
a Difference between estimate and 2008 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2008 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2007 and 2008.
TOTAL 13.3 14.0 5.0 4.8 2.1 1.9
AGE            
12-17 9.7 9.4 6.7 6.5 2.7a 2.3
18-25 24.8 24.4 12.1 12.0 4.6 4.6
26 or Older 11.8a 12.7 3.6 3.3 1.6 1.4
GENDER            
Male 15.0 15.6 5.7 5.3 2.6b 2.0
Female 11.7 12.4 4.4 4.3 1.7 1.8
HISPANIC ORIGIN AND RACE            
Not Hispanic or Latino 13.8 14.4 5.1 4.9 2.1 2.0
White 15.0 15.6 5.4 5.2 2.2 2.1
Black or African American 9.1 10.1 4.1 3.9 1.9 1.6
American Indian or Alaska Native 15.1 13.3 6.5 5.8 4.2 2.5
Native Hawaiian or Other Pacific Islander 11.2 15.2 5.8 * * 1.3
Asian 6.0 6.5 2.5 2.5 1.3 0.9
Two or More Races 19.3 16.0 8.0 5.1 3.1 2.4
Hispanic or Latino 10.7 11.3 4.4 3.9 1.8 1.4
90331
Table 1.55A – Nonmedical Use of Pain Relievers in Lifetime, Past Year, and Past Month among Persons Aged 12 to 17, by Demographic Characteristics: Numbers in Thousands, 2007 and 2008
Demographic Characteristic Lifetime
(2007)
Lifetime
(2008)
Past Year
(2007)
Past Year
(2008)
Past Month
(2007)
Past Month
(2008)
*Low precision; no estimate reported.
a Difference between estimate and 2008 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2008 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2007 and 2008.
TOTAL 2,452 2,346 1,681 1,608 669a 567
GENDER            
Male 1,195a 1,064 816 728 324a 250
Female 1,256 1,282 864 880 345 317
HISPANIC ORIGIN AND RACE            
Not Hispanic or Latino 2,026 1,952 1,405 1,343 566a 482
White 1,592 1,543 1,113 1,067 429 385
Black or African American 317 268 212 173 100a 64
American Indian or Alaska Native 25 17 * 14 * 5
Native Hawaiian or Other Pacific Islander * * * * * *
Asian 47 51 33 35 8 7
Two or More Races 38a 61 22a 43 12 19
Hispanic or Latino 425 394 275 266 104 85
GENDER/RACE/HISPANIC ORIGIN            
Male, White, Not Hispanic 775 684 542 482 219 179
Female, White, Not Hispanic 817 858 571 585 210 206
Male, Black, Not Hispanic 150 141 84 82 37 26
Female, Black, Not Hispanic 167 127 128 90 63a 38
Male, Hispanic 208 186 146 124 46 30
Female, Hispanic 217 207 129 142 57 54
90331
Table 1.55B – Nonmedical Use of Pain Relievers in Lifetime, Past Year, and Past Month among Persons Aged 12 to 17, by Demographic Characteristics: Percentages, 2007 and 2008
Demographic Characteristic Lifetime
(2007)
Lifetime
(2008)
Past Year
(2007)
Past Year
(2008)
Past Month
(2007)
Past Month
(2008)
*Low precision; no estimate reported.
a Difference between estimate and 2008 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2008 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2007 and 2008.
TOTAL 9.7 9.4 6.7 6.5 2.7a 2.3
GENDER            
Male 9.3 8.4 6.3 5.7 2.5a 2.0
Female 10.2 10.5 7.0 7.2 2.8 2.6
HISPANIC ORIGIN AND RACE            
Not Hispanic or Latino 9.8 9.7 6.8 6.7 2.7 2.4
White 10.6 10.5 7.4 7.3 2.8 2.6
Black or African American 8.2 7.1 5.5 4.6 2.6 1.7
American Indian or Alaska Native 15.2 12.8 * 10.4 * 4.0
Native Hawaiian or Other Pacific Islander * * * * * *
Asian 4.6 5.3 3.2 3.7 0.8 0.7
Two or More Races 9.0 12.1 5.3 8.5 2.8 3.8
Hispanic or Latino 9.1 8.3 5.9 5.6 2.2 1.8
GENDER/RACE/HISPANIC ORIGIN            
Male, White, Not Hispanic 10.1 9.1 7.0 6.4 2.8 2.4
Female, White, Not Hispanic 11.1 12.0 7.8 8.2 2.9 2.9
Male, Black, Not Hispanic 7.7 7.4 4.3 4.3 1.9 1.4
Female, Black, Not Hispanic 8.8 6.8 6.7 4.8 3.3a 2.0
Male, Hispanic 8.7 7.7 6.1 5.1 1.9 1.3
Female, Hispanic 9.5 9.0 5.6 6.1 2.5 2.4
90331
Table 1.56A – Nonmedical Use of Pain Relievers in Lifetime, Past Year, and Past Month among Persons Aged 18 to 25, by Demographic Characteristics: Numbers in Thousands, 2007 and 2008
Demographic Characteristic Lifetime
(2007)
Lifetime
(2008)
Past Year
(2007)
Past Year
(2008)
Past Month
(2007)
Past Month
(2008)
*Low precision; no estimate reported.
a Difference between estimate and 2008 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2008 estimate is statistically significant at the 0.01 level.
1 The Other Employment category includes retired persons, disabled persons, homemakers, students, or other persons not in the labor force.
Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2007 and 2008.
TOTAL 8,128 8,042 3,970 3,941 1,517 1,502
GENDER            
Male 4,489 4,397 2,269 2,173 855 833
Female 3,639 3,645 1,701 1,768 663 669
HISPANIC ORIGIN AND RACE            
Not Hispanic or Latino 7,069 7,015 3,458 3,477 1,372 1,345
White 6,061 5,972 2,972 2,916 1,161 1,102
Black or African American 641 660 320 362 135 165
American Indian or Alaska Native * 44 * 21 * 10
Native Hawaiian or Other Pacific Islander 22 * 10 * 3 *
Asian 153 190 48a 97 24 36
Two or More Races 138 119 79 57 28 29
Hispanic or Latino 1,058 1,026 512 464 145 156
EDUCATION            
< High School 1,626 1,557 869 804 378 339
High School Graduate 2,819 2,762 1,441 1,421 579 599
Some College 2,702 2,714 1,334 1,326 450 447
College Graduate 981 1,007 327 390 110 117
CURRENT EMPLOYMENT            
Full-Time 4,098 3,951 1,945 1,853 747 744
Part-Time 1,941 1,874 940 912 371 325
Unemployed 726a 851 381 444 153 170
Other1 1,362 1,365 705 734 247 262
90331
Table 1.56B – Nonmedical Use of Pain Relievers in Lifetime, Past Year, and Past Month among Persons Aged 18 to 25, by Demographic Characteristics: Percentages, 2007 and 2008
Demographic Characteristic Lifetime
(2007)
Lifetime
(2008)
Past Year
(2007)
Past Year
(2008)
Past Month
(2007)
Past Month
(2008)
*Low precision; no estimate reported.
a Difference between estimate and 2008 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2008 estimate is statistically significant at the 0.01 level.
1 The Other Employment category includes retired persons, disabled persons, homemakers, students, or other persons not in the labor force.
Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2007 and 2008.
TOTAL 24.8 24.4 12.1 12.0 4.6 4.6
GENDER            
Male 27.2 26.5 13.8 13.1 5.2 5.0
Female 22.4 22.3 10.5 10.8 4.1 4.1
HISPANIC ORIGIN AND RACE            
Not Hispanic or Latino 26.2 25.8 12.8 12.8 5.1 5.0
White 30.0 29.4 14.7 14.4 5.7 5.4
Black or African American 14.2 14.2 7.1 7.8 3.0 3.5
American Indian or Alaska Native * 25.3 * 12.2 * 5.8
Native Hawaiian or Other Pacific Islander 16.5 * 7.7 * 2.2 *
Asian 10.6 12.7 3.3a 6.5 1.6 2.4
Two or More Races 31.3 28.9 18.0 14.0 6.2 7.1
Hispanic or Latino 18.3 17.7 8.9 8.0 2.5 2.7
EDUCATION            
< High School 26.2 26.5 14.0 13.7 6.1 5.8
High School Graduate 25.3 23.8 12.9 12.2 5.2 5.2
Some College 24.6 25.0 12.2 12.2 4.1 4.1
College Graduate 22.2 22.0 7.4 8.5 2.5 2.6
CURRENT EMPLOYMENT            
Full-Time 26.7 26.4 12.7 12.4 4.9 5.0
Part-Time 23.0 21.9 11.2 10.7 4.4 3.8
Unemployed 27.8 27.8 14.6 14.5 5.9 5.6
Other1 21.4 21.5 11.1 11.6 3.9 4.1
90331
Table 1.57A – Nonmedical Use of Pain Relievers in Lifetime, Past Year, and Past Month among Persons Aged 26 or Older, by Demographic Characteristics: Numbers in Thousands, 2007 and 2008
Demographic Characteristic Lifetime
(2007)
Lifetime
(2008)
Past Year
(2007)
Past Year
(2008)
Past Month
(2007)
Past Month
(2008)
*Low precision; no estimate reported.
a Difference between estimate and 2008 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2008 estimate is statistically significant at the 0.01 level.
1 The Other Employment category includes retired persons, disabled persons, homemakers, students, or other persons not in the labor force.
Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2007 and 2008.
TOTAL 22,481a 24,473 6,815 6,336 2,987 2,678
GENDER            
Male 12,408 13,452 3,805 3,472 1,889a 1,387
Female 10,073 11,022 3,010 2,864 1,098 1,292
HISPANIC ORIGIN AND RACE            
Not Hispanic or Latino 20,285a 21,947 6,083 5,686 2,627 2,422
White 17,640 18,941 5,069 4,804 2,133 2,069
Black or African American 1,696 2,072 657 607 310 254
American Indian or Alaska Native 111 83 35 27 19 12
Native Hawaiian or Other Pacific Islander * * * * * *
Asian 436 457 180 140 104 56
Two or More Races 351 302 118 55 46 24
Hispanic or Latino 2,196 2,526 732 649 361 257
EDUCATION            
< High School 3,117 3,369 1,252a 918 670 441
High School Graduate 6,752a 7,705 2,041 2,062 1,026 830
Some College 6,720 7,139 2,023 1,920 763 926
College Graduate 5,891 6,260 1,498 1,436 528 481
CURRENT EMPLOYMENT            
Full-Time 14,939 16,200 4,375 3,974 1,905a 1,477
Part-Time 2,750 3,112 940 699 417 299
Unemployed 909a 1,208 324a 554 144 245
Other1 3,883 3,953 1,177 1,108 522 657
90331
Table 1.57B – Nonmedical Use of Pain Relievers in Lifetime, Past Year, and Past Month among Persons Aged 26 or Older, by Demographic Characteristics: Percentages, 2007 and 2008
Demographic Characteristic Lifetime
(2007)
Lifetime
(2008)
Past Year
(2007)
Past Year
(2008)
Past Month
(2007)
Past Month
(2008)
*Low precision; no estimate reported.
a Difference between estimate and 2008 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2008 estimate is statistically significant at the 0.01 level.
1 The Other Employment category includes retired persons, disabled persons, homemakers, students, or other persons not in the labor force.
Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2007 and 2008.
TOTAL 11.8a 12.7 3.6 3.3 1.6 1.4
GENDER            
Male 13.7 14.6 4.2 3.8 2.1a 1.5
Female 10.2 11.0 3.0 2.9 1.1 1.3
HISPANIC ORIGIN AND RACE            
Not Hispanic or Latino 12.2a 13.1 3.7 3.4 1.6 1.4
White 13.2 14.1 3.8 3.6 1.6 1.5
Black or African American 8.1 9.8 3.2 2.9 1.5 1.2
American Indian or Alaska Native 11.9 10.7 3.7 3.5 2.1 1.5
Native Hawaiian or Other Pacific Islander * * * * * *
Asian 5.4 5.5 2.2 1.7 1.3 0.7
Two or More Races 18.7 14.4 6.3 2.6 2.4 1.2
Hispanic or Latino 9.2 10.3 3.1 2.6 1.5 1.0
EDUCATION            
< High School 10.4 11.6 4.2 3.1 2.2 1.5
High School Graduate 11.8 13.2 3.6 3.5 1.8 1.4
Some College 14.5 15.4 4.4 4.1 1.6 2.0
College Graduate 10.5 10.8 2.7 2.5 0.9 0.8
CURRENT EMPLOYMENT            
Full-Time 14.1 15.1 4.1 3.7 1.8a 1.4
Part-Time 13.0 14.4 4.5 3.2 2.0 1.4
Unemployed 20.2 20.4 7.2 9.4 3.2 4.1
Other1 6.7 6.9 2.0 1.9 0.9 1.2
90331
Table 1.58A – Nonmedical Use of Pain Relievers in Lifetime, Past Year, and Past Month among Persons Aged 18 or Older, by Demographic Characteristics: Numbers in Thousands, 2007 and 2008
Demographic Characteristic Lifetime
(2007)
Lifetime
(2008)
Past Year
(2007)
Past Year
(2008)
Past Month
(2007)
Past Month
(2008)
*Low precision; no estimate reported.
a Difference between estimate and 2008 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2008 estimate is statistically significant at the 0.01 level.
1 The Other Employment category includes retired persons, disabled persons, homemakers, students, or other persons not in the labor force.
Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2007 and 2008.
TOTAL 30,608a 32,515 10,785 10,277 4,505 4,180
GENDER            
Male 16,897 17,849 6,074 5,645 2,743a 2,219
Female 13,711 14,666 4,711 4,632 1,761 1,961
HISPANIC ORIGIN AND RACE            
Not Hispanic or Latino 27,354a 28,962 9,541 9,164 3,999 3,767
White 23,701 24,913 8,041 7,720 3,294 3,171
Black or African American 2,337 2,732 977 969 445 419
American Indian or Alaska Native 166 126 63 48 41 22
Native Hawaiian or Other Pacific Islander 72 * 34 * * 10
Asian 588 647 228 238 128 92
Two or More Races 489 421 198 112 73 54
Hispanic or Latino 3,254 3,553 1,244 1,113 506 413
EDUCATION            
< High School 4,744 4,927 2,121a 1,722 1,048a 780
High School Graduate 9,571 10,468 3,482 3,483 1,605 1,429
Some College 9,422 9,853 3,357 3,246 1,213 1,373
College Graduate 6,872 7,267 1,825 1,826 639 598
CURRENT EMPLOYMENT            
Full-Time 19,037 20,151 6,320 5,827 2,652 2,221
Part-Time 4,691 4,986 1,880 1,611 787 624
Unemployed 1,635a 2,059 705b 998 297 415
Other1 5,245 5,318 1,882 1,842 769 919
90331
Table 1.58B – Nonmedical Use of Pain Relievers in Lifetime, Past Year, and Past Month among Persons Aged 18 or Older, by Demographic Characteristics: Percentages, 2007 and 2008
Demographic Characteristic Lifetime
(2007)
Lifetime
(2008)
Past Year
(2007)
Past Year
(2008)
Past Month
(2007)
Past Month
(2008)
*Low precision; no estimate reported.
a Difference between estimate and 2008 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2008 estimate is statistically significant at the 0.01 level.
1 The Other Employment category includes retired persons, disabled persons, homemakers, students, or other persons not in the labor force.
Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2007 and 2008.
TOTAL 13.8 14.5 4.8 4.6 2.0 1.9
GENDER            
Male 15.7 16.4 5.7 5.2 2.6a 2.0
Female 11.9 12.6 4.1 4.0 1.5 1.7
HISPANIC ORIGIN AND RACE            
Not Hispanic or Latino 14.2 14.9 4.9 4.7 2.1 1.9
White 15.4 16.1 5.2 5.0 2.1 2.0
Black or African American 9.2 10.6 3.8 3.8 1.8 1.6
American Indian or Alaska Native 15.0 13.3 5.8 5.1 3.7 2.3
Native Hawaiian or Other Pacific Islander 11.4 * 5.4 * * 1.3
Asian 6.1 6.6 2.4 2.4 1.3 0.9
Two or More Races 21.1 16.8 8.5a 4.5 3.2 2.1
Hispanic or Latino 11.0 11.7 4.2 3.7 1.7 1.4
EDUCATION            
< High School 13.1 14.1 5.8 4.9 2.9 2.2
High School Graduate 14.0 14.9 5.1 5.0 2.4 2.0
Some College 16.4 17.2 5.8 5.7 2.1 2.4
College Graduate 11.3 11.6 3.0 2.9 1.1 1.0
CURRENT EMPLOYMENT            
Full-Time 15.7 16.5 5.2 4.8 2.2a 1.8
Part-Time 15.9 16.5 6.4 5.3 2.7 2.1
Unemployed 23.0 22.9 9.9 11.1 4.2 4.6
Other1 8.1 8.4 2.9 2.9 1.2 1.4
120411
Table 1.59A (REVISED) – Illicit Drug Use in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Geographic Characteristics: Numbers in Thousands, 2007 and 2008
Geographic Characteristic Lifetime
(2007)
Lifetime
(2008)
Past Year
(2007)
Past Year
(2008)
Past Month
(2007)
Past Month
(2008)
*Low precision; no estimate reported.
NOTE: This table was revised in May 2012 due to updates (for details, see the introduction to these 2008 detailed tables).
NOTE: Illicit Drugs include marijuana/hashish, cocaine (including crack), heroin, hallucinogens, inhalants, or prescription-type psychotherapeutics used nonmedically, based on data from original questions not including methamphetamine items added in 2005 and 2006.
a Difference between estimate and 2008 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2008 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2007 and 2008.
TOTAL 114,509a 117,815 35,789 35,643 19,892 20,123
GEOGRAPHIC DIVISION            
Northeast 21,018 21,840 6,498 6,310 3,595 3,812
New England 5,975 6,308 1,827 1,859 1,054 1,200
Middle Atlantic 15,044 15,532 4,670 4,451 2,541 2,612
Midwest 26,012 26,107 7,608 7,505 4,303 4,172
East North Central 18,344 18,348 5,574 5,511 3,144 3,136
West North Central 7,668 7,759 2,034 1,994 1,160 1,036
South 39,781 40,988 12,265 12,049 6,649 6,450
South Atlantic 21,451 22,591 6,516 6,676 3,507 3,588
East South Central 6,499 6,117 2,100 1,882 1,190 1,067
West South Central 11,831 12,280 3,649 3,491 1,952 1,796
West 27,698 28,880 9,419 9,779 5,345 5,688
Mountain 8,705 8,742 2,791 2,777 1,617 1,625
Pacific 18,994 20,137 6,628 7,002 3,727 4,063
COUNTY TYPE            
Large Metro 62,848 63,996 19,887 19,965 11,046 11,361
Small Metro 34,396 35,691 10,784 10,708 6,080 6,158
250K - 1 Mil. Pop. 22,910 23,821 7,238 7,102 4,108 4,255
< 250K Pop. 11,486 11,870 3,546 3,606 1,972 1,903
Nonmetro 17,265 18,127 5,118 4,969 2,766 2,605
Urbanized 7,732 8,123 2,427 2,267 1,255 1,237
Less Urbanized 7,882 8,416 2,387 2,325 1,324 1,122
Completely Rural 1,652 1,588 304 377 187 245
120411
Table 1.59B (REVISED) – Illicit Drug Use in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Geographic Characteristics: Percentages, 2007 and 2008
Geographic Characteristic Lifetime
(2007)
Lifetime
(2008)
Past Year
(2007)
Past Year
(2008)
Past Month
(2007)
Past Month
(2008)
*Low precision; no estimate reported.
NOTE: This table was revised in May 2012 due to updates (for details, see the introduction to these 2008 detailed tables).
NOTE: Illicit Drugs include marijuana/hashish, cocaine (including crack), heroin, hallucinogens, inhalants, or prescription-type psychotherapeutics used nonmedically, based on data from original questions not including methamphetamine items added in 2005 and 2006.
a Difference between estimate and 2008 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2008 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2007 and 2008.
TOTAL 46.2 47.2 14.4 14.3 8.0 8.1
GEOGRAPHIC DIVISION            
Northeast 45.8 47.4 14.2 13.7 7.8 8.3
New England 49.7 52.3 15.2 15.4 8.8 10.0
Middle Atlantic 44.4 45.6 13.8 13.1 7.5 7.7
Midwest 47.5 47.5 13.9 13.7 7.9 7.6
East North Central 47.9 47.8 14.6 14.4 8.2 8.2
West North Central 46.5 46.8 12.3 12.0 7.0 6.3
South 44.2 45.1 13.6 13.2 7.4 7.1
South Atlantic 45.1 47.1 13.7 13.9 7.4 7.5
East South Central 44.1 41.2 14.3 12.7 8.1 7.2
West South Central 42.8 43.7 13.2 12.4 7.1 6.4
West 48.4 50.0 16.5 16.9 9.3 9.8
Mountain 50.4 49.7 16.2 15.8 9.4 9.2
Pacific 47.5 50.1 16.6 17.4 9.3 10.1
COUNTY TYPE            
Large Metro 47.4 48.1 15.0 15.0 8.3 8.5
Small Metro 46.4 47.3 14.6 14.2 8.2 8.2
250K - 1 Mil. Pop. 46.2 47.6 14.6 14.2 8.3 8.5
< 250K Pop. 46.8 46.6 14.4 14.2 8.0 7.5
Nonmetro 42.0 43.9 12.5 12.0 6.7 6.3
Urbanized 46.0 47.3 14.4 13.2 7.5 7.2
Less Urbanized 40.1 42.0 12.1 11.6 6.7 5.6
Completely Rural 35.9 39.4 6.6 9.4 4.1 6.1
120411
Table 1.60A (REVISED) – Illicit Drug Use in Lifetime, Past Year, and Past Month among Persons Aged 12 to 17, by Geographic Characteristics: Numbers in Thousands, 2007 and 2008
Geographic Characteristic Lifetime
(2007)
Lifetime
(2008)
Past Year
(2007)
Past Year
(2008)
Past Month
(2007)
Past Month
(2008)
*Low precision; no estimate reported.
NOTE: This table was revised in May 2012 due to updates (for details, see the introduction to these 2008 detailed tables).
NOTE: Illicit Drugs include marijuana/hashish, cocaine (including crack), heroin, hallucinogens, inhalants, or prescription-type psychotherapeutics used nonmedically, based on data from original questions not including methamphetamine items added in 2005 and 2006.
a Difference between estimate and 2008 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2008 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2007 and 2008.
TOTAL 6,638 6,565 4,737 4,751 2,415 2,312
GEOGRAPHIC DIVISION            
Northeast 1,058 1,080 786 822 410 459
New England 324 291 248 220 135 122
Middle Atlantic 734 789 537 602 275a 337
Midwest 1,502a 1,374 1,070 1,015 537 501
East North Central 1,105a 993 783 734 392 375
West North Central 397 381 287 281 145 126
South 2,428 2,365 1,696 1,618 851a 719
South Atlantic 1,234 1,325 844 906 416 405
East South Central 392a 331 267a 215 120 94
West South Central 802 709 585a 497 315b 220
West 1,650 1,746 1,185 1,297 617 633
Mountain 526 554 391 409 203 211
Pacific 1,124 1,193 795 888 414 422
COUNTY TYPE            
Large Metro 3,547 3,425 2,497 2,534 1,300 1,241
Small Metro 1,985 2,064 1,476 1,455 757 746
250K - 1 Mil. Pop. 1,318 1,405 981 1,000 506 495
< 250K Pop. 667 659 495 455 251 252
Nonmetro 1,106 1,075 764 762 358 325
Urbanized 467 491 328 365 173 159
Less Urbanized 544 499 369 344 149 139
Completely Rural 94 85 67 53 37 26
120411
Table 1.60B (REVISED) – Illicit Drug Use in Lifetime, Past Year, and Past Month among Persons Aged 12 to 17, by Geographic Characteristics: Percentages, 2007 and 2008
Geographic Characteristic Lifetime
(2007)
Lifetime
(2008)
Past Year
(2007)
Past Year
(2008)
Past Month
(2007)
Past Month
(2008)
*Low precision; no estimate reported.
NOTE: This table was revised in May 2012 due to updates (for details, see the introduction to these 2008 detailed tables).
NOTE: Illicit Drugs include marijuana/hashish, cocaine (including crack), heroin, hallucinogens, inhalants, or prescription-type psychotherapeutics used nonmedically, based on data from original questions not including methamphetamine items added in 2005 and 2006.
a Difference between estimate and 2008 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2008 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2007 and 2008.
TOTAL 26.3 26.4 18.8 19.1 9.6 9.3
GEOGRAPHIC DIVISION            
Northeast 23.7 24.7 17.6 18.8 9.2 10.5
New England 28.0 25.7 21.5 19.4 11.7 10.8
Middle Atlantic 22.2 24.3 16.3 18.6 8.3a 10.4
Midwest 26.7 24.9 19.1 18.4 9.6 9.1
East North Central 28.0a 25.7 19.9 19.0 9.9 9.7
West North Central 23.7 23.2 17.2 17.1 8.7 7.7
South 26.6 26.1 18.6 17.9 9.3a 7.9
South Atlantic 26.6 29.0 18.2 19.8 9.0 8.9
East South Central 26.4a 22.5 18.0a 14.6 8.1 6.4
West South Central 26.7 23.6 19.5a 16.5 10.5b 7.3
West 27.3 29.3 19.6 21.8 10.2 10.6
Mountain 29.1 30.6 21.6 22.6 11.2 11.7
Pacific 26.6 28.7 18.8 21.4 9.8 10.2
COUNTY TYPE            
Large Metro 25.9 25.8 18.2 19.0 9.5 9.3
Small Metro 26.9 27.9 20.0 19.6 10.3 10.1
250K - 1 Mil. Pop. 26.4 28.7 19.7 20.4 10.2 10.1
< 250K Pop. 27.9 26.3 20.7 18.1 10.5 10.0
Nonmetro 26.5 25.7 18.3 18.2 8.6 7.8
Urbanized 27.2 27.5 19.1 20.4 10.1 8.9
Less Urbanized 26.9 24.8 18.2 17.1 7.4 6.9
Completely Rural 22.0 22.6 15.8 14.1 8.6 6.8
120411
Table 1.61A (REVISED) – Illicit Drug Use in Lifetime, Past Year, and Past Month among Persons Aged 18 to 25, by Geographic Characteristics: Numbers in Thousands, 2007 and 2008
Geographic Characteristic Lifetime
(2007)
Lifetime
(2008)
Past Year
(2007)
Past Year
(2008)
Past Month
(2007)
Past Month
(2008)
*Low precision; no estimate reported.
NOTE: This table was revised in May 2012 due to updates (for details, see the introduction to these 2008 detailed tables).
NOTE: Illicit Drugs include marijuana/hashish, cocaine (including crack), heroin, hallucinogens, inhalants, or prescription-type psychotherapeutics used nonmedically, based on data from original questions not including methamphetamine items added in 2005 and 2006.
a Difference between estimate and 2008 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2008 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2007 and 2008.
TOTAL 18,831 18,772 10,889 11,090 6,475 6,490
GEOGRAPHIC DIVISION            
Northeast 3,399a 3,600 2,090 2,243 1,262a 1,421
New England 1,005 982 663 631 399 407
Middle Atlantic 2,394b 2,618 1,427a 1,611 864a 1,015
Midwest 4,351 4,213 2,437 2,414 1,448 1,370
East North Central 3,082b 2,901 1,767 1,707 1,051 984
West North Central 1,269 1,312 670 707 397 385
South 6,527 6,377 3,650 3,609 2,104 2,064
South Atlantic 3,419 3,276 2,005 1,898 1,173 1,075
East South Central 1,023 970 566 562 346 350
West South Central 2,085 2,131 1,079 1,150 585 638
West 4,554 4,581 2,712 2,824 1,661 1,635
Mountain 1,376 1,452 781 814 492 484
Pacific 3,178 3,129 1,931 2,010 1,169 1,151
COUNTY TYPE            
Large Metro 9,773 10,081 5,775 6,086 3,515 3,584
Small Metro 6,131 5,904 3,520 3,485 2,021 2,045
250K - 1 Mil. Pop. 4,035 3,788 2,345 2,207 1,365 1,294
< 250K Pop. 2,096 2,116 1,175 1,278 656 750
Nonmetro 2,927 2,787 1,594 1,519 939 861
Urbanized 1,333 1,350 758 741 460 404
Less Urbanized 1,405 1,263 726 688 422 399
Completely Rural 190 174 109 90 57 58
120411
Table 1.61B (REVISED) – Illicit Drug Use in Lifetime, Past Year, and Past Month among Persons Aged 18 to 25, by Geographic Characteristics: Percentages, 2007 and 2008
Geographic Characteristic Lifetime
(2007)
Lifetime
(2008)
Past Year
(2007)
Past Year
(2008)
Past Month
(2007)
Past Month
(2008)
*Low precision; no estimate reported.
NOTE: This table was revised in May 2012 due to updates (for details, see the introduction to these 2008 detailed tables).
NOTE: Illicit Drugs include marijuana/hashish, cocaine (including crack), heroin, hallucinogens, inhalants, or prescription-type psychotherapeutics used nonmedically, based on data from original questions not including methamphetamine items added in 2005 and 2006.
a Difference between estimate and 2008 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2008 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2007 and 2008.
TOTAL 57.5 57.0 33.3 33.7 19.8 19.7
GEOGRAPHIC DIVISION            
Northeast 57.6 60.1 35.4 37.5 21.4 23.7
New England 65.8 63.1 43.4 40.6 26.1 26.1
Middle Atlantic 54.7a 59.1 32.6a 36.4 19.7a 22.9
Midwest 59.7 57.9 33.4 33.2 19.9 18.8
East North Central 61.3b 57.6 35.2 33.9 20.9 19.6
West North Central 56.1 58.6 29.6 31.6 17.5 17.2
South 55.8 54.2 31.2 30.7 18.0 17.5
South Atlantic 57.9 54.9 33.9 31.8 19.9 18.0
East South Central 54.7 51.8 30.3 30.0 18.5 18.7
West South Central 53.3 54.3 27.6 29.3 15.0 16.3
West 58.0 57.9 34.5 35.7 21.2 20.7
Mountain 58.4 61.3 33.2 34.3 20.9 20.4
Pacific 57.8 56.5 35.1 36.3 21.3 20.8
COUNTY TYPE            
Large Metro 56.5 56.5 33.4 34.1 20.3 20.1
Small Metro 59.4 58.5 34.1 34.5 19.6 20.2
250K - 1 Mil. Pop. 59.6 57.9 34.6 33.7 20.2 19.8
< 250K Pop. 59.0 59.5 33.1 35.9 18.5 21.1
Nonmetro 57.4 55.8 31.3 30.4 18.4 17.2
Urbanized 58.5 59.1 33.2 32.4 20.2 17.7
Less Urbanized 57.4 53.7 29.7 29.2 17.3 16.9
Completely Rural 51.0 48.9 29.5 25.4 15.3 16.2
120411
Table 1.62A (REVISED) – Illicit Drug Use in Lifetime, Past Year, and Past Month among Persons Aged 26 or Older, by Geographic Characteristics: Numbers in Thousands, 2007 and 2008
Geographic Characteristic Lifetime
(2007)
Lifetime
(2008)
Past Year
(2007)
Past Year
(2008)
Past Month
(2007)
Past Month
(2008)
*Low precision; no estimate reported.
NOTE: This table was revised in May 2012 due to updates (for details, see the introduction to these 2008 detailed tables).
NOTE: Illicit Drugs include marijuana/hashish, cocaine (including crack), heroin, hallucinogens, inhalants, or prescription-type psychotherapeutics used nonmedically, based on data from original questions not including methamphetamine items added in 2005 and 2006.
a Difference between estimate and 2008 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2008 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2007 and 2008.
TOTAL 89,040b 92,478 20,163 19,801 11,001 11,321
GEOGRAPHIC DIVISION            
Northeast 16,561 17,160 3,622 3,245 1,922 1,932
New England 4,645 5,035 916 1,008 520 672
Middle Atlantic 11,916 12,125 2,707 2,237 1,402 1,260
Midwest 20,159 20,520 4,100 4,076 2,318 2,302
East North Central 14,157 14,454 3,024 3,069 1,700 1,777
West North Central 6,002 6,066 1,076 1,006 618 525
South 30,826 32,245 6,919 6,822 3,694 3,668
South Atlantic 16,797 17,991 3,667 3,872 1,918 2,108
East South Central 5,084 4,815 1,267 1,105 724 622
West South Central 8,944 9,440 1,985 1,845 1,052 938
West 21,494 22,552 5,522 5,659 3,067 3,420
Mountain 6,803 6,737 1,619 1,555 923 930
Pacific 14,691 15,815 3,903 4,103 2,144 2,490
COUNTY TYPE            
Large Metro 49,528 50,490 11,614 11,346 6,232 6,535
Small Metro 26,280 27,723 5,789 5,768 3,301 3,367
250K - 1 Mil. Pop. 17,558 18,628 3,912 3,895 2,237 2,466
< 250K Pop. 8,722 9,095 1,876 1,873 1,064 901
Nonmetro 13,232 14,265 2,760 2,688 1,468 1,420
Urbanized 5,932 6,283 1,341 1,160 622 674
Less Urbanized 5,932 6,653 1,292 1,293 753 584
Completely Rural 1,368 1,329 127 234 93 162
120411
Table 1.62B (REVISED) – Illicit Drug Use in Lifetime, Past Year, and Past Month among Persons Aged 26 or Older, by Geographic Characteristics: Percentages, 2007 and 2008
Geographic Characteristic Lifetime
(2007)
Lifetime
(2008)
Past Year
(2007)
Past Year
(2008)
Past Month
(2007)
Past Month
(2008)
*Low precision; no estimate reported.
NOTE: This table was revised in May 2012 due to updates (for details, see the introduction to these 2008 detailed tables).
NOTE: Illicit Drugs include marijuana/hashish, cocaine (including crack), heroin, hallucinogens, inhalants, or prescription-type psychotherapeutics used nonmedically, based on data from original questions not including methamphetamine items added in 2005 and 2006.
a Difference between estimate and 2008 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2008 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2007 and 2008.
TOTAL 46.9 48.2 10.6 10.3 5.8 5.9
GEOGRAPHIC DIVISION            
Northeast 46.6 48.0 10.2 9.1 5.4 5.4
New England 49.7 53.7 9.8 10.8 5.6 7.2
Middle Atlantic 45.5 46.0 10.3 8.5 5.4 4.8
Midwest 48.1 48.7 9.8 9.7 5.5 5.5
East North Central 48.3 49.0 10.3 10.4 5.8 6.0
West North Central 47.8 47.8 8.6 7.9 4.9 4.1
South 44.6 46.0 10.0 9.7 5.3 5.2
South Atlantic 45.4 48.0 9.9 10.3 5.2 5.6
East South Central 44.7 41.8 11.1 9.6 6.4 5.4
West South Central 43.2 44.6 9.6 8.7 5.1 4.4
West 49.6 51.3 12.7 12.9 7.1 7.8
Mountain 51.9 50.2 12.3 11.6 7.0 6.9
Pacific 48.6 51.8 12.9 13.4 7.1 8.2
COUNTY TYPE            
Large Metro 48.7 49.5 11.4 11.1 6.1 6.4
Small Metro 46.6 47.8 10.3 10.0 5.9 5.8
250K - 1 Mil. Pop. 46.4 48.3 10.3 10.1 5.9 6.4
< 250K Pop. 46.9 46.9 10.1 9.6 5.7 4.6
Nonmetro 41.6 44.5 8.7 8.4 4.6 4.4
Urbanized 46.3 48.0 10.5 8.9 4.9 5.1
Less Urbanized 39.0 42.4 8.5 8.2 5.0 3.7
Completely Rural 36.0 40.3 3.3 7.1 2.4 4.9
120411
Table 1.63A (REVISED) – Illicit Drug Use in Lifetime, Past Year, and Past Month among Persons Aged 18 or Older, by Geographic Characteristics: Numbers in Thousands, 2007 and 2008
Geographic Characteristic Lifetime
(2007)
Lifetime
(2008)
Past Year
(2007)
Past Year
(2008)
Past Month
(2007)
Past Month
(2008)
*Low precision; no estimate reported.
NOTE: This table was revised in May 2012 due to updates (for details, see the introduction to these 2008 detailed tables).
NOTE: Illicit Drugs include marijuana/hashish, cocaine (including crack), heroin, hallucinogens, inhalants, or prescription-type psychotherapeutics used nonmedically, based on data from original questions not including methamphetamine items added in 2005 and 2006.
a Difference between estimate and 2008 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2008 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2007 and 2008.
TOTAL 107,871a 111,250 31,052 30,892 17,477 17,811
GEOGRAPHIC DIVISION            
Northeast 19,961 20,760 5,712 5,488 3,184 3,353
New England 5,651 6,017 1,579 1,639 919 1,078
Middle Atlantic 14,310 14,743 4,133 3,848 2,266 2,275
Midwest 24,510 24,733 6,537 6,490 3,767 3,672
East North Central 17,239 17,355 4,791 4,777 2,752 2,761
West North Central 7,271 7,378 1,746 1,714 1,015 911
South 37,353 38,623 10,569 10,431 5,798 5,731
South Atlantic 20,216 21,267 5,671 5,770 3,091 3,183
East South Central 6,107 5,785 1,833 1,667 1,070 973
West South Central 11,029 11,571 3,064 2,994 1,637 1,576
West 26,048 27,133 8,234 8,482 4,728 5,055
Mountain 8,178 8,189 2,400 2,369 1,414 1,414
Pacific 17,870 18,945 5,833 6,114 3,313 3,641
COUNTY TYPE            
Large Metro 59,301 60,571 17,389 17,432 9,746 10,119
Small Metro 32,411 33,627 9,308 9,253 5,323 5,412
250K - 1 Mil. Pop. 21,593 22,416 6,257 6,102 3,602 3,761
< 250K Pop. 10,819 11,211 3,051 3,151 1,721 1,651
Nonmetro 16,159 17,052 4,354 4,207 2,407 2,280
Urbanized 7,264 7,632 2,099 1,901 1,082 1,078
Less Urbanized 7,337 7,917 2,018 1,981 1,176 983
Completely Rural 1,558 1,503 236 324 150 220
120411
Table 1.63B (REVISED) – Illicit Drug Use in Lifetime, Past Year, and Past Month among Persons Aged 18 or Older, by Geographic Characteristics: Percentages, 2007 and 2008
Geographic Characteristic Lifetime
(2007)
Lifetime
(2008)
Past Year
(2007)
Past Year
(2008)
Past Month
(2007)
Past Month
(2008)
*Low precision; no estimate reported.
NOTE: This table was revised in May 2012 due to updates (for details, see the introduction to these 2008 detailed tables).
NOTE: Illicit Drugs include marijuana/hashish, cocaine (including crack), heroin, hallucinogens, inhalants, or prescription-type psychotherapeutics used nonmedically, based on data from original questions not including methamphetamine items added in 2005 and 2006.
a Difference between estimate and 2008 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2008 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2007 and 2008.
TOTAL 48.5 49.5 13.9 13.7 7.9 7.9
GEOGRAPHIC DIVISION            
Northeast 48.2 49.8 13.8 13.2 7.7 8.0
New England 52.0 55.1 14.5 15.0 8.5 9.9
Middle Atlantic 46.8 47.9 13.5 12.5 7.4 7.4
Midwest 49.8 50.0 13.3 13.1 7.7 7.4
East North Central 50.2 50.3 13.9 13.8 8.0 8.0
West North Central 49.0 49.4 11.8 11.5 6.8 6.1
South 46.2 47.2 13.1 12.7 7.2 7.0
South Atlantic 47.1 49.0 13.2 13.3 7.2 7.3
East South Central 46.1 43.2 13.8 12.4 8.1 7.3
West South Central 44.8 46.1 12.4 11.9 6.6 6.3
West 50.9 52.3 16.1 16.4 9.2 9.8
Mountain 52.9 51.9 15.5 15.0 9.1 9.0
Pacific 50.0 52.5 16.3 17.0 9.3 10.1
COUNTY TYPE            
Large Metro 49.8 50.6 14.6 14.6 8.2 8.4
Small Metro 48.6 49.4 14.0 13.6 8.0 8.0
250K - 1 Mil. Pop. 48.4 49.7 14.0 13.5 8.1 8.3
< 250K Pop. 48.8 48.8 13.8 13.7 7.8 7.2
Nonmetro 43.8 46.0 11.8 11.3 6.5 6.2
Urbanized 48.1 49.6 13.9 12.4 7.2 7.0
Less Urbanized 41.6 43.9 11.4 11.0 6.7 5.4
Completely Rural 37.3 41.2 5.7 8.9 3.6 6.0
120411
Table 1.64A (REVISED) – Marijuana Use in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Geographic Characteristics: Numbers in Thousands, 2007 and 2008
Geographic Characteristic Lifetime
(2007)
Lifetime
(2008)
Past Year
(2007)
Past Year
(2008)
Past Month
(2007)
Past Month
(2008)
*Low precision; no estimate reported.
NOTE: This table was revised in May 2012 due to updates (for details, see the introduction to these 2008 detailed tables).
a Difference between estimate and 2008 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2008 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2007 and 2008.
TOTAL 100,737 102,857 25,136 25,891 14,470 15,269
GEOGRAPHIC DIVISION            
Northeast 19,248 19,406 4,833 4,854 2,754 2,910
New England 5,558 5,778 1,475 1,470 863 918
Middle Atlantic 13,690 13,628 3,358 3,384 1,891 1,992
Midwest 23,043 23,071 5,506 5,389 3,224 3,148
East North Central 16,263 16,263 3,975 3,992 2,336 2,364
West North Central 6,780 6,808 1,531 1,397 889 783
South 34,274 35,422 8,228 8,522 4,671 4,825
South Atlantic 18,623 19,814 4,656 4,895 2,651 2,730
East South Central 5,672 5,183 1,292 1,303 744 774
West South Central 9,980 10,426 2,281 2,323 1,275 1,322
West 24,172 24,959 6,569 7,126 3,821 4,386
Mountain 7,585 7,473 1,873 2,001 1,141 1,280
Pacific 16,587 17,486 4,696 5,125 2,679 3,106
COUNTY TYPE            
Large Metro 55,365 55,558 14,119 14,746 8,007 8,661
Small Metro 30,195 31,365 7,583 7,726 4,468 4,651
250K - 1 Mil. Pop. 20,171 20,951 5,093 5,176 3,051 3,144
< 250K Pop. 10,024 10,414 2,490 2,550 1,417 1,507
Nonmetro 15,177 15,934 3,433 3,419 1,994 1,956
Urbanized 6,885 7,221 1,681 1,603 957 923
Less Urbanized 6,910 7,324 1,540 1,512 891 821
Completely Rural 1,382 1,389 212 304 146 213
120411
Table 1.64B (REVISED) – Marijuana Use in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Geographic Characteristics: Percentages, 2007 and 2008
Geographic Characteristic Lifetime
(2007)
Lifetime
(2008)
Past Year
(2007)
Past Year
(2008)
Past Month
(2007)
Past Month
(2008)
*Low precision; no estimate reported.
NOTE: This table was revised in May 2012 due to updates (for details, see the introduction to these 2008 detailed tables).
a Difference between estimate and 2008 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2008 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2007 and 2008.
TOTAL 40.6 41.2 10.1 10.4 5.8 6.1
GEOGRAPHIC DIVISION            
Northeast 42.0 42.1 10.5 10.5 6.0 6.3
New England 46.2 47.9 12.3 12.2 7.2 7.6
Middle Atlantic 40.4 40.0 9.9 9.9 5.6 5.9
Midwest 42.0 42.0 10.0 9.8 5.9 5.7
East North Central 42.5 42.4 10.4 10.4 6.1 6.2
West North Central 41.1 41.1 9.3 8.4 5.4 4.7
South 38.1 38.9 9.1 9.4 5.2 5.3
South Atlantic 39.1 41.3 9.8 10.2 5.6 5.7
East South Central 38.5 34.9 8.8 8.8 5.1 5.2
West South Central 36.1 37.1 8.3 8.3 4.6 4.7
West 42.2 43.2 11.5 12.3 6.7 7.6
Mountain 43.9 42.5 10.8 11.4 6.6 7.3
Pacific 41.5 43.5 11.8 12.7 6.7 7.7
COUNTY TYPE            
Large Metro 41.7 41.7 10.6 11.1 6.0 6.5
Small Metro 40.8 41.6 10.2 10.2 6.0 6.2
250K - 1 Mil. Pop. 40.7 41.9 10.3 10.4 6.2 6.3
< 250K Pop. 40.8 40.9 10.1 10.0 5.8 5.9
Nonmetro 36.9 38.6 8.4 8.3 4.9 4.7
Urbanized 41.0 42.1 10.0 9.3 5.7 5.4
Less Urbanized 35.1 36.5 7.8 7.5 4.5 4.1
Completely Rural 30.0 34.5 4.6 7.6 3.2 5.3
120411
Table 1.65A (REVISED) – Marijuana Use in Lifetime, Past Year, and Past Month among Persons Aged 12 to 17, by Geographic Characteristics: Numbers in Thousands, 2007 and 2008
Geographic Characteristic Lifetime
(2007)
Lifetime
(2008)
Past Year
(2007)
Past Year
(2008)
Past Month
(2007)
Past Month
(2008)
*Low precision; no estimate reported.
NOTE: This table was revised in May 2012 due to updates (for details, see the introduction to these 2008 detailed tables).
a Difference between estimate and 2008 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2008 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2007 and 2008.
TOTAL 4,096 4,138 3,158 3,258 1,693 1,668
GEOGRAPHIC DIVISION            
Northeast 707 724 591 614 328 367
New England 235 208 193 176 113 106
Middle Atlantic 472 516 398 438 215 261
Midwest 929 876 727 689 388 362
East North Central 696 639 534 500 286 273
West North Central 233 236 193 189 102 89
South 1,450 1,399 1,071 1,048 565a 476
South Atlantic 723 814 534a 636 290 273
East South Central 249a 194 179b 127 79 58
West South Central 478a 390 358a 284 195a 145
West 1,010 1,139 769a 907 412 462
Mountain 324 354 251 291 130 154
Pacific 686 785 518 616 283 309
COUNTY TYPE            
Large Metro 2,180 2,180 1,669 1,761 934 899
Small Metro 1,245 1,328 974 1,032 513 554
250K - 1 Mil. Pop. 832 922 656 717 355 371
< 250K Pop. 413 406 318 315 158 183
Nonmetro 671 630 515 464 246 215
Urbanized 297 310 238 230 127 110
Less Urbanized 330 273 240 203 99 92
Completely Rural 44 46 36 31 20 13
120411
Table 1.65B (REVISED) – Marijuana Use in Lifetime, Past Year, and Past Month among Persons Aged 12 to 17, by Geographic Characteristics: Percentages, 2007 and 2008
Geographic Characteristic Lifetime
(2007)
Lifetime
(2008)
Past Year
(2007)
Past Year
(2008)
Past Month
(2007)
Past Month
(2008)
*Low precision; no estimate reported.
NOTE: This table was revised in May 2012 due to updates (for details, see the introduction to these 2008 detailed tables).
a Difference between estimate and 2008 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2008 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2007 and 2008.
TOTAL 16.2 16.6 12.5 13.1 6.7 6.7
GEOGRAPHIC DIVISION            
Northeast 15.9 16.5 13.2 14.0 7.4 8.4
New England 20.3 18.4 16.7 15.6 9.8 9.4
Middle Atlantic 14.3 15.9 12.1 13.5 6.5a 8.1
Midwest 16.6 15.9 12.9 12.5 6.9 6.6
East North Central 17.7 16.5 13.5 12.9 7.3 7.1
West North Central 14.0 14.4 11.6 11.5 6.1 5.4
South 15.9 15.5 11.7 11.6 6.2 5.3
South Atlantic 15.6 17.8 11.5a 13.9 6.3 6.0
East South Central 16.8a 13.2 12.0b 8.6 5.3 3.9
West South Central 15.9a 13.0 11.9a 9.5 6.5a 4.8
West 16.7a 19.1 12.7a 15.2 6.8 7.8
Mountain 17.9 19.6 13.9 16.1 7.2 8.5
Pacific 16.2 18.9 12.2a 14.8 6.7 7.4
COUNTY TYPE            
Large Metro 15.9 16.4 12.2 13.2 6.8 6.8
Small Metro 16.9 17.9 13.2 13.9 7.0 7.5
250K - 1 Mil. Pop. 16.7a 18.8 13.2 14.6 7.1 7.6
< 250K Pop. 17.2 16.2 13.3 12.6 6.6 7.3
Nonmetro 16.1 15.1 12.3 11.1 5.9 5.1
Urbanized 17.3 17.3 13.9 12.9 7.4 6.1
Less Urbanized 16.3a 13.5 11.9 10.1 4.9 4.6
Completely Rural 10.3 12.3 8.5 8.3 4.8 3.5
120411
Table 1.66A (REVISED) – Marijuana Use in Lifetime, Past Year, and Past Month among Persons Aged 18 to 25, by Geographic Characteristics: Numbers in Thousands, 2007 and 2008
Geographic Characteristic Lifetime
(2007)
Lifetime
(2008)
Past Year
(2007)
Past Year
(2008)
Past Month
(2007)
Past Month
(2008)
*Low precision; no estimate reported.
NOTE: This table was revised in May 2012 due to updates (for details, see the introduction to these 2008 detailed tables).
a Difference between estimate and 2008 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2008 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2007 and 2008.
TOTAL 16,652 16,718 9,008 9,154 5,392 5,459
GEOGRAPHIC DIVISION            
Northeast 3,138 3,311 1,841 1,951 1,109 1,246
New England 933 922 586 568 350 365
Middle Atlantic 2,205a 2,389 1,254 1,383 759a 881
Midwest 3,920 3,789 2,089 1,994 1,232 1,176
East North Central 2,775a 2,617 1,494 1,410 881 824
West North Central 1,145 1,172 595 584 351 352
South 5,630 5,517 2,848 2,841 1,677 1,671
South Atlantic 2,986 2,881 1,624 1,543 985 883
East South Central 867 834 422 449 257 289
West South Central 1,776 1,803 803 849 435 498
West 3,964 4,101 2,230 2,369 1,374 1,367
Mountain 1,218 1,279 615 665 394 396
Pacific 2,747 2,821 1,615 1,704 980 971
COUNTY TYPE            
Large Metro 8,666 8,968 4,854 5,090 2,929 3,051
Small Metro 5,400 5,275 2,883 2,845 1,701 1,702
250K - 1 Mil. Pop. 3,564 3,390 1,910 1,807 1,155 1,058
< 250K Pop. 1,836 1,885 973 1,038 546 645
Nonmetro 2,587 2,475 1,271 1,219 762 706
Urbanized 1,202 1,229 620 615 380 341
Less Urbanized 1,227 1,084 576 529 339 313
Completely Rural 157 162 76 76 43 53
120411
Table 1.66B (REVISED) – Marijuana Use in Lifetime, Past Year, and Past Month among Persons Aged 18 to 25, by Geographic Characteristics: Percentages, 2007 and 2008
Geographic Characteristic Lifetime
(2007)
Lifetime
(2008)
Past Year
(2007)
Past Year
(2008)
Past Month
(2007)
Past Month
(2008)
*Low precision; no estimate reported.
NOTE: This table was revised in May 2012 due to updates (for details, see the introduction to these 2008 detailed tables).
a Difference between estimate and 2008 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2008 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2007 and 2008.
TOTAL 50.9 50.8 27.5 27.8 16.5 16.6
GEOGRAPHIC DIVISION            
Northeast 53.2 55.3 31.2 32.6 18.8 20.8
New England 61.1 59.2 38.4 36.5 22.9 23.5
Middle Atlantic 50.4 53.9 28.7 31.2 17.3 19.9
Midwest 53.8 52.1 28.7 27.4 16.9 16.2
East North Central 55.2b 52.0 29.7 28.0 17.5 16.4
West North Central 50.6 52.3 26.3 26.0 15.5 15.7
South 48.2 46.9 24.4 24.1 14.4 14.2
South Atlantic 50.6 48.3 27.5 25.9 16.7 14.8
East South Central 46.4 44.5 22.6 23.9 13.8 15.4
West South Central 45.4 45.9 20.5 21.6 11.1 12.7
West 50.5 51.8 28.4 29.9 17.5 17.3
Mountain 51.7 54.0 26.1 28.1 16.7 16.7
Pacific 50.0 50.9 29.4 30.7 17.8 17.5
COUNTY TYPE            
Large Metro 50.1 50.3 28.0 28.5 16.9 17.1
Small Metro 52.3 52.2 27.9 28.2 16.5 16.9
250K - 1 Mil. Pop. 52.7 51.8 28.2 27.6 17.1 16.2
< 250K Pop. 51.7 53.0 27.4 29.2 15.4 18.1
Nonmetro 50.7 49.6 24.9 24.4 14.9 14.1
Urbanized 52.7 53.8 27.2 26.9 16.7 14.9
Less Urbanized 50.2 46.0 23.5 22.5 13.8 13.3
Completely Rural 42.4 45.7 20.4 21.3 11.6 14.8
120411
Table 1.67A (REVISED) – Marijuana Use in Lifetime, Past Year, and Past Month among Persons Aged 26 or Older, by Geographic Characteristics: Numbers in Thousands, 2007 and 2008
Geographic Characteristic Lifetime
(2007)
Lifetime
(2008)
Past Year
(2007)
Past Year
(2008)
Past Month
(2007)
Past Month
(2008)
*Low precision; no estimate reported.
NOTE: This table was revised in May 2012 due to updates (for details, see the introduction to these 2008 detailed tables).
a Difference between estimate and 2008 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2008 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2007 and 2008.
TOTAL 79,988 82,001 12,970 13,479 7,385 8,142
GEOGRAPHIC DIVISION            
Northeast 15,403 15,371 2,401 2,289 1,317 1,297
New England 4,390 4,648 695 726 400 447
Middle Atlantic 11,013 10,723 1,706 1,563 917 850
Midwest 18,193 18,406 2,690 2,706 1,604 1,610
East North Central 12,792 13,006 1,948 2,082 1,168 1,267
West North Central 5,401 5,400 742 625 436 343
South 27,195 28,506 4,309 4,633 2,429 2,678
South Atlantic 14,913a 16,119 2,498 2,716 1,376 1,574
East South Central 4,556 4,154 691 727 408 427
West South Central 7,725 8,233 1,120 1,190 645 678
West 19,197 19,719 3,570 3,850 2,034 2,557
Mountain 6,043 5,839 1,007 1,045 617 731
Pacific 13,154 13,879 2,562 2,806 1,417 1,826
COUNTY TYPE            
Large Metro 44,520 44,410 7,596 7,894 4,145 4,710
Small Metro 23,549 24,762 3,726 3,849 2,253 2,396
250K - 1 Mil. Pop. 15,774 16,638 2,527 2,652 1,540 1,715
< 250K Pop. 7,775 8,123 1,199 1,197 713 680
Nonmetro 11,919 12,830 1,647 1,736 987 1,036
Urbanized 5,386 5,682 824 758 451 473
Less Urbanized 5,353 5,967 724 780 453 416
Completely Rural 1,180 1,180 100 198 83 147
120411
Table 1.67B (REVISED) – Marijuana Use in Lifetime, Past Year, and Past Month among Persons Aged 26 or Older, by Geographic Characteristics: Percentages, 2007 and 2008
Geographic Characteristic Lifetime
(2007)
Lifetime
(2008)
Past Year
(2007)
Past Year
(2008)
Past Month
(2007)
Past Month
(2008)
*Low precision; no estimate reported.
NOTE: This table was revised in May 2012 due to updates (for details, see the introduction to these 2008 detailed tables).
a Difference between estimate and 2008 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2008 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2007 and 2008.
TOTAL 42.1 42.7 6.8 7.0 3.9 4.2
GEOGRAPHIC DIVISION            
Northeast 43.4 43.0 6.8 6.4 3.7 3.6
New England 47.0 49.6 7.4 7.7 4.3 4.8
Middle Atlantic 42.1 40.7 6.5 5.9 3.5 3.2
Midwest 43.4 43.6 6.4 6.4 3.8 3.8
East North Central 43.6 44.1 6.6 7.1 4.0 4.3
West North Central 43.0 42.5 5.9 4.9 3.5 2.7
South 39.3 40.6 6.2 6.6 3.5 3.8
South Atlantic 40.3 43.0 6.7 7.2 3.7 4.2
East South Central 40.0 36.1 6.1 6.3 3.6 3.7
West South Central 37.3 38.9 5.4 5.6 3.1 3.2
West 44.3 44.9 8.2 8.8 4.7 5.8
Mountain 46.1 43.5 7.7 7.8 4.7 5.4
Pacific 43.5 45.5 8.5 9.2 4.7 6.0
COUNTY TYPE            
Large Metro 43.8 43.6 7.5 7.7 4.1 4.6
Small Metro 41.8 42.7 6.6 6.6 4.0 4.1
250K - 1 Mil. Pop. 41.7 43.2 6.7 6.9 4.1 4.4
< 250K Pop. 41.8 41.8 6.5 6.2 3.8 3.5
Nonmetro 37.5 40.0 5.2 5.4 3.1 3.2
Urbanized 42.0 43.4 6.4 5.8 3.5 3.6
Less Urbanized 35.2 38.0 4.8 5.0 3.0 2.7
Completely Rural 31.1 35.8 2.6 6.0 2.2 4.5
120411
Table 1.68A (REVISED) – Marijuana Use in Lifetime, Past Year, and Past Month among Persons Aged 18 or Older, by Geographic Characteristics: Numbers in Thousands, 2007 and 2008
Geographic Characteristic Lifetime
(2007)
Lifetime
(2008)
Past Year
(2007)
Past Year
(2008)
Past Month
(2007)
Past Month
(2008)
*Low precision; no estimate reported.
NOTE: This table was revised in May 2012 due to updates (for details, see the introduction to these 2008 detailed tables).
a Difference between estimate and 2008 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2008 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2007 and 2008.
TOTAL 96,641 98,720 21,978 22,633 12,777 13,601
GEOGRAPHIC DIVISION            
Northeast 18,541 18,682 4,242 4,240 2,426 2,543
New England 5,323 5,570 1,282 1,294 751 812
Middle Atlantic 13,218 13,112 2,960 2,946 1,676 1,731
Midwest 22,113 22,195 4,779 4,700 2,836 2,786
East North Central 15,567 15,623 3,442 3,492 2,049 2,091
West North Central 6,547 6,572 1,337 1,208 787 694
South 32,824 34,023 7,157 7,474 4,106 4,349
South Atlantic 17,900 18,999 4,121 4,259 2,361 2,457
East South Central 5,423 4,988 1,113 1,176 665 716
West South Central 9,501 10,035 1,923 2,039 1,080 1,177
West 23,162 23,819 5,800 6,219 3,408 3,924
Mountain 7,261 7,119 1,622 1,710 1,011 1,126
Pacific 15,901 16,701 4,177 4,509 2,397 2,797
COUNTY TYPE            
Large Metro 53,185 53,378 12,450 12,984 7,074 7,762
Small Metro 28,949 30,037 6,609 6,694 3,954 4,098
250K - 1 Mil. Pop. 19,339 20,029 4,437 4,459 2,696 2,773
< 250K Pop. 9,611 10,008 2,172 2,235 1,259 1,325
Nonmetro 14,506 15,304 2,919 2,955 1,748 1,742
Urbanized 6,588 6,911 1,443 1,373 831 814
Less Urbanized 6,580 7,051 1,300 1,309 792 729
Completely Rural 1,338 1,343 176 273 126 200
120411
Table 1.68B (REVISED) – Marijuana Use in Lifetime, Past Year, and Past Month among Persons Aged 18 or Older, by Geographic Characteristics: Percentages, 2007 and 2008
Geographic Characteristic Lifetime
(2007)
Lifetime
(2008)
Past Year
(2007)
Past Year
(2008)
Past Month
(2007)
Past Month
(2008)
*Low precision; no estimate reported.
NOTE: This table was revised in May 2012 due to updates (for details, see the introduction to these 2008 detailed tables).
a Difference between estimate and 2008 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2008 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2007 and 2008.
TOTAL 43.4 43.9 9.9 10.1 5.7 6.0
GEOGRAPHIC DIVISION            
Northeast 44.8 44.8 10.2 10.2 5.9 6.1
New England 49.0 51.0 11.8 11.8 6.9 7.4
Middle Atlantic 43.3 42.6 9.7 9.6 5.5 5.6
Midwest 45.0 44.9 9.7 9.5 5.8 5.6
East North Central 45.3 45.3 10.0 10.1 6.0 6.1
West North Central 44.2 44.0 9.0 8.1 5.3 4.6
South 40.6 41.5 8.9 9.1 5.1 5.3
South Atlantic 41.7 43.7 9.6 9.8 5.5 5.7
East South Central 40.9 37.2 8.4 8.8 5.0 5.3
West South Central 38.6 40.0 7.8 8.1 4.4 4.7
West 45.2 45.9 11.3 12.0 6.7 7.6
Mountain 46.9 45.1 10.5 10.8 6.5 7.1
Pacific 44.5 46.3 11.7 12.5 6.7 7.8
COUNTY TYPE            
Large Metro 44.7 44.6 10.5 10.8 5.9 6.5
Small Metro 43.4 44.1 9.9 9.8 5.9 6.0
250K - 1 Mil. Pop. 43.4 44.4 10.0 9.9 6.0 6.1
< 250K Pop. 43.4 43.6 9.8 9.7 5.7 5.8
Nonmetro 39.3 41.3 7.9 8.0 4.7 4.7
Urbanized 43.7 44.9 9.6 8.9 5.5 5.3
Less Urbanized 37.3 39.1 7.4 7.3 4.5 4.0
Completely Rural 32.1 36.8 4.2 7.5 3.0 5.5
120411
Table 1.69A (REVISED) – Cocaine Use in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Geographic Characteristics: Numbers in Thousands, 2007 and 2008
Geographic Characteristic Lifetime
(2007)
Lifetime
(2008)
Past Year
(2007)
Past Year
(2008)
Past Month
(2007)
Past Month
(2008)
*Low precision; no estimate reported.
NOTE: This table was revised in May 2012 due to updates (for details, see the introduction to these 2008 detailed tables).
a Difference between estimate and 2008 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2008 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2007 and 2008.
TOTAL 35,947 36,916 5,748 5,283 2,077 1,865
GEOGRAPHIC DIVISION            
Northeast 6,562 6,796 973 1,074 403 456
New England 1,841 2,167 276 254 83 93
Middle Atlantic 4,721 4,629 697 821 320 363
Midwest 7,049 7,477 1,147 1,105 371 374
East North Central 4,928 5,255 874 821 298 284
West North Central 2,121 2,222 273 284 73 90
South 11,843 12,261 2,120a 1,727 741 608
South Atlantic 6,779 7,168 1,234 946 434 324
East South Central 1,825 1,656 287 231 91 57
West South Central 3,239 3,437 599 550 216 228
West 10,493 10,382 1,507 1,377 562 427
Mountain 3,223 3,342 552 419 225 122
Pacific 7,269 7,040 955 958 337 304
COUNTY TYPE            
Large Metro 20,385 20,524 3,184 2,995 1,136 1,117
Small Metro 10,565 11,132 1,754 1,640 716 557
250K - 1 Mil. Pop. 7,345 7,609 1,300 1,081 547 422
< 250K Pop. 3,220 3,522 454 559 169 135
Nonmetro 4,997 5,260 810 648 225 191
Urbanized 2,353 2,298 426 306 121 98
Less Urbanized 2,294 2,471 347 307 86 79
Completely Rural 350 491 37 34 18 14
120411
Table 1.69B (REVISED) – Cocaine Use in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Geographic Characteristics: Percentages, 2007 and 2008
Geographic Characteristic Lifetime
(2007)
Lifetime
(2008)
Past Year
(2007)
Past Year
(2008)
Past Month
(2007)
Past Month
(2008)
*Low precision; no estimate reported.
NOTE: This table was revised in May 2012 due to updates (for details, see the introduction to these 2008 detailed tables).
a Difference between estimate and 2008 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2008 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2007 and 2008.
TOTAL 14.5 14.8 2.3 2.1 0.8 0.7
GEOGRAPHIC DIVISION            
Northeast 14.3 14.7 2.1 2.3 0.9 1.0
New England 15.3 18.0 2.3 2.1 0.7 0.8
Middle Atlantic 13.9 13.6 2.1 2.4 0.9 1.1
Midwest 12.9 13.6 2.1 2.0 0.7 0.7
East North Central 12.9 13.7 2.3 2.1 0.8 0.7
West North Central 12.9 13.4 1.7 1.7 0.4 0.5
South 13.2 13.5 2.4a 1.9 0.8 0.7
South Atlantic 14.2 14.9 2.6 2.0 0.9 0.7
East South Central 12.4 11.1 1.9 1.6 0.6 0.4
West South Central 11.7 12.2 2.2 2.0 0.8 0.8
West 18.3 18.0 2.6 2.4 1.0 0.7
Mountain 18.7 19.0 3.2 2.4 1.3 0.7
Pacific 18.2 17.5 2.4 2.4 0.8 0.8
COUNTY TYPE            
Large Metro 15.4 15.4 2.4 2.3 0.9 0.8
Small Metro 14.3 14.7 2.4 2.2 1.0 0.7
250K - 1 Mil. Pop. 14.8 15.2 2.6 2.2 1.1 0.8
< 250K Pop. 13.1 13.8 1.8 2.2 0.7 0.5
Nonmetro 12.2 12.8 2.0 1.6 0.5 0.5
Urbanized 14.0 13.4 2.5 1.8 0.7 0.6
Less Urbanized 11.7 12.3 1.8 1.5 0.4 0.4
Completely Rural 7.6 12.2 0.8 0.9 0.4 0.3
120411
Table 1.70A (REVISED) – Cocaine Use in Lifetime, Past Year, and Past Month among Persons Aged 12 to 17, by Geographic Characteristics: Numbers in Thousands, 2007 and 2008
Geographic Characteristic Lifetime
(2007)
Lifetime
(2008)
Past Year
(2007)
Past Year
(2008)
Past Month
(2007)
Past Month
(2008)
*Low precision; no estimate reported.
NOTE: This table was revised in May 2012 due to updates (for details, see the introduction to these 2008 detailed tables).
a Difference between estimate and 2008 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2008 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2007 and 2008.
TOTAL 544 473 385a 306 104 98
GEOGRAPHIC DIVISION            
Northeast 63 64 52 46 19 17
New England 22 18 15 15 5 5
Middle Atlantic 41 46 37 30 13 11
Midwest 115 98 74 66 24 20
East North Central 78 64 47 46 16 15
West North Central 37 34 27 20 8 4
South 195 163 144b 91 36 29
South Atlantic 72 90 52 44 11 12
East South Central 32 13 23a 6 5 2
West South Central 91 60 69 42 19 16
West 171 147 115 103 27 32
Mountain 74 64 53 41 14 19
Pacific 97 83 62 62 12 13
COUNTY TYPE            
Large Metro 290 246 211 167 56 42
Small Metro 160 164 109 105 34 44
250K - 1 Mil. Pop. 109 101 74 75 21 38
< 250K Pop. 50 63 35 30 13 6
Nonmetro 95a 63 66b 34 14 12
Urbanized 47 28 35a 16 9 6
Less Urbanized 41 29 26 15 4 5
Completely Rural 7 6 5 3 1 1
120411
Table 1.70B (REVISED) – Cocaine Use in Lifetime, Past Year, and Past Month among Persons Aged 12 to 17, by Geographic Characteristics: Percentages, 2007 and 2008
Geographic Characteristic Lifetime
(2007)
Lifetime
(2008)
Past Year
(2007)
Past Year
(2008)
Past Month
(2007)
Past Month
(2008)
*Low precision; no estimate reported.
NOTE: This table was revised in May 2012 due to updates (for details, see the introduction to these 2008 detailed tables).
a Difference between estimate and 2008 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2008 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2007 and 2008.
TOTAL 2.2 1.9 1.5a 1.2 0.4 0.4
GEOGRAPHIC DIVISION            
Northeast 1.4 1.5 1.2 1.0 0.4 0.4
New England 1.9 1.6 1.3 1.4 0.5 0.5
Middle Atlantic 1.2 1.4 1.1 0.9 0.4 0.3
Midwest 2.1 1.8 1.3 1.2 0.4 0.4
East North Central 2.0 1.7 1.2 1.2 0.4 0.4
West North Central 2.2 2.1 1.6 1.2 0.5 0.3
South 2.1 1.8 1.6a 1.0 0.4 0.3
South Atlantic 1.6 2.0 1.1 1.0 0.2 0.3
East South Central 2.1 0.9 1.6a 0.4 0.3 0.1
West South Central 3.0 2.0 2.3 1.4 0.6 0.5
West 2.8 2.5 1.9 1.7 0.4 0.5
Mountain 4.1 3.5 2.9 2.3 0.8 1.1
Pacific 2.3 2.0 1.5 1.5 0.3 0.3
COUNTY TYPE            
Large Metro 2.1 1.8 1.5 1.3 0.4 0.3
Small Metro 2.2 2.2 1.5 1.4 0.5 0.6
250K - 1 Mil. Pop. 2.2 2.1 1.5 1.5 0.4 0.8
< 250K Pop. 2.1 2.5 1.5 1.2 0.5 0.2
Nonmetro 2.3a 1.5 1.6b 0.8 0.3 0.3
Urbanized 2.7a 1.6 2.0a 0.9 0.5 0.3
Less Urbanized 2.0 1.4 1.3 0.8 0.2 0.3
Completely Rural 1.6 1.6 1.1 0.7 0.1 0.2
120411
Table 1.71A (REVISED) – Cocaine Use in Lifetime, Past Year, and Past Month among Persons Aged 18 to 25, by Geographic Characteristics: Numbers in Thousands, 2007 and 2008
Geographic Characteristic Lifetime
(2007)
Lifetime
(2008)
Past Year
(2007)
Past Year
(2008)
Past Month
(2007)
Past Month
(2008)
*Low precision; no estimate reported.
NOTE: This table was revised in May 2012 due to updates (for details, see the introduction to these 2008 detailed tables).
a Difference between estimate and 2008 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2008 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2007 and 2008.
TOTAL 4,925 4,772 2,087a 1,844 572 515
GEOGRAPHIC DIVISION            
Northeast 871 859 403 367 129 136
New England 283 257 131 102 35 23
Middle Atlantic 588 602 273 265 94 113
Midwest 1,069 1,074 439 398 111 94
East North Central 747 720 324 277 86 73
West North Central 322 355 115 121 25 21
South 1,689a 1,492 689a 545 161 152
South Atlantic 849 741 401b 273 100 80
East South Central 278a 216 106 78 23 22
West South Central 562 535 182 193 37 50
West 1,297 1,347 556 534 172 133
Mountain 437 513 197 180 57 51
Pacific 859 834 359 353 114 82
COUNTY TYPE            
Large Metro 2,454 2,396 1,071 994 296 294
Small Metro 1,676 1,643 694 608 188 160
250K - 1 Mil. Pop. 1,141 1,070 499a 380 141 114
< 250K Pop. 535 573 195 229 47 47
Nonmetro 795 734 323a 241 88 60
Urbanized 351 341 142 111 39 26
Less Urbanized 384 348 158 120 40 31
Completely Rural 60 44 23 10 10 3
120411
Table 1.71B (REVISED) – Cocaine Use in Lifetime, Past Year, and Past Month among Persons Aged 18 to 25, by Geographic Characteristics: Percentages, 2007 and 2008
Geographic Characteristic Lifetime
(2007)
Lifetime
(2008)
Past Year
(2007)
Past Year
(2008)
Past Month
(2007)
Past Month
(2008)
*Low precision; no estimate reported.
NOTE: This table was revised in May 2012 due to updates (for details, see the introduction to these 2008 detailed tables).
a Difference between estimate and 2008 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2008 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2007 and 2008.
TOTAL 15.0 14.5 6.4a 5.6 1.7 1.6
GEOGRAPHIC DIVISION            
Northeast 14.8 14.4 6.8 6.1 2.2 2.3
New England 18.5 16.5 8.5 6.6 2.3 1.5
Middle Atlantic 13.4 13.6 6.2 6.0 2.1 2.5
Midwest 14.7 14.8 6.0 5.5 1.5 1.3
East North Central 14.9 14.3 6.4 5.5 1.7 1.4
West North Central 14.2 15.8 5.1 5.4 1.1 0.9
South 14.5a 12.7 5.9a 4.6 1.4 1.3
South Atlantic 14.4 12.4 6.8b 4.6 1.7 1.3
East South Central 14.9a 11.5 5.7 4.2 1.2 1.2
West South Central 14.4 13.6 4.6 4.9 1.0 1.3
West 16.5 17.0 7.1 6.7 2.2 1.7
Mountain 18.6 21.7 8.4 7.6 2.4 2.2
Pacific 15.6 15.0 6.5 6.4 2.1 1.5
COUNTY TYPE            
Large Metro 14.2 13.4 6.2 5.6 1.7 1.6
Small Metro 16.2 16.3 6.7 6.0 1.8 1.6
250K - 1 Mil. Pop. 16.9 16.4 7.4a 5.8 2.1 1.7
< 250K Pop. 15.1 16.1 5.5 6.4 1.3 1.3
Nonmetro 15.6 14.7 6.3a 4.8 1.7 1.2
Urbanized 15.4 14.9 6.2 4.9 1.7 1.1
Less Urbanized 15.7 14.8 6.4 5.1 1.6 1.3
Completely Rural 16.0 12.5 6.2 2.9 2.6 0.8
120411
Table 1.72A (REVISED) – Cocaine Use in Lifetime, Past Year, and Past Month among Persons Aged 26 or Older, by Geographic Characteristics: Numbers in Thousands, 2007 and 2008
Geographic Characteristic Lifetime
(2007)
Lifetime
(2008)
Past Year
(2007)
Past Year
(2008)
Past Month
(2007)
Past Month
(2008)
*Low precision; no estimate reported.
NOTE: This table was revised in May 2012 due to updates (for details, see the introduction to these 2008 detailed tables).
a Difference between estimate and 2008 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2008 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2007 and 2008.
TOTAL 30,477 31,671 3,275 3,133 1,400 1,252
GEOGRAPHIC DIVISION            
Northeast 5,628 5,872 518 661 255 304
New England 1,536a 1,892 131 136 43 64
Middle Atlantic 4,092 3,980 387 525 213 240
Midwest 5,865 6,305 634 640 236 261
East North Central 4,103 4,472 503 497 196 196
West North Central 1,762 1,833 131 143 40 65
South 9,959 10,606 1,287 1,091 545 427
South Atlantic 5,858 6,337 781 629 323 232
East South Central 1,515 1,427 157 147 62 33
West South Central 2,586 2,841 348 315 160 162
West 9,025 8,889 836 740 364 262
Mountain 2,713 2,765 302 198 153 52
Pacific 6,313 6,123 535 543 211 210
COUNTY TYPE            
Large Metro 17,641 17,882 1,902 1,833 783 781
Small Metro 8,729 9,325 951 927 494 352
250K - 1 Mil. Pop. 6,095 6,439 727 627 385 270
< 250K Pop. 2,634 2,886 224 300 109 82
Nonmetro 4,107 4,464 421 372 123 119
Urbanized 1,955 1,929 249 179 73 66
Less Urbanized 1,869 2,094 163 173 42 43
Completely Rural 284 441 9 21 8 11
120411
Table 1.72B (REVISED) – Cocaine Use in Lifetime, Past Year, and Past Month among Persons Aged 26 or Older, by Geographic Characteristics: Percentages, 2007 and 2008
Geographic Characteristic Lifetime
(2007)
Lifetime
(2008)
Past Year
(2007)
Past Year
(2008)
Past Month
(2007)
Past Month
(2008)
*Low precision; no estimate reported.
NOTE: This table was revised in May 2012 due to updates (for details, see the introduction to these 2008 detailed tables).
a Difference between estimate and 2008 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2008 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2007 and 2008.
TOTAL 16.1 16.5 1.7 1.6 0.7 0.7
GEOGRAPHIC DIVISION            
Northeast 15.8 16.4 1.5 1.8 0.7 0.8
New England 16.4 20.2 1.4 1.4 0.5 0.7
Middle Atlantic 15.6 15.1 1.5 2.0 0.8 0.9
Midwest 14.0 14.9 1.5 1.5 0.6 0.6
East North Central 14.0 15.2 1.7 1.7 0.7 0.7
West North Central 14.0 14.4 1.0 1.1 0.3 0.5
South 14.4 15.1 1.9 1.6 0.8 0.6
South Atlantic 15.8 16.9 2.1 1.7 0.9 0.6
East South Central 13.3 12.4 1.4 1.3 0.5 0.3
West South Central 12.5 13.4 1.7 1.5 0.8 0.8
West 20.8 20.2 1.9 1.7 0.8 0.6
Mountain 20.7 20.6 2.3 1.5 1.2 0.4
Pacific 20.9 20.1 1.8 1.8 0.7 0.7
COUNTY TYPE            
Large Metro 17.4 17.5 1.9 1.8 0.8 0.8
Small Metro 15.5 16.1 1.7 1.6 0.9 0.6
250K - 1 Mil. Pop. 16.1 16.7 1.9 1.6 1.0 0.7
< 250K Pop. 14.2 14.9 1.2 1.5 0.6 0.4
Nonmetro 12.9 13.9 1.3 1.2 0.4 0.4
Urbanized 15.3 14.7 1.9 1.4 0.6 0.5
Less Urbanized 12.3 13.4 1.1 1.1 0.3 0.3
Completely Rural 7.5a 13.4 0.2 0.6 0.2 0.3
120411
Table 1.73A (REVISED) – Cocaine Use in Lifetime, Past Year, and Past Month among Persons Aged 18 or Older, by Geographic Characteristics: Numbers in Thousands, 2007 and 2008
Geographic Characteristic Lifetime
(2007)
Lifetime
(2008)
Past Year
(2007)
Past Year
(2008)
Past Month
(2007)
Past Month
(2008)
*Low precision; no estimate reported.
NOTE: This table was revised in May 2012 due to updates (for details, see the introduction to these 2008 detailed tables).
a Difference between estimate and 2008 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2008 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2007 and 2008.
TOTAL 35,402 36,443 5,362 4,977 1,972 1,767
GEOGRAPHIC DIVISION            
Northeast 6,499 6,731 921 1,028 384 439
New England 1,819 2,149 261 238 77 87
Middle Atlantic 4,680 4,582 660 790 307 352
Midwest 6,934 7,379 1,073 1,039 347 354
East North Central 4,850 5,191 827 775 282 268
West North Central 2,084 2,187 246 264 65 86
South 11,648 12,098 1,976 1,636 706 579
South Atlantic 6,707 7,079 1,182 902 423 312
East South Central 1,793 1,643 263 226 86 55
West South Central 3,148 3,377 530 508 197 212
West 10,322 10,235 1,393 1,274 536 394
Mountain 3,150 3,278 499 378 210 103
Pacific 7,172 6,957 894 896 325 291
COUNTY TYPE            
Large Metro 20,095 20,278 2,973 2,827 1,079 1,075
Small Metro 10,405 10,968 1,645 1,535 682 513
250K - 1 Mil. Pop. 7,236 7,509 1,226 1,007 526 384
< 250K Pop. 3,169 3,459 419 529 156 129
Nonmetro 4,902 5,197 744 614 212 179
Urbanized 2,306 2,270 391 290 112 92
Less Urbanized 2,252 2,443 321 292 82 74
Completely Rural 343 485 33 32 17 13
120411
Table 1.73B (REVISED) – Cocaine Use in Lifetime, Past Year, and Past Month among Persons Aged 18 or Older, by Geographic Characteristics: Percentages, 2007 and 2008
Geographic Characteristic Lifetime
(2007)
Lifetime
(2008)
Past Year
(2007)
Past Year
(2008)
Past Month
(2007)
Past Month
(2008)
*Low precision; no estimate reported.
NOTE: This table was revised in May 2012 due to updates (for details, see the introduction to these 2008 detailed tables).
a Difference between estimate and 2008 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2008 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2007 and 2008.
TOTAL 15.9 16.2 2.4 2.2 0.9 0.8
GEOGRAPHIC DIVISION            
Northeast 15.7 16.1 2.2 2.5 0.9 1.1
New England 16.7 19.7 2.4 2.2 0.7 0.8
Middle Atlantic 15.3 14.9 2.2 2.6 1.0 1.1
Midwest 14.1 14.9 2.2 2.1 0.7 0.7
East North Central 14.1 15.0 2.4 2.2 0.8 0.8
West North Central 14.1 14.6 1.7 1.8 0.4 0.6
South 14.4 14.8 2.4 2.0 0.9 0.7
South Atlantic 15.6 16.3 2.8 2.1 1.0 0.7
East South Central 13.5 12.3 2.0 1.7 0.6 0.4
West South Central 12.8 13.5 2.2 2.0 0.8 0.8
West 20.2 19.7 2.7 2.5 1.0 0.8
Mountain 20.4 20.8 3.2 2.4 1.4 0.7
Pacific 20.1 19.3 2.5 2.5 0.9 0.8
COUNTY TYPE            
Large Metro 16.9 16.9 2.5 2.4 0.9 0.9
Small Metro 15.6 16.1 2.5 2.3 1.0 0.8
250K - 1 Mil. Pop. 16.2 16.6 2.8 2.2 1.2 0.9
< 250K Pop. 14.3 15.1 1.9 2.3 0.7 0.6
Nonmetro 13.3 14.0 2.0 1.7 0.6 0.5
Urbanized 15.3 14.8 2.6 1.9 0.7 0.6
Less Urbanized 12.8 13.5 1.8 1.6 0.5 0.4
Completely Rural 8.2 13.3 0.8 0.9 0.4 0.4
120411
Table 1.74A (REVISED) – Crack Use in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Geographic Characteristics: Numbers in Thousands, 2007 and 2008
Geographic Characteristic Lifetime
(2007)
Lifetime
(2008)
Past Year
(2007)
Past Year
(2008)
Past Month
(2007)
Past Month
(2008)
*Low precision; no estimate reported.
NOTE: This table was revised in May 2012 due to updates (for details, see the introduction to these 2008 detailed tables).
a Difference between estimate and 2008 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2008 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2007 and 2008.
TOTAL 8,615 8,454 1,452a 1,113 611b 363
GEOGRAPHIC DIVISION            
Northeast 1,176 1,330 184 255 67 98
New England 300 332 55 62 14 34
Middle Atlantic 876 998 128 193 53 64
Midwest 1,776 1,700 361 275 141 74
East North Central 1,211 1,086 281 198 117 60
West North Central 566 614 80 77 25 14
South 3,158 3,089 639a 374 285a 142
South Atlantic 1,795 1,703 394a 201 179 73
East South Central 539 656 103 47 51a 11
West South Central 824 730 141 126 55 58
West 2,506 2,335 268 209 117 49
Mountain 773 627 100 58 43 8
Pacific 1,733 1,708 169 151 74 41
COUNTY TYPE            
Large Metro 4,865 4,333 748 588 298 186
Small Metro 2,360 2,593 445 388 245 145
250K - 1 Mil. Pop. 1,568 1,779 319 256 165 114
< 250K Pop. 792 813 126 132 80 31
Nonmetro 1,390 1,528 259a 137 67 31
Urbanized 697 593 109 56 25 7
Less Urbanized 570 748 133a 58 34 19
Completely Rural 123 187 17 22 9 5
120411
Table 1.74B (REVISED) – Crack Use in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Geographic Characteristics: Percentages, 2007 and 2008
Geographic Characteristic Lifetime
(2007)
Lifetime
(2008)
Past Year
(2007)
Past Year
(2008)
Past Month
(2007)
Past Month
(2008)
*Low precision; no estimate reported.
NOTE: This table was revised in May 2012 due to updates (for details, see the introduction to these 2008 detailed tables).
a Difference between estimate and 2008 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2008 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2007 and 2008.
TOTAL 3.5 3.4 0.6a 0.4 0.2b 0.1
GEOGRAPHIC DIVISION            
Northeast 2.6 2.9 0.4 0.6 0.1 0.2
New England 2.5 2.8 0.5 0.5 0.1 0.3
Middle Atlantic 2.6 2.9 0.4 0.6 0.2 0.2
Midwest 3.2 3.1 0.7 0.5 0.3 0.1
East North Central 3.2 2.8 0.7 0.5 0.3 0.2
West North Central 3.4 3.7 0.5 0.5 0.1 0.1
South 3.5 3.4 0.7a 0.4 0.3a 0.2
South Atlantic 3.8 3.5 0.8a 0.4 0.4 0.2
East South Central 3.7 4.4 0.7 0.3 0.3a 0.1
West South Central 3.0 2.6 0.5 0.4 0.2 0.2
West 4.4 4.0 0.5 0.4 0.2 0.1
Mountain 4.5 3.6 0.6 0.3 0.2 0.0
Pacific 4.3 4.2 0.4 0.4 0.2 0.1
COUNTY TYPE            
Large Metro 3.7 3.3 0.6 0.4 0.2 0.1
Small Metro 3.2 3.4 0.6 0.5 0.3 0.2
250K - 1 Mil. Pop. 3.2 3.6 0.6 0.5 0.3 0.2
< 250K Pop. 3.2 3.2 0.5 0.5 0.3 0.1
Nonmetro 3.4 3.7 0.6b 0.3 0.2 0.1
Urbanized 4.1 3.5 0.7 0.3 0.1 0.0
Less Urbanized 2.9 3.7 0.7a 0.3 0.2 0.1
Completely Rural 2.7 4.6 0.4 0.6 0.2 0.1
120411
Table 1.75A (REVISED) – Hallucinogen Use in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Geographic Characteristics: Numbers in Thousands, 2007 and 2008
Geographic Characteristic Lifetime
(2007)
Lifetime
(2008)
Past Year
(2007)
Past Year
(2008)
Past Month
(2007)
Past Month
(2008)
*Low precision; no estimate reported.
NOTE: This table was revised in May 2012 due to updates (for details, see the introduction to these 2008 detailed tables).
a Difference between estimate and 2008 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2008 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2007 and 2008.
TOTAL 34,278a 36,064 3,759 3,670 998 1,059
GEOGRAPHIC DIVISION            
Northeast 6,178 6,743 609 601 179 173
New England 1,830 2,088 172 186 40 36
Middle Atlantic 4,348 4,655 438 415 139 137
Midwest 7,113 7,632 756 777 176 203
East North Central 5,079 5,485 536 505 111 120
West North Central 2,034 2,147 220 272 65 83
South 10,868 11,237 1,315 1,138 351 305
South Atlantic 5,756 6,474 582 575 139 153
East South Central 1,813 1,585 230 192 61 62
West South Central 3,299 3,177 503 372 152 90
West 10,118 10,453 1,078 1,154 291 378
Mountain 3,228 3,338 380 389 107 113
Pacific 6,891 7,115 698 765 184 265
COUNTY TYPE            
Large Metro 19,021 19,753 2,040 2,013 576 607
Small Metro 10,595 11,281 1,226 1,185 320 336
250K - 1 Mil. Pop. 7,400 7,497 889 771 217 233
< 250K Pop. 3,195a 3,784 337 413 103 103
Nonmetro 4,661 5,030 493 473 102 115
Urbanized 2,188 2,320 242 245 59 51
Less Urbanized 2,158 2,244 231 206 39 58
Completely Rural 315 466 20 21 4 7
120411
Table 1.75B (REVISED) – Hallucinogen Use in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Geographic Characteristics: Percentages, 2007 and 2008
Geographic Characteristic Lifetime
(2007)
Lifetime
(2008)
Past Year
(2007)
Past Year
(2008)
Past Month
(2007)
Past Month
(2008)
*Low precision; no estimate reported.
NOTE: This table was revised in May 2012 due to updates (for details, see the introduction to these 2008 detailed tables).
a Difference between estimate and 2008 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2008 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2007 and 2008.
TOTAL 13.8 14.4 1.5 1.5 0.4 0.4
GEOGRAPHIC DIVISION            
Northeast 13.5 14.6 1.3 1.3 0.4 0.4
New England 15.2 17.3 1.4 1.5 0.3 0.3
Middle Atlantic 12.8 13.7 1.3 1.2 0.4 0.4
Midwest 13.0 13.9 1.4 1.4 0.3 0.4
East North Central 13.3 14.3 1.4 1.3 0.3 0.3
West North Central 12.3 13.0 1.3 1.6 0.4 0.5
South 12.1 12.4 1.5 1.3 0.4 0.3
South Atlantic 12.1 13.5 1.2 1.2 0.3 0.3
East South Central 12.3 10.7 1.6 1.3 0.4 0.4
West South Central 11.9 11.3 1.8 1.3 0.5 0.3
West 17.7 18.1 1.9 2.0 0.5 0.7
Mountain 18.7 19.0 2.2 2.2 0.6 0.6
Pacific 17.2 17.7 1.7 1.9 0.5 0.7
COUNTY TYPE            
Large Metro 14.3 14.8 1.5 1.5 0.4 0.5
Small Metro 14.3 14.9 1.7 1.6 0.4 0.4
250K - 1 Mil. Pop. 14.9 15.0 1.8 1.5 0.4 0.5
< 250K Pop. 13.0 14.9 1.4 1.6 0.4 0.4
Nonmetro 11.3 12.2 1.2 1.1 0.2 0.3
Urbanized 13.0 13.5 1.4 1.4 0.4 0.3
Less Urbanized 11.0 11.2 1.2 1.0 0.2 0.3
Completely Rural 6.8a 11.6 0.4 0.5 0.1 0.2
120411
Table 1.76A (REVISED) – Inhalant Use in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Geographic Characteristics: Numbers in Thousands, 2007 and 2008
Geographic Characteristic Lifetime
(2007)
Lifetime
(2008)
Past Year
(2007)
Past Year
(2008)
Past Month
(2007)
Past Month
(2008)
*Low precision; no estimate reported.
NOTE: This table was revised in May 2012 due to updates (for details, see the introduction to these 2008 detailed tables).
a Difference between estimate and 2008 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2008 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2007 and 2008.
TOTAL 22,558 22,430 2,085 2,065 617 644
GEOGRAPHIC DIVISION            
Northeast 4,322 4,238 390 352 139 78
New England 1,081 1,146 92 83 45 29
Middle Atlantic 3,241 3,092 298 269 95 49
Midwest 5,007 5,155 427 377 99 103
East North Central 3,474 3,626 314 264 66 78
West North Central 1,533 1,529 112 113 34 25
South 7,242 7,238 647 612 168 180
South Atlantic 3,885 4,302 342 290 89 81
East South Central 1,138 994 58 79 13 25
West South Central 2,220 1,942 248 242 67 73
West 5,987 5,799 621 724 210 284
Mountain 1,866 1,783 200 153 67 56
Pacific 4,121 4,016 421 571 143 228
COUNTY TYPE            
Large Metro 12,550 12,382 1,197 1,183 362 348
Small Metro 6,751 6,703 627 562 184 201
250K - 1 Mil. Pop. 4,493 4,659 392 380 101 158
< 250K Pop. 2,259 2,044 235 182 83 43
Nonmetro 3,256 3,345 261 319 71 96
Urbanized 1,536 1,561 114 164 31 47
Less Urbanized 1,512 1,517 121 134 33 43
Completely Rural 208 267 26 21 7 6
120411
Table 1.76B (REVISED) – Inhalant Use in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Geographic Characteristics: Percentages, 2007 and 2008
Geographic Characteristic Lifetime
(2007)
Lifetime
(2008)
Past Year
(2007)
Past Year
(2008)
Past Month
(2007)
Past Month
(2008)
*Low precision; no estimate reported.
NOTE: This table was revised in May 2012 due to updates (for details, see the introduction to these 2008 detailed tables).
a Difference between estimate and 2008 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2008 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2007 and 2008.
TOTAL 9.1 9.0 0.8 0.8 0.2 0.3
GEOGRAPHIC DIVISION            
Northeast 9.4 9.2 0.8 0.8 0.3 0.2
New England 9.0 9.5 0.8 0.7 0.4 0.2
Middle Atlantic 9.6 9.1 0.9 0.8 0.3 0.1
Midwest 9.1 9.4 0.8 0.7 0.2 0.2
East North Central 9.1 9.4 0.8 0.7 0.2 0.2
West North Central 9.3 9.2 0.7 0.7 0.2 0.2
South 8.1 8.0 0.7 0.7 0.2 0.2
South Atlantic 8.2 9.0 0.7 0.6 0.2 0.2
East South Central 7.7 6.7 0.4 0.5 0.1 0.2
West South Central 8.0 6.9 0.9 0.9 0.2 0.3
West 10.5 10.0 1.1 1.3 0.4 0.5
Mountain 10.8 10.1 1.2 0.9 0.4 0.3
Pacific 10.3 10.0 1.1 1.4 0.4 0.6
COUNTY TYPE            
Large Metro 9.5 9.3 0.9 0.9 0.3 0.3
Small Metro 9.1 8.9 0.8 0.7 0.2 0.3
250K - 1 Mil. Pop. 9.1 9.3 0.8 0.8 0.2 0.3
< 250K Pop. 9.2 8.0 1.0 0.7 0.3 0.2
Nonmetro 7.9 8.1 0.6 0.8 0.2 0.2
Urbanized 9.1 9.1 0.7 1.0 0.2 0.3
Less Urbanized 7.7 7.6 0.6 0.7 0.2 0.2
Completely Rural 4.5 6.6 0.6 0.5 0.1 0.1
120411
Table 1.77A (REVISED) – Inhalant Use in Lifetime, Past Year, and Past Month among Persons Aged 12 to 17, by Geographic Characteristics: Numbers in Thousands, 2007 and 2008
Geographic Characteristic Lifetime
(2007)
Lifetime
(2008)
Past Year
(2007)
Past Year
(2008)
Past Month
(2007)
Past Month
(2008)
*Low precision; no estimate reported.
NOTE: This table was revised in May 2012 due to updates (for details, see the introduction to these 2008 detailed tables).
a Difference between estimate and 2008 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2008 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2007 and 2008.
TOTAL 2,428 2,326 995 986 294 270
GEOGRAPHIC DIVISION            
Northeast 377 355 150 151 42 37
New England 113 98 44 44 17 14
Middle Atlantic 264 257 106 107 25 22
Midwest 520 484 226 208 54 56
East North Central 371 337 164 141 38 38
West North Central 148 147 62 67 16 18
South 883 813 350 308 97 74
South Atlantic 453 464 182 149 52 31
East South Central 137 121 45 47 9 12
West South Central 293a 227 123 111 36 30
West 648 674 268 319 101 104
Mountain 210 236 90 91 31 30
Pacific 438 438 178 228 70 74
COUNTY TYPE            
Large Metro 1,290 1,177 511 519 148 146
Small Metro 716 706 323 274 99 85
250K - 1 Mil. Pop. 477 460 198 185 59 67
< 250K Pop. 239 247 125 90 40 19
Nonmetro 422 442 160 192 48 39
Urbanized 171 195 64 91 24 16
Less Urbanized 205 204 75 85 17 17
Completely Rural 46 43 21 16 6 6
120411
Table 1.77B (REVISED) – Inhalant Use in Lifetime, Past Year, and Past Month among Persons Aged 12 to 17, by Geographic Characteristics: Percentages, 2007 and 2008
Geographic Characteristic Lifetime
(2007)
Lifetime
(2008)
Past Year
(2007)
Past Year
(2008)
Past Month
(2007)
Past Month
(2008)
*Low precision; no estimate reported.
NOTE: This table was revised in May 2012 due to updates (for details, see the introduction to these 2008 detailed tables).
a Difference between estimate and 2008 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2008 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2007 and 2008.
TOTAL 9.6 9.3 3.9 4.0 1.2 1.1
GEOGRAPHIC DIVISION            
Northeast 8.5 8.1 3.4 3.5 0.9 0.8
New England 9.7 8.7 3.8 3.9 1.5 1.3
Middle Atlantic 8.0 7.9 3.2 3.3 0.8 0.7
Midwest 9.3 8.8 4.0 3.8 1.0 1.0
East North Central 9.4 8.7 4.2 3.6 1.0 1.0
West North Central 8.9 8.9 3.7 4.1 0.9 1.1
South 9.7 9.0 3.8 3.4 1.1 0.8
South Atlantic 9.8 10.1 3.9 3.3 1.1 0.7
East South Central 9.3 8.3 3.1 3.2 0.6 0.8
West South Central 9.7a 7.6 4.1 3.7 1.2 1.0
West 10.7 11.3 4.4 5.4 1.7 1.7
Mountain 11.6 13.1 5.0 5.1 1.7 1.7
Pacific 10.4 10.6 4.2 5.5 1.7 1.8
COUNTY TYPE            
Large Metro 9.4 8.8 3.7 3.9 1.1 1.1
Small Metro 9.7 9.5 4.4 3.7 1.3 1.2
250K - 1 Mil. Pop. 9.6 9.4 4.0 3.8 1.2 1.4
< 250K Pop. 10.0 9.8 5.2a 3.6 1.7 0.7
Nonmetro 10.1 10.6 3.8 4.6 1.1 0.9
Urbanized 10.0 10.9 3.8 5.1 1.4 0.9
Less Urbanized 10.1 10.1 3.7 4.2 0.9 0.9
Completely Rural 10.7 11.5 5.0 4.3 1.5 1.5
120411
Table 1.78A (REVISED) – Nonmedical Use of Prescription-Type Psychotherapeutics in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Geographic Characteristics: Numbers in Thousands, 2007 and 2008
Geographic Characteristic Lifetime
(2007)
Lifetime
(2008)
Past Year
(2007)
Past Year
(2008)
Past Month
(2007)
Past Month
(2008)
*Low precision; no estimate reported.
NOTE: This table was revised in May 2012 due to updates (for details, see the introduction to these 2008 detailed tables).
NOTE: Nonmedical use of prescription-type psychotherapeutics includes the nonmedical use of pain relievers, tranquilizers, stimulants, or sedatives and does not include over-the-counter drugs.
NOTE: Estimates in this table include data from methamphetamine items added in 2005 and 2006 and are not comparable with estimates presented in NSDUH reports prior to the 2007 National Findings report. See Section B.4.8 in Appendix B of the Results from the 2008 National Survey on Drug Use and Health: National Findings.
a Difference between estimate and 2008 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2008 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2007 and 2008.
TOTAL 50,541 52,154 16,334a 15,190 6,907a 6,210
GEOGRAPHIC DIVISION            
Northeast 8,038 8,806 2,583 2,427 987 1,037
New England 2,168 2,418 665 723 287 382
Middle Atlantic 5,871 6,387 1,919 1,705 700 655
Midwest 10,869 11,179 3,395 3,353 1,468 1,402
East North Central 7,637 7,866 2,499 2,462 1,051 1,057
West North Central 3,233 3,313 896 891 417 345
South 18,417 18,123 6,155a 5,361 2,676a 2,203
South Atlantic 9,350 9,753 2,880 2,692 1,174 1,104
East South Central 3,317 2,890 1,271a 967 633 463
West South Central 5,751 5,480 2,005 1,703 870a 635
West 13,216 14,047 4,200 4,048 1,777 1,568
Mountain 4,306 4,288 1,374 1,248 563 437
Pacific 8,910 9,759 2,826 2,801 1,214 1,131
COUNTY TYPE            
Large Metro 27,288 27,857 8,750 7,999 3,653 3,233
Small Metro 15,302 16,242 4,900 4,804 2,100 1,998
250K - 1 Mil. Pop. 10,290 10,943 3,190 3,148 1,297 1,399
< 250K Pop. 5,012 5,299 1,710 1,657 803 599
Nonmetro 7,951 8,055 2,684 2,386 1,154 978
Urbanized 3,522 3,494 1,187 1,019 440 437
Less Urbanized 3,723 3,845 1,346 1,223 635 484
Completely Rural 707 716 152 144 78 57
120411
Table 1.78B (REVISED) – Nonmedical Use of Prescription-Type Psychotherapeutics in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Geographic Characteristics: Percentages, 2007 and 2008
Geographic Characteristic Lifetime
(2007)
Lifetime
(2008)
Past Year
(2007)
Past Year
(2008)
Past Month
(2007)
Past Month
(2008)
*Low precision; no estimate reported.
NOTE: This table was revised in May 2012 due to updates (for details, see the introduction to these 2008 detailed tables).
NOTE: Nonmedical use of prescription-type psychotherapeutics includes the nonmedical use of pain relievers, tranquilizers, stimulants, or sedatives and does not include over-the-counter drugs.
NOTE: Estimates in this table include data from methamphetamine items added in 2005 and 2006 and are not comparable with estimates presented in NSDUH reports prior to the 2007 National Findings report. See Section B.4.8 in Appendix B of the Results from the 2008 National Survey on Drug Use and Health: National Findings.
a Difference between estimate and 2008 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2008 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2007 and 2008.
TOTAL 20.4 20.9 6.6a 6.1 2.8a 2.5
GEOGRAPHIC DIVISION            
Northeast 17.5 19.1 5.6 5.3 2.2 2.2
New England 18.0 20.1 5.5 6.0 2.4 3.2
Middle Atlantic 17.3 18.8 5.7 5.0 2.1 1.9
Midwest 19.8 20.3 6.2 6.1 2.7 2.6
East North Central 19.9 20.5 6.5 6.4 2.7 2.8
West North Central 19.6 20.0 5.4 5.4 2.5 2.1
South 20.5 19.9 6.8b 5.9 3.0a 2.4
South Atlantic 19.7 20.3 6.1 5.6 2.5 2.3
East South Central 22.5 19.4 8.6a 6.5 4.3 3.1
West South Central 20.8 19.5 7.3 6.1 3.1a 2.3
West 23.1 24.3 7.3 7.0 3.1 2.7
Mountain 24.9 24.4 8.0 7.1 3.3 2.5
Pacific 22.3 24.3 7.1 7.0 3.0 2.8
COUNTY TYPE            
Large Metro 20.6 20.9 6.6 6.0 2.8 2.4
Small Metro 20.7 21.5 6.6 6.4 2.8 2.6
250K - 1 Mil. Pop. 20.8 21.9 6.4 6.3 2.6 2.8
< 250K Pop. 20.4 20.8 7.0 6.5 3.3a 2.4
Nonmetro 19.4 19.5 6.5 5.8 2.8 2.4
Urbanized 21.0 20.4 7.1 5.9 2.6 2.5
Less Urbanized 18.9 19.2 6.8 6.1 3.2 2.4
Completely Rural 15.4 17.8 3.3 3.6 1.7 1.4
120411
Table 1.79A (REVISED) – Nonmedical Use of Prescription-Type Psychotherapeutics in Lifetime, Past Year, and Past Month among Persons Aged 12 to 17, by Geographic Characteristics: Numbers in Thousands, 2007 and 2008
Geographic Characteristic Lifetime
(2007)
Lifetime
(2008)
Past Year
(2007)
Past Year
(2008)
Past Month
(2007)
Past Month
(2008)
*Low precision; no estimate reported.
NOTE: This table was revised in May 2012 due to updates (for details, see the introduction to these 2008 detailed tables).
NOTE: Nonmedical use of prescription-type psychotherapeutics includes the nonmedical use of pain relievers, tranquilizers, stimulants, or sedatives and does not include over-the-counter drugs.
NOTE: Estimates in this table include data from methamphetamine items added in 2005 and 2006 and are not comparable with estimates presented in NSDUH reports prior to the 2007 National Findings report. See Section B.4.8 in Appendix B of the Results from the 2008 National Survey on Drug Use and Health: National Findings.
a Difference between estimate and 2008 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2008 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2007 and 2008.
TOTAL 2,954 2,783 2,037 1,919 830a 711
GEOGRAPHIC DIVISION            
Northeast 406 355 268 259 90 112
New England 118 90 80 63 23 19
Middle Atlantic 287 265 188 196 68 93
Midwest 672 635 469 445 190 175
East North Central 479 450 339 317 131 134
West North Central 194 185 130 128 59 41
South 1,149 1,066 812a 677 351b 253
South Atlantic 531 553 354 340 135 133
East South Central 202 160 140a 100 57 40
West South Central 417 353 318a 237 158b 80
West 726 727 487 538 198 170
Mountain 233 234 173 179 68 72
Pacific 494 493 314 358 130 98
COUNTY TYPE            
Large Metro 1,538a 1,362 1,067 966 409 358
Small Metro 898 888 631 601 278a 215
250K - 1 Mil. Pop. 584 575 399 394 166 131
< 250K Pop. 314 313 232 208 112 84
Nonmetro 518 533 339 351 143 138
Urbanized 219 224 142 159 57 60
Less Urbanized 248 266 160 168 64 68
Completely Rural 50 44 37 24 22a 10
120411
Table 1.79B (REVISED) – Nonmedical Use of Prescription-Type Psychotherapeutics in Lifetime, Past Year, and Past Month among Persons Aged 12 to 17, by Geographic Characteristics: Percentages, 2007 and 2008
Geographic Characteristic Lifetime
(2007)
Lifetime
(2008)
Past Year
(2007)
Past Year
(2008)
Past Month
(2007)
Past Month
(2008)
*Low precision; no estimate reported.
NOTE: This table was revised in May 2012 due to updates (for details, see the introduction to these 2008 detailed tables).
NOTE: Nonmedical use of prescription-type psychotherapeutics includes the nonmedical use of pain relievers, tranquilizers, stimulants, or sedatives and does not include over-the-counter drugs.
NOTE: Estimates in this table include data from methamphetamine items added in 2005 and 2006 and are not comparable with estimates presented in NSDUH reports prior to the 2007 National Findings report. See Section B.4.8 in Appendix B of the Results from the 2008 National Survey on Drug Use and Health: National Findings.
a Difference between estimate and 2008 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2008 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2007 and 2008.
TOTAL 11.7 11.2 8.1 7.7 3.3a 2.9
GEOGRAPHIC DIVISION            
Northeast 9.1 8.1 6.0 5.9 2.0 2.6
New England 10.2 8.0 6.9 5.6 2.0 1.7
Middle Atlantic 8.7 8.2 5.7 6.0 2.1 2.9
Midwest 12.0 11.5 8.4 8.1 3.4 3.2
East North Central 12.1 11.6 8.6 8.2 3.3 3.5
West North Central 11.6 11.3 7.8 7.8 3.5 2.5
South 12.6 11.8 8.9a 7.5 3.8b 2.8
South Atlantic 11.4 12.1 7.6 7.4 2.9 2.9
East South Central 13.6 10.9 9.5a 6.8 3.9 2.7
West South Central 13.9 11.7 10.6a 7.9 5.3b 2.6
West 12.0 12.2 8.1 9.0 3.3 2.8
Mountain 12.9 13.0 9.6 9.9 3.8 4.0
Pacific 11.7 11.9 7.4 8.6 3.1 2.4
COUNTY TYPE            
Large Metro 11.2 10.2 7.8 7.3 3.0 2.7
Small Metro 12.2 12.0 8.5 8.1 3.8a 2.9
250K - 1 Mil. Pop. 11.7 11.7 8.0 8.0 3.3 2.7
< 250K Pop. 13.1 12.5 9.7 8.3 4.7 3.3
Nonmetro 12.4 12.8 8.1 8.4 3.4 3.3
Urbanized 12.8 12.5 8.3 8.9 3.3 3.4
Less Urbanized 12.3 13.2 7.9 8.4 3.2 3.3
Completely Rural 11.8 11.7 8.6 6.4 5.2 2.7
120411
Table 1.80A (REVISED) – Nonmedical Use of Prescription-Type Psychotherapeutics in Lifetime, Past Year, and Past Month among Persons Aged 18 to 25, by Geographic Characteristics: Numbers in Thousands, 2007 and 2008
Geographic Characteristic Lifetime
(2007)
Lifetime
(2008)
Past Year
(2007)
Past Year
(2008)
Past Month
(2007)
Past Month
(2008)
*Low precision; no estimate reported.
NOTE: This table was revised in May 2012 due to updates (for details, see the introduction to these 2008 detailed tables).
NOTE: Nonmedical use of prescription-type psychotherapeutics includes the nonmedical use of pain relievers, tranquilizers, stimulants, or sedatives and does not include over-the-counter drugs.
NOTE: Estimates in this table include data from methamphetamine items added in 2005 and 2006 and are not comparable with estimates presented in NSDUH reports prior to the 2007 National Findings report. See Section B.4.8 in Appendix B of the Results from the 2008 National Survey on Drug Use and Health: National Findings.
a Difference between estimate and 2008 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2008 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2007 and 2008.
TOTAL 9,807 9,694 4,920 4,891 1,947 1,936
GEOGRAPHIC DIVISION            
Northeast 1,586 1,737 807 870 294 356
New England 507 472 266 241 94 92
Middle Atlantic 1,079b 1,265 541 628 200 264
Midwest 2,168 2,155 1,055 1,067 438 416
East North Central 1,546 1,473 791 753 319 312
West North Central 623 682 265 314 119 105
South 3,503 3,341 1,792 1,741 745 731
South Atlantic 1,733a 1,547 912 801 377 324
East South Central 630 558 330 308 149 145
West South Central 1,140 1,235 550 633 220 263
West 2,550 2,461 1,266 1,214 470 432
Mountain 808 861 397 370 158 142
Pacific 1,742 1,600 870 843 312 290
COUNTY TYPE            
Large Metro 4,967 5,008 2,485 2,499 998 960
Small Metro 3,242 3,177 1,597 1,641 593 653
250K - 1 Mil. Pop. 2,166 2,049 1,084 1,027 389 421
< 250K Pop. 1,076 1,128 512 614 204 232
Nonmetro 1,598 1,509 838 751 356 323
Urbanized 735 692 381 319 160 141
Less Urbanized 757 731 394 385 168 161
Completely Rural 106 85 63 47 29 21
120411
Table 1.80B (REVISED) – Nonmedical Use of Prescription-Type Psychotherapeutics in Lifetime, Past Year, and Past Month among Persons Aged 18 to 25, by Geographic Characteristics: Percentages, 2007 and 2008
Geographic Characteristic Lifetime
(2007)
Lifetime
(2008)
Past Year
(2007)
Past Year
(2008)
Past Month
(2007)
Past Month
(2008)
*Low precision; no estimate reported.
NOTE: This table was revised in May 2012 due to updates (for details, see the introduction to these 2008 detailed tables).
NOTE: Nonmedical use of prescription-type psychotherapeutics includes the nonmedical use of pain relievers, tranquilizers, stimulants, or sedatives and does not include over-the-counter drugs.
NOTE: Estimates in this table include data from methamphetamine items added in 2005 and 2006 and are not comparable with estimates presented in NSDUH reports prior to the 2007 National Findings report. See Section B.4.8 in Appendix B of the Results from the 2008 National Survey on Drug Use and Health: National Findings.
a Difference between estimate and 2008 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2008 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2007 and 2008.
TOTAL 30.0 29.4 15.0 14.9 5.9 5.9
GEOGRAPHIC DIVISION            
Northeast 26.9 29.0 13.7 14.5 5.0 5.9
New England 33.2 30.3 17.4 15.5 6.2 5.9
Middle Atlantic 24.7a 28.5 12.4 14.2 4.6 6.0
Midwest 29.8 29.6 14.5 14.7 6.0 5.7
East North Central 30.8 29.2 15.7 15.0 6.3 6.2
West North Central 27.5 30.4 11.7 14.0 5.3 4.7
South 30.0 28.4 15.3 14.8 6.4 6.2
South Atlantic 29.3a 25.9 15.4 13.4 6.4 5.4
East South Central 33.7 29.8 17.6 16.4 8.0 7.7
West South Central 29.1 31.5 14.1 16.1 5.6 6.7
West 32.5 31.1 16.1 15.3 6.0 5.5
Mountain 34.3 36.3 16.8 15.6 6.7 6.0
Pacific 31.7 28.9 15.8 15.2 5.7 5.2
COUNTY TYPE            
Large Metro 28.7 28.1 14.4 14.0 5.8 5.4
Small Metro 31.4 31.5 15.5 16.2 5.7 6.5
250K - 1 Mil. Pop. 32.0 31.3 16.0 15.7 5.7 6.4
< 250K Pop. 30.3 31.7 14.4a 17.3 5.7 6.5
Nonmetro 31.3 30.2 16.4 15.0 7.0 6.5
Urbanized 32.2 30.3 16.7 14.0 7.0 6.2
Less Urbanized 30.9 31.1 16.1 16.4 6.9 6.8
Completely Rural 28.4 24.0 17.0 13.1 7.7 6.0
120411
Table 1.81A (REVISED) – Nonmedical Use of Prescription-Type Psychotherapeutics in Lifetime, Past Year, and Past Month among Persons Aged 26 or Older, by Geographic Characteristics: Numbers in Thousands, 2007 and 2008
Geographic Characteristic Lifetime
(2007)
Lifetime
(2008)
Past Year
(2007)
Past Year
(2008)
Past Month
(2007)
Past Month
(2008)
*Low precision; no estimate reported.
NOTE: This table was revised in May 2012 due to updates (for details, see the introduction to these 2008 detailed tables).
NOTE: Nonmedical use of prescription-type psychotherapeutics includes the nonmedical use of pain relievers, tranquilizers, stimulants, or sedatives and does not include over-the-counter drugs.
NOTE: Estimates in this table include data from methamphetamine items added in 2005 and 2006 and are not comparable with estimates presented in NSDUH reports prior to the 2007 National Findings report. See Section B.4.8 in Appendix B of the Results from the 2008 National Survey on Drug Use and Health: National Findings.
a Difference between estimate and 2008 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2008 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2007 and 2008.
TOTAL 37,781 39,677 9,377a 8,380 4,130 3,563
GEOGRAPHIC DIVISION            
Northeast 6,046 6,713 1,508 1,299 602 569
New England 1,542 1,856 319 418 170 270
Middle Atlantic 4,505 4,857 1,189 881 433 299
Midwest 8,029 8,389 1,871 1,840 840 810
East North Central 5,612 5,943 1,370 1,392 602 612
West North Central 2,416 2,446 501 449 238 198
South 13,766 13,715 3,551a 2,943 1,579 1,218
South Atlantic 7,086 7,652 1,614 1,551 661 647
East South Central 2,485 2,171 801a 559 427 278
West South Central 4,194 3,892 1,137 833 492a 293
West 9,940 10,858 2,447 2,297 1,109 966
Mountain 3,265 3,192 804 698 337 223
Pacific 6,675 7,666 1,642 1,599 771 743
COUNTY TYPE            
Large Metro 20,782 21,486 5,198 4,534 2,246 1,916
Small Metro 11,163 12,178 2,672 2,562 1,230 1,130
250K - 1 Mil. Pop. 7,540 8,319 1,706 1,727 743 847
< 250K Pop. 3,623 3,858 966 835 487a 283
Nonmetro 5,836 6,013 1,507 1,284 655 518
Urbanized 2,568 2,578 664 541 224 236
Less Urbanized 2,717 2,848 791 670 403 256
Completely Rural 551 587 52 73 27 25
120411
Table 1.81B (REVISED) – Nonmedical Use of Prescription-Type Psychotherapeutics in Lifetime, Past Year, and Past Month among Persons Aged 26 or Older, by Geographic Characteristics: Percentages, 2007 and 2008
Geographic Characteristic Lifetime
(2007)
Lifetime
(2008)
Past Year
(2007)
Past Year
(2008)
Past Month
(2007)
Past Month
(2008)
*Low precision; no estimate reported.
NOTE: This table was revised in May 2012 due to updates (for details, see the introduction to these 2008 detailed tables).
NOTE: Nonmedical use of prescription-type psychotherapeutics includes the nonmedical use of pain relievers, tranquilizers, stimulants, or sedatives and does not include over-the-counter drugs.
NOTE: Estimates in this table include data from methamphetamine items added in 2005 and 2006 and are not comparable with estimates presented in NSDUH reports prior to the 2007 National Findings report. See Section B.4.8 in Appendix B of the Results from the 2008 National Survey on Drug Use and Health: National Findings.
a Difference between estimate and 2008 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2008 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2007 and 2008.
TOTAL 19.9 20.7 4.9a 4.4 2.2 1.9
GEOGRAPHIC DIVISION            
Northeast 17.0 18.8 4.2 3.6 1.7 1.6
New England 16.5 19.8 3.4 4.5 1.8 2.9
Middle Atlantic 17.2 18.4 4.5 3.3 1.7 1.1
Midwest 19.2 19.9 4.5 4.4 2.0 1.9
East North Central 19.1 20.2 4.7 4.7 2.1 2.1
West North Central 19.2 19.3 4.0 3.5 1.9 1.6
South 19.9 19.6 5.1a 4.2 2.3a 1.7
South Atlantic 19.1 20.4 4.4 4.1 1.8 1.7
East South Central 21.8 18.8 7.0a 4.9 3.7 2.4
West South Central 20.2 18.4 5.5a 3.9 2.4a 1.4
West 22.9 24.7 5.6 5.2 2.6 2.2
Mountain 24.9 23.8 6.1 5.2 2.6 1.7
Pacific 22.1 25.1 5.4 5.2 2.6 2.4
COUNTY TYPE            
Large Metro 20.4 21.1 5.1 4.4 2.2 1.9
Small Metro 19.8 21.0 4.7 4.4 2.2 1.9
250K - 1 Mil. Pop. 19.9 21.6 4.5 4.5 2.0 2.2
< 250K Pop. 19.5 19.9 5.2 4.3 2.6a 1.5
Nonmetro 18.3 18.7 4.7 4.0 2.1 1.6
Urbanized 20.0 19.7 5.2 4.1 1.7 1.8
Less Urbanized 17.9 18.2 5.2 4.3 2.7 1.6
Completely Rural 14.5 17.8 1.4 2.2 0.7 0.8
120411
Table 1.82A (REVISED) – Nonmedical Use of Prescription-Type Psychotherapeutics in Lifetime, Past Year, and Past Month among Persons Aged 18 or Older, by Geographic Characteristics: Numbers in Thousands, 2007 and 2008
Geographic Characteristic Lifetime
(2007)
Lifetime
(2008)
Past Year
(2007)
Past Year
(2008)
Past Month
(2007)
Past Month
(2008)
*Low precision; no estimate reported.
NOTE: This table was revised in May 2012 due to updates (for details, see the introduction to these 2008 detailed tables).
NOTE: Nonmedical use of prescription-type psychotherapeutics includes the nonmedical use of pain relievers, tranquilizers, stimulants, or sedatives and does not include over-the-counter drugs.
NOTE: Estimates in this table include data from methamphetamine items added in 2005 and 2006 and are not comparable with estimates presented in NSDUH reports prior to the 2007 National Findings report. See Section B.4.8 in Appendix B of the Results from the 2008 National Survey on Drug Use and Health: National Findings.
a Difference between estimate and 2008 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2008 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2007 and 2008.
TOTAL 47,588 49,371 14,297a 13,271 6,077 5,499
GEOGRAPHIC DIVISION            
Northeast 7,633 8,450 2,315 2,169 897 925
New England 2,049 2,328 585 660 264 362
Middle Atlantic 5,583 6,122 1,731 1,509 633 562
Midwest 10,197 10,544 2,926 2,907 1,278 1,227
East North Central 7,158 7,416 2,160 2,145 920 923
West North Central 3,039 3,128 766 762 358 303
South 17,268 17,056 5,343a 4,684 2,325 1,950
South Atlantic 8,819 9,200 2,526 2,351 1,038 971
East South Central 3,115 2,729 1,130a 867 575 423
West South Central 5,334 5,127 1,687 1,466 711 556
West 12,490 13,320 3,713 3,511 1,578 1,398
Mountain 4,073 4,053 1,201 1,068 495 365
Pacific 8,416 9,267 2,512 2,442 1,083 1,033
COUNTY TYPE            
Large Metro 25,749 26,495 7,683 7,033 3,244 2,875
Small Metro 14,405 15,355 4,269 4,203 1,823 1,783
250K - 1 Mil. Pop. 9,706 10,369 2,791 2,754 1,132 1,268
< 250K Pop. 4,698 4,986 1,478 1,449 691 515
Nonmetro 7,434 7,522 2,345 2,035 1,011 840
Urbanized 3,303 3,270 1,045 860 383 377
Less Urbanized 3,474 3,579 1,185 1,055 571 417
Completely Rural 656 672 115 120 56 47
120411
Table 1.82B (REVISED) – Nonmedical Use of Prescription-Type Psychotherapeutics in Lifetime, Past Year, and Past Month among Persons Aged 18 or Older, by Geographic Characteristics: Percentages, 2007 and 2008
Geographic Characteristic Lifetime
(2007)
Lifetime
(2008)
Past Year
(2007)
Past Year
(2008)
Past Month
(2007)
Past Month
(2008)
*Low precision; no estimate reported.
NOTE: This table was revised in May 2012 due to updates (for details, see the introduction to these 2008 detailed tables).
NOTE: Nonmedical use of prescription-type psychotherapeutics includes the nonmedical use of pain relievers, tranquilizers, stimulants, or sedatives and does not include over-the-counter drugs.
NOTE: Estimates in this table include data from methamphetamine items added in 2005 and 2006 and are not comparable with estimates presented in NSDUH reports prior to the 2007 National Findings report. See Section B.4.8 in Appendix B of the Results from the 2008 National Survey on Drug Use and Health: National Findings.
a Difference between estimate and 2008 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2008 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2007 and 2008.
TOTAL 21.4 22.0 6.4a 5.9 2.7 2.4
GEOGRAPHIC DIVISION            
Northeast 18.4 20.3 5.6 5.2 2.2 2.2
New England 18.9 21.3 5.4 6.0 2.4 3.3
Middle Atlantic 18.3 19.9 5.7 4.9 2.1 1.8
Midwest 20.7 21.3 5.9 5.9 2.6 2.5
East North Central 20.8 21.5 6.3 6.2 2.7 2.7
West North Central 20.5 20.9 5.2 5.1 2.4 2.0
South 21.4 20.8 6.6a 5.7 2.9a 2.4
South Atlantic 20.5 21.2 5.9 5.4 2.4 2.2
East South Central 23.5 20.4 8.5a 6.5 4.3 3.2
West South Central 21.7 20.4 6.8 5.8 2.9 2.2
West 24.4 25.7 7.3 6.8 3.1 2.7
Mountain 26.3 25.7 7.8 6.8 3.2 2.3
Pacific 23.6 25.7 7.0 6.8 3.0 2.9
COUNTY TYPE            
Large Metro 21.6 22.1 6.5 5.9 2.7 2.4
Small Metro 21.6 22.6 6.4 6.2 2.7 2.6
250K - 1 Mil. Pop. 21.8 23.0 6.3 6.1 2.5 2.8
< 250K Pop. 21.2 21.7 6.7 6.3 3.1 2.2
Nonmetro 20.1 20.3 6.4 5.5 2.7 2.3
Urbanized 21.9 21.3 6.9 5.6 2.5 2.5
Less Urbanized 19.7 19.8 6.7 5.8 3.2 2.3
Completely Rural 15.7 18.4 2.8 3.3 1.3 1.3
120411
Table 1.83A (REVISED) – Nonmedical Use of Pain Relievers in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Geographic Characteristics: Numbers in Thousands, 2007 and 2008
Geographic Characteristic Lifetime
(2007)
Lifetime
(2008)
Past Year
(2007)
Past Year
(2008)
Past Month
(2007)
Past Month
(2008)
*Low precision; no estimate reported.
NOTE: This table was revised in May 2012 due to updates (for details, see the introduction to these 2008 detailed tables).
a Difference between estimate and 2008 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2008 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2007 and 2008.
TOTAL 33,132a 34,992 12,517 11,916 5,188 4,732
GEOGRAPHIC DIVISION            
Northeast 5,230 5,914 1,872 1,899 744 792
New England 1,487 1,777 535 600 209 310
Middle Atlantic 3,743 4,137 1,337 1,299 535 482
Midwest 7,474 7,494 2,685 2,691 1,123 1,088
East North Central 5,419 5,602 2,057 2,020 855 840
West North Central 2,055 1,892 628 671 267 248
South 11,815 12,165 4,709a 4,107 2,001a 1,601
South Atlantic 5,778 6,208 2,146 1,975 900 776
East South Central 2,287 2,040 1,045 832 524 392
West South Central 3,751 3,917 1,519 1,300 577a 433
West 8,614 9,419 3,251 3,219 1,321 1,251
Mountain 2,788 2,930 1,082 975 449 332
Pacific 5,826 6,490 2,169 2,244 872 919
COUNTY TYPE            
Large Metro 17,808 18,716 6,540 6,284 2,659 2,462
Small Metro 10,080 10,815 3,847 3,818 1,597 1,517
250K - 1 Mil. Pop. 6,611 7,094 2,425 2,422 960 1,001
< 250K Pop. 3,469 3,721 1,422 1,396 637 517
Nonmetro 5,244 5,461 2,130a 1,814 932 752
Urbanized 2,334 2,455 934 771 358 321
Less Urbanized 2,467 2,609 1,065 920 511 383
Completely Rural 443 398 130 123 63 47
120411
Table 1.83B (REVISED) – Nonmedical Use of Pain Relievers in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Geographic Characteristics: Percentages, 2007 and 2008
Geographic Characteristic Lifetime
(2007)
Lifetime
(2008)
Past Year
(2007)
Past Year
(2008)
Past Month
(2007)
Past Month
(2008)
*Low precision; no estimate reported.
NOTE: This table was revised in May 2012 due to updates (for details, see the introduction to these 2008 detailed tables).
a Difference between estimate and 2008 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2008 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2007 and 2008.
TOTAL 13.4 14.0 5.1 4.8 2.1 1.9
GEOGRAPHIC DIVISION            
Northeast 11.4 12.8 4.1 4.1 1.6 1.7
New England 12.4 14.7 4.4 5.0 1.7 2.6
Middle Atlantic 11.1 12.2 3.9 3.8 1.6 1.4
Midwest 13.6 13.6 4.9 4.9 2.0 2.0
East North Central 14.1 14.6 5.4 5.3 2.2 2.2
West North Central 12.5 11.4 3.8 4.0 1.6 1.5
South 13.1 13.4 5.2a 4.5 2.2a 1.8
South Atlantic 12.1 12.9 4.5 4.1 1.9 1.6
East South Central 15.5 13.7 7.1 5.6 3.6 2.6
West South Central 13.6 13.9 5.5 4.6 2.1a 1.5
West 15.1 16.3 5.7 5.6 2.3 2.2
Mountain 16.1 16.7 6.3 5.5 2.6 1.9
Pacific 14.6 16.1 5.4 5.6 2.2 2.3
COUNTY TYPE            
Large Metro 13.4 14.1 4.9 4.7 2.0 1.8
Small Metro 13.6 14.3 5.2 5.1 2.2 2.0
250K - 1 Mil. Pop. 13.3 14.2 4.9 4.8 1.9 2.0
< 250K Pop. 14.1 14.6 5.8 5.5 2.6 2.0
Nonmetro 12.8 13.2 5.2a 4.4 2.3 1.8
Urbanized 13.9 14.3 5.6 4.5 2.1 1.9
Less Urbanized 12.5 13.0 5.4 4.6 2.6 1.9
Completely Rural 9.6 9.9 2.8 3.0 1.4 1.2
120411
Table 1.84A (REVISED) – Nonmedical Use of Pain Relievers in Lifetime, Past Year, and Past Month among Persons Aged 12 to 17, by Geographic Characteristics: Numbers in Thousands, 2007 and 2008
Geographic Characteristic Lifetime
(2007)
Lifetime
(2008)
Past Year
(2007)
Past Year
(2008)
Past Month
(2007)
Past Month
(2008)
*Low precision; no estimate reported.
NOTE: This table was revised in May 2012 due to updates (for details, see the introduction to these 2008 detailed tables).
a Difference between estimate and 2008 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2008 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2007 and 2008.
TOTAL 2,457 2,353 1,684 1,613 671a 566
GEOGRAPHIC DIVISION            
Northeast 335 293 229 213 75 94
New England 90 69 61 50 12 14
Middle Atlantic 245 224 169 163 62 80
Midwest 570 550 388 382 152 140
East North Central 407 396 285 274 105 103
West North Central 162 154 103 108 46 37
South 939 877 674b 544 295b 194
South Atlantic 432 457 303 284 124 95
East South Central 167 138 114 86 48 34
West South Central 340 281 256b 174 122b 65
West 613 634 393 474 150 139
Mountain 187 202 139 163 53 53
Pacific 426 432 254 310 97 86
COUNTY TYPE            
Large Metro 1,271 1,127 884 795 328 280
Small Metro 752 753 525 511 227 178
250K - 1 Mil. Pop. 477 481 328 327 133 111
< 250K Pop. 275 272 197 183 94 68
Nonmetro 434 474 276 307 116 108
Urbanized 180 190 110 135 46 41
Less Urbanized 206 242 131 152 49 60
Completely Rural 48 42 34 20 21a 7
120411
Table 1.84B (REVISED) – Nonmedical Use of Pain Relievers in Lifetime, Past Year, and Past Month among Persons Aged 12 to 17, by Geographic Characteristics: Percentages, 2007 and 2008
Geographic Characteristic Lifetime
(2007)
Lifetime
(2008)
Past Year
(2007)
Past Year
(2008)
Past Month
(2007)
Past Month
(2008)
*Low precision; no estimate reported.
NOTE: This table was revised in May 2012 due to updates (for details, see the introduction to these 2008 detailed tables).
a Difference between estimate and 2008 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2008 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2007 and 2008.
TOTAL 9.7 9.5 6.7 6.5 2.7a 2.3
GEOGRAPHIC DIVISION            
Northeast 7.5 6.7 5.1 4.9 1.7 2.1
New England 7.8 6.1 5.2 4.4 1.1 1.2
Middle Atlantic 7.4 6.9 5.1 5.0 1.9 2.5
Midwest 10.1 10.0 6.9 6.9 2.7 2.5
East North Central 10.3 10.2 7.2 7.1 2.7 2.7
West North Central 9.7 9.3 6.2 6.6 2.8 2.2
South 10.3 9.7 7.4a 6.0 3.2b 2.1
South Atlantic 9.3 10.0 6.5 6.2 2.7 2.1
East South Central 11.3 9.4 7.7 5.9 3.3 2.3
West South Central 11.3 9.4 8.5b 5.8 4.1b 2.2
West 10.2 10.6 6.5a 8.0 2.5 2.3
Mountain 10.4 11.2 7.7 9.0 2.9 2.9
Pacific 10.1 10.4 6.0 7.5 2.3 2.1
COUNTY TYPE            
Large Metro 9.3 8.5 6.5 6.0 2.4 2.1
Small Metro 10.2 10.2 7.1 6.9 3.1 2.4
250K - 1 Mil. Pop. 9.6 9.8 6.6 6.7 2.7 2.3
< 250K Pop. 11.5 10.8 8.2 7.3 3.9 2.7
Nonmetro 10.4 11.3 6.6 7.4 2.8 2.6
Urbanized 10.5 10.6 6.4 7.6 2.7 2.3
Less Urbanized 10.2 12.0 6.5 7.5 2.4 3.0
Completely Rural 11.2 11.0 8.1 5.4 4.8a 1.8
120411
Table 1.85A (REVISED) – Nonmedical Use of Pain Relievers in Lifetime, Past Year, and Past Month among Persons Aged 18 to 25, by Geographic Characteristics: Numbers in Thousands, 2007 and 2008
Geographic Characteristic Lifetime
(2007)
Lifetime
(2008)
Past Year
(2007)
Past Year
(2008)
Past Month
(2007)
Past Month
(2008)
*Low precision; no estimate reported.
NOTE: This table was revised in May 2012 due to updates (for details, see the introduction to these 2008 detailed tables).
a Difference between estimate and 2008 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2008 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2007 and 2008.
TOTAL 8,143 8,096 3,981 3,956 1,518 1,489
GEOGRAPHIC DIVISION            
Northeast 1,307 1,418 640 686 216 262
New England 406 384 214 196 64 68
Middle Atlantic 901a 1,034 426 491 152 194
Midwest 1,841 1,858 871 900 333 333
East North Central 1,348 1,299 664 641 246 254
West North Central 493 559 207 259 87 80
South 2,848 2,777 1,425 1,400 590 555
South Atlantic 1,396 1,303 720 649 310 244
East South Central 527 465 270 261 122 118
West South Central 924 1,009 434 490 158 193
West 2,147 2,043 1,046 970 379 339
Mountain 679 712 312 314 120 118
Pacific 1,469 1,331 734 655 259 221
COUNTY TYPE            
Large Metro 4,125 4,170 2,004 1,989 765 729
Small Metro 2,697 2,681 1,291 1,344 467 509
250K - 1 Mil. Pop. 1,824 1,713 906 842 308 313
< 250K Pop. 874 967 385a 502 159 196
Nonmetro 1,320 1,246 686 623 286 251
Urbanized 591 575 320 272 129 103
Less Urbanized 637 598 314 311 134 128
Completely Rural 93 73 52 40 23 20
120411
Table 1.85B (REVISED) – Nonmedical Use of Pain Relievers in Lifetime, Past Year, and Past Month among Persons Aged 18 to 25, by Geographic Characteristics: Percentages, 2007 and 2008
Geographic Characteristic Lifetime
(2007)
Lifetime
(2008)
Past Year
(2007)
Past Year
(2008)
Past Month
(2007)
Past Month
(2008)
*Low precision; no estimate reported.
NOTE: This table was revised in May 2012 due to updates (for details, see the introduction to these 2008 detailed tables).
a Difference between estimate and 2008 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2008 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2007 and 2008.
TOTAL 24.9 24.6 12.2 12.0 4.6 4.5
GEOGRAPHIC DIVISION            
Northeast 22.1 23.7 10.8 11.5 3.7 4.4
New England 26.6 24.7 14.0 12.6 4.2 4.4
Middle Atlantic 20.6 23.3 9.7 11.1 3.5 4.4
Midwest 25.3 25.5 12.0 12.4 4.6 4.6
East North Central 26.8 25.8 13.2 12.7 4.9 5.0
West North Central 21.8 24.9 9.2 11.6 3.8 3.6
South 24.4 23.6 12.2 11.9 5.1 4.7
South Atlantic 23.6 21.8 12.2 10.9 5.3 4.1
East South Central 28.2 24.8 14.4 13.9 6.5 6.3
West South Central 23.6 25.7 11.1 12.5 4.0 4.9
West 27.3 25.8 13.3 12.3 4.8 4.3
Mountain 28.8 30.1 13.2 13.3 5.1 5.0
Pacific 26.7 24.0 13.3 11.8 4.7 4.0
COUNTY TYPE            
Large Metro 23.8 23.4 11.6 11.1 4.4 4.1
Small Metro 26.1 26.5 12.5 13.3 4.5 5.0
250K - 1 Mil. Pop. 26.9 26.2 13.4 12.9 4.6 4.8
< 250K Pop. 24.6 27.2 10.8b 14.1 4.5 5.5
Nonmetro 25.9 25.0 13.4 12.5 5.6 5.0
Urbanized 25.9 25.2 14.0 11.9 5.6 4.5
Less Urbanized 26.0 25.4 12.8 13.2 5.5 5.5
Completely Rural 24.9 20.4 14.0 11.4 6.3 5.7
120411
Table 1.86A (REVISED) – Nonmedical Use of Pain Relievers in Lifetime, Past Year, and Past Month among Persons Aged 26 or Older, by Geographic Characteristics: Numbers in Thousands, 2007 and 2008
Geographic Characteristic Lifetime
(2007)
Lifetime
(2008)
Past Year
(2007)
Past Year
(2008)
Past Month
(2007)
Past Month
(2008)
*Low precision; no estimate reported.
NOTE: This table was revised in May 2012 due to updates (for details, see the introduction to these 2008 detailed tables).
a Difference between estimate and 2008 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2008 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2007 and 2008.
TOTAL 22,533b 24,543 6,851 6,347 2,998 2,676
GEOGRAPHIC DIVISION            
Northeast 3,588 4,203 1,003 1,000 453 436
New England 991a 1,323 261 354 132 229
Middle Atlantic 2,597 2,879 742 645 321 208
Midwest 5,063 5,087 1,425 1,409 638 615
East North Central 3,664 3,907 1,107 1,105 504 484
West North Central 1,399 1,180 318 303 134 131
South 8,029 8,511 2,611 2,163 1,115 852
South Atlantic 3,950 4,448 1,122 1,042 466 436
East South Central 1,593 1,436 661 485 353 240
West South Central 2,486 2,627 828 636 296 175
West 5,853a 6,742 1,813 1,776 792 773
Mountain 1,922 2,015 631 497 276 161
Pacific 3,931a 4,727 1,181 1,279 516 612
COUNTY TYPE            
Large Metro 12,412 13,419 3,652 3,500 1,566 1,453
Small Metro 6,631 7,381 2,032 1,963 902 830
250K - 1 Mil. Pop. 4,311 4,900 1,192 1,253 519 577
< 250K Pop. 2,320 2,481 840 711 383 253
Nonmetro 3,490 3,742 1,168a 884 531 394
Urbanized 1,563 1,690 504 364 184 178
Less Urbanized 1,624 1,768 621 458 328 195
Completely Rural 303 284 43 62 19 21
120411
Table 1.86B (REVISED) – Nonmedical Use of Pain Relievers in Lifetime, Past Year, and Past Month among Persons Aged 26 or Older, by Geographic Characteristics: Percentages, 2007 and 2008
Geographic Characteristic Lifetime
(2007)
Lifetime
(2008)
Past Year
(2007)
Past Year
(2008)
Past Month
(2007)
Past Month
(2008)
*Low precision; no estimate reported.
NOTE: This table was revised in May 2012 due to updates (for details, see the introduction to these 2008 detailed tables).
a Difference between estimate and 2008 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2008 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2007 and 2008.
TOTAL 11.9a 12.8 3.6 3.3 1.6 1.4
GEOGRAPHIC DIVISION            
Northeast 10.1 11.8 2.8 2.8 1.3 1.2
New England 10.6a 14.1 2.8 3.8 1.4 2.4
Middle Atlantic 9.9 10.9 2.8 2.4 1.2 0.8
Midwest 12.1 12.1 3.4 3.3 1.5 1.5
East North Central 12.5 13.3 3.8 3.8 1.7 1.6
West North Central 11.1 9.3 2.5 2.4 1.1 1.0
South 11.6 12.1 3.8a 3.1 1.6 1.2
South Atlantic 10.7 11.9 3.0 2.8 1.3 1.2
East South Central 14.0 12.5 5.8 4.2 3.1 2.1
West South Central 12.0 12.4 4.0 3.0 1.4a 0.8
West 13.5 15.3 4.2 4.0 1.8 1.8
Mountain 14.7 15.0 4.8 3.7 2.1 1.2
Pacific 13.0a 15.5 3.9 4.2 1.7 2.0
COUNTY TYPE            
Large Metro 12.2 13.2 3.6 3.4 1.5 1.4
Small Metro 11.8 12.7 3.6 3.4 1.6 1.4
250K - 1 Mil. Pop. 11.4 12.7 3.2 3.2 1.4 1.5
< 250K Pop. 12.5 12.8 4.5 3.7 2.1 1.3
Nonmetro 11.0 11.7 3.7a 2.8 1.7 1.2
Urbanized 12.2 12.9 3.9 2.8 1.4 1.4
Less Urbanized 10.7 11.3 4.1 2.9 2.2a 1.2
Completely Rural 8.0 8.6 1.1 1.9 0.5 0.6
120411
Table 1.87A (REVISED) – Nonmedical Use of Pain Relievers in Lifetime, Past Year, and Past Month among Persons Aged 18 or Older, by Geographic Characteristics: Numbers in Thousands, 2007 and 2008
Geographic Characteristic Lifetime
(2007)
Lifetime
(2008)
Past Year
(2007)
Past Year
(2008)
Past Month
(2007)
Past Month
(2008)
*Low precision; no estimate reported.
NOTE: This table was revised in May 2012 due to updates (for details, see the introduction to these 2008 detailed tables).
a Difference between estimate and 2008 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2008 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2007 and 2008.
TOTAL 30,676a 32,639 10,833 10,304 4,517 4,165
GEOGRAPHIC DIVISION            
Northeast 4,895a 5,621 1,642 1,686 669 698
New England 1,397 1,708 474 550 197 297
Middle Atlantic 3,498 3,913 1,168 1,136 473 402
Midwest 6,904 6,945 2,297 2,309 971 949
East North Central 5,012 5,206 1,772 1,746 750 737
West North Central 1,892 1,738 525 563 221 211
South 10,876 11,288 4,036 3,563 1,706 1,407
South Atlantic 5,346 5,751 1,843 1,691 776 681
East South Central 2,120 1,902 931 746 475 358
West South Central 3,411 3,636 1,262 1,126 454 368
West 8,000 8,785 2,858 2,745 1,171 1,112
Mountain 2,600 2,727 943 812 396 279
Pacific 5,400 6,058 1,915 1,934 775 832
COUNTY TYPE            
Large Metro 16,537 17,589 5,656 5,489 2,331 2,182
Small Metro 9,328 10,062 3,323 3,307 1,369 1,339
250K - 1 Mil. Pop. 6,134 6,613 2,098 2,095 827 890
< 250K Pop. 3,194 3,449 1,225 1,213 542 449
Nonmetro 4,810 4,988 1,854a 1,507 817 645
Urbanized 2,154 2,265 824 636 312 280
Less Urbanized 2,261 2,367 934 769 462 324
Completely Rural 395 356 95 102 42 41
120411
Table 1.87B (REVISED) – Nonmedical Use of Pain Relievers in Lifetime, Past Year, and Past Month among Persons Aged 18 or Older, by Geographic Characteristics: Percentages, 2007 and 2008
Geographic Characteristic Lifetime
(2007)
Lifetime
(2008)
Past Year
(2007)
Past Year
(2008)
Past Month
(2007)
Past Month
(2008)
*Low precision; no estimate reported.
NOTE: This table was revised in May 2012 due to updates (for details, see the introduction to these 2008 detailed tables).
a Difference between estimate and 2008 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2008 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2007 and 2008.
TOTAL 13.8a 14.5 4.9 4.6 2.0 1.9
GEOGRAPHIC DIVISION            
Northeast 11.8 13.5 4.0 4.0 1.6 1.7
New England 12.9 15.6 4.4 5.0 1.8 2.7
Middle Atlantic 11.5 12.7 3.8 3.7 1.5 1.3
Midwest 14.0 14.0 4.7 4.7 2.0 1.9
East North Central 14.6 15.1 5.2 5.1 2.2 2.1
West North Central 12.8 11.6 3.5 3.8 1.5 1.4
South 13.5 13.8 5.0a 4.3 2.1 1.7
South Atlantic 12.5 13.2 4.3 3.9 1.8 1.6
East South Central 16.0 14.2 7.0 5.6 3.6 2.7
West South Central 13.9 14.5 5.1 4.5 1.8 1.5
West 15.6 16.9 5.6 5.3 2.3 2.1
Mountain 16.8 17.3 6.1 5.1 2.6 1.8
Pacific 15.1 16.8 5.4 5.4 2.2 2.3
COUNTY TYPE            
Large Metro 13.9 14.7 4.8 4.6 2.0 1.8
Small Metro 14.0 14.8 5.0 4.9 2.1 2.0
250K - 1 Mil. Pop. 13.8 14.7 4.7 4.6 1.9 2.0
< 250K Pop. 14.4 15.0 5.5 5.3 2.4 2.0
Nonmetro 13.0 13.5 5.0a 4.1 2.2 1.7
Urbanized 14.3 14.7 5.5a 4.1 2.1 1.8
Less Urbanized 12.8 13.1 5.3 4.3 2.6 1.8
Completely Rural 9.5 9.8 2.3 2.8 1.0 1.1
90331
Table 1.88A – Specific Hallucinogen, Inhalant, Needle, and Heroin Use in Lifetime, by Age Group: Numbers in Thousands, 2007 and 2008
Drug or Method of Administration Total
(2007)
Total
(2008)
Aged
12-17
(2007)
Aged
12-17
(2008)
Aged
18-25
(2007)
Aged
18-25
(2008)
Aged
26+
(2007)
Aged
26+
(2008)
*Low precision; no estimate reported.
a Difference between estimate and 2008 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2008 estimate is statistically significant at the 0.01 level.
1 Refers to lifetime use of a needle to inject a drug that was not prescribed, or that was taken only for the experience or feeling it caused.
2 These drug estimates are generated from data collected on a "noncore" module of the NSDUH questionnaire. Therefore, these estimates may be somewhat inconsistent with drug estimates based on data collected from the "core" modules because NSDUH data are not edited for consistency across the "core" and "noncore" modules of the interview.
3 Estimates of Stimulant Needle Use, Methamphetamine Needle Use, and the Needle Use summary variable include data from methamphetamine items added in 2005 and 2006 and are not comparable with estimates presented in NSDUH reports prior to the 2007 National Findings report. See Section B.4.8 in Appendix B of the Results from the 2008 National Survey on Drug Use and Health: National Findings.
Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2007 and 2008.
HALLUCINOGENS 34,215a 35,963 896 973 6,287b 5,836 27,032a 29,155
PCP (Angel Dust, Phencyclidine) 6,140 6,631 104 102 539 513 5,497 6,016
LSD (Acid) 22,656 23,547 200a 268 2,374a 2,145 20,083 21,133
Peyote 5,476 5,375 51 55 361 379 5,064 4,941
Mescaline 7,832 8,188 41 42 366 348 7,426 7,798
Psilocybin (Mushrooms) 18,909 19,792 408 413 3,722 3,511 14,779 15,869
"Ecstasy" (MDMA) 12,426 12,924 446a 531 4,191 3,992 7,788 8,400
INHALANTS 22,477 22,274 2,422 2,307 3,690a 3,411 16,365 16,555
Amyl Nitrite, "Poppers," Locker Room
  Odorizers, or "Rush"
7,920 8,117 461 399 608 596 6,851 7,123
Correction Fluid, Degreaser, or Cleaning Fluid 2,119 1,912 545 536 355 303 1,218 1,072
Gasoline or Lighter Fluid 3,892 3,674 874 774 565 521 2,452 2,378
Glue, Shoe Polish, or Toluene 3,919 3,794 1,013a 863 545 469 2,361 2,462
Halothane, Ether, or Other Anesthetics 1,132 1,054 98 79 209 203 825 772
Lacquer Thinner or Other Paint Solvents 1,990 1,725 414 375 423b 286 1,152 1,064
Lighter Gases (Butane, Propane) 1,001 960 266 246 223 165 512 549
Nitrous Oxide or "Whippits" 11,712 11,187 296 237 2,340 2,189 9,076 8,761
Spray Paints 2,141 2,105 769 754 392 374 980 977
Other Aerosol Sprays 1,998 2,213 546 531 533 616 919 1,066
NEEDLE USE1,2,3 4,084 4,114 58 59 410a 307 3,616 3,748
Heroin Needle Use1,2 1,972 1,911 27 25 203 157 1,741 1,729
Cocaine Needle Use1,2 2,096 2,366 18 15 160 117 1,918 2,234
Stimulant Needle Use1,2,3 1,808 2,013 27 26 192a 129 1,589 1,858
Methamphetamine Needle Use1,2,3 1,585 1,481 22 18 155a 98 1,409 1,366
HEROIN 3,780 3,788 54 68 493 457 3,233 3,263
Smoke Heroin2 1,229 1,255 21 29 187 168 1,021 1,058
Sniff or Snort Heroin2 2,414 2,686 26 34 356 324 2,032 2,328
90331
Table 1.88B – Specific Hallucinogen, Inhalant, Needle, and Heroin Use in Lifetime, by Age Group: Percentages, 2007 and 2008
Drug or Method of Administration Total
(2007)
Total
(2008)
Aged
12-17
(2007)
Aged
12-17
(2008)
Aged
18-25
(2007)
Aged
18-25
(2008)
Aged
26+
(2007)
Aged
26+
(2008)
*Low precision; no estimate reported.
a Difference between estimate and 2008 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2008 estimate is statistically significant at the 0.01 level.
1 Refers to lifetime use of a needle to inject a drug that was not prescribed, or that was taken only for the experience or feeling it caused.
2 These drug estimates are generated from data collected on a "noncore" module of the NSDUH questionnaire. Therefore, these estimates may be somewhat inconsistent with drug estimates based on data collected from the "core" modules because NSDUH data are not edited for consistency across the "core" and "noncore" modules of the interview.
3 Estimates of Stimulant Needle Use, Methamphetamine Needle Use, and the Needle Use summary variable include data from methamphetamine items added in 2005 and 2006 and are not comparable with estimates presented in NSDUH reports prior to the 2007 National Findings report. See Section B.4.8 in Appendix B of the Results from the 2008 National Survey on Drug Use and Health: National Findings.
Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2007 and 2008.
HALLUCINOGENS 13.8 14.4 3.5 3.9 19.2b 17.7 14.2a 15.2
PCP (Angel Dust, Phencyclidine) 2.5 2.7 0.4 0.4 1.6 1.6 2.9 3.1
LSD (Acid) 9.1 9.4 0.8b 1.1 7.3a 6.5 10.6 11.0
Peyote 2.2 2.2 0.2 0.2 1.1 1.2 2.7 2.6
Mescaline 3.2 3.3 0.2 0.2 1.1 1.1 3.9 4.1
Psilocybin (Mushrooms) 7.6 7.9 1.6 1.7 11.4 10.7 7.8 8.3
"Ecstasy" (MDMA) 5.0 5.2 1.8a 2.1 12.8 12.1 4.1 4.4
INHALANTS 9.1 8.9 9.6 9.3 11.3a 10.4 8.6 8.6
Amyl Nitrite, "Poppers," Locker Room
  Odorizers, or "Rush"
3.2 3.2 1.8 1.6 1.9 1.8 3.6 3.7
Correction Fluid, Degreaser, or Cleaning Fluid 0.9 0.8 2.2 2.2 1.1 0.9 0.6 0.6
Gasoline or Lighter Fluid 1.6 1.5 3.5 3.1 1.7 1.6 1.3 1.2
Glue, Shoe Polish, or Toluene 1.6 1.5 4.0a 3.5 1.7 1.4 1.2 1.3
Halothane, Ether, or Other Anesthetics 0.5 0.4 0.4 0.3 0.6 0.6 0.4 0.4
Lacquer Thinner or Other Paint Solvents 0.8 0.7 1.6 1.5 1.3b 0.9 0.6 0.6
Lighter Gases (Butane, Propane) 0.4 0.4 1.1 1.0 0.7 0.5 0.3 0.3
Nitrous Oxide or "Whippits" 4.7 4.5 1.2 1.0 7.2 6.6 4.8 4.6
Spray Paints 0.9 0.8 3.0 3.0 1.2 1.1 0.5 0.5
Other Aerosol Sprays 0.8 0.9 2.2 2.1 1.6 1.9 0.5 0.6
NEEDLE USE1,2,3 1.6 1.6 0.2 0.2 1.3a 0.9 1.9 2.0
Heroin Needle Use1,2 0.8 0.8 0.1 0.1 0.6 0.5 0.9 0.9
Cocaine Needle Use1,2 0.8 0.9 0.1 0.1 0.5 0.4 1.0 1.2
Stimulant Needle Use1,2,3 0.7 0.8 0.1 0.1 0.6a 0.4 0.8 1.0
Methamphetamine Needle Use1,2,3 0.6 0.6 0.1 0.1 0.5a 0.3 0.7 0.7
HEROIN 1.5 1.5 0.2 0.3 1.5 1.4 1.7 1.7
Smoke Heroin2 0.5 0.5 0.1 0.1 0.6 0.5 0.5 0.6
Sniff or Snort Heroin2 1.0 1.1 0.1 0.1 1.1 1.0 1.1 1.2
90331
Table 1.89A – Nonmedical Use of Specific Pain Relievers in Lifetime, by Age Group: Numbers in Thousands, 2007 and 2008
Pain Reliever Total
(2007)
Total
(2008)
Aged
12-17
(2007)
Aged
12-17
(2008)
Aged
18-25
(2007)
Aged
18-25
(2008)
Aged
26+
(2007)
Aged
26+
(2008)
*Low precision; no estimate reported.
a Difference between estimate and 2008 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2008 estimate is statistically significant at the 0.01 level.
1 Includes other-specify drug responses that are not asked about explicitly in the Pain Relievers module but fall into this category.
2 Includes Darvocet®, Darvon® or Tylenol® with Codeine, codeine, Phenaphen® with Codeine, propoxyphene, and SK-65®.
3 Includes Percocet®, Percodan® or Tylox®, and OxyContin®.
4 Includes Vicodin®, Lortab®, or Lorcet®, and hydrocodone.
5 Includes tramadol and Ultram®.
Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2007 and 2008.
Darvocet®, Darvon®, or Tylenol® with Codeine 18,817 19,180 1,182b 1,017 3,722a 3,451 13,913 14,712
Percocet®, Percodan®, or Tylox® 11,599 12,262 429 411 2,877 2,894 8,293 8,957
Vicodin®, Lortab®, or Lorcet® 20,072 21,224 1,161 1,167 5,870 5,922 13,041a 14,134
Codeine 6,658 6,721 401a 329 1,872 1,790 4,385 4,603
Demerol® 2,446 2,121 91b 52 537b 400 1,818 1,669
Dilaudid® 1,011 1,212 15 16 148 153 849 1,044
Fioricet® 450 538 24 17 71 54 356 467
Fiorinal® 278 349 14 15 29 33 235 301
Hydrocodone 7,637a 8,363 424 387 2,565 2,667 4,647 5,309
Methadone 1,611 1,811 128 116 605 660 878 1,034
Morphine 2,351 2,677 214 173 885 822 1,253a 1,682
OxyContin® 4,354 4,842 360 341 1,706 1,736 2,289a 2,766
Phenaphen® with Codeine 669 650 53 34 152 145 464 471
Propoxyphene 371 379 20 27 96 90 256 262
SK-65® 46 56 20 10 16 11 10 35
Stadol® 148 172 7 7 35a 15 105 150
Talacen® 61 39 15 10 11 11 36 18
Talwin® 356 293 13 7 38a 12 304 275
Talwin® NX 114 75 10 2 22 10 81 62
Tramadol 801 971 59 41 233b 346 509 584
Ultram® 1,157 1,019 45 42 293 294 819 683
SELECTED GROUPS OF DRUGS1                
Propoxyphene or Codeine Products2 20,461 21,128 1,320a 1,173 4,287 4,069 14,854 15,886
Oxycodone Products3 13,055 13,759 638 601 3,538 3,561 8,879 9,597
Hydrocodone Products4 21,335a 22,838 1,297 1,295 6,251 6,323 13,787a 15,219
Tramadol Products5 1,559 1,607 92 74 415a 522 1,052 1,012
90331
Table 1.89B – Nonmedical Use of Specific Pain Relievers in Lifetime, by Age Group: Percentages, 2007 and 2008
Pain Reliever Total
(2007)
Total
(2008)
Aged
12-17
(2007)
Aged
12-17
(2008)
Aged
18-25
(2007)
Aged
18-25
(2008)
Aged
26+
(2007)
Aged
26+
(2008)
*Low precision; no estimate reported.
a Difference between estimate and 2008 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2008 estimate is statistically significant at the 0.01 level.
1 Includes other-specify drug responses that are not asked about explicitly in the Pain Relievers module but fall into this category.
2 Includes Darvocet®, Darvon® or Tylenol® with Codeine, codeine, Phenaphen® with Codeine, propoxyphene, and SK-65®.
3 Includes Percocet®, Percodan® or Tylox®, and OxyContin®.
4 Includes Vicodin®, Lortab®, or Lorcet®, and hydrocodone.
5 Includes tramadol and Ultram®.
Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2007 and 2008.
Darvocet®, Darvon®, or Tylenol® with Codeine 7.6 7.7 4.7a 4.1 11.4a 10.5 7.3 7.7
Percocet®, Percodan®, or Tylox® 4.7 4.9 1.7 1.7 8.8 8.8 4.4 4.7
Vicodin®, Lortab®, or Lorcet® 8.1 8.5 4.6 4.7 17.9 18.0 6.9 7.4
Codeine 2.7 2.7 1.6 1.3 5.7 5.4 2.3 2.4
Demerol® 1.0 0.8 0.4b 0.2 1.6b 1.2 1.0 0.9
Dilaudid® 0.4 0.5 0.1 0.1 0.5 0.5 0.4 0.5
Fioricet® 0.2 0.2 0.1 0.1 0.2 0.2 0.2 0.2
Fiorinal® 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.2
Hydrocodone 3.1 3.3 1.7 1.6 7.8 8.1 2.4 2.8
Methadone 0.6 0.7 0.5 0.5 1.8 2.0 0.5 0.5
Morphine 0.9 1.1 0.8 0.7 2.7 2.5 0.7a 0.9
OxyContin® 1.8 1.9 1.4 1.4 5.2 5.3 1.2 1.4
Phenaphen® with Codeine 0.3 0.3 0.2 0.1 0.5 0.4 0.2 0.2
Propoxyphene 0.1 0.2 0.1 0.1 0.3 0.3 0.1 0.1
SK-65® 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0
Stadol® 0.1 0.1 0.0 0.0 0.1a 0.0 0.1 0.1
Talacen® 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0
Talwin® 0.1 0.1 0.1 0.0 0.1b 0.0 0.2 0.1
Talwin® NX 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0
Tramadol 0.3 0.4 0.2 0.2 0.7b 1.1 0.3 0.3
Ultram® 0.5 0.4 0.2 0.2 0.9 0.9 0.4 0.4
SELECTED GROUPS OF DRUGS1                
Propoxyphene or Codeine Products2 8.3 8.5 5.2 4.7 13.1 12.4 7.8 8.3
Oxycodone Products3 5.3 5.5 2.5 2.4 10.8 10.8 4.7 5.0
Hydrocodone Products4 8.6a 9.1 5.1 5.2 19.1 19.2 7.3a 7.9
Tramadol Products5 0.6 0.6 0.4 0.3 1.3a 1.6 0.6 0.5
90331
Table 1.90A – Nonmedical Use of Specific Tranquilizers in Lifetime, by Age Group: Numbers in Thousands, 2007 and 2008
Tranquilizer Total
(2007)
Total
(2008)
Aged
12-17
(2007)
Aged
12-17
(2008)
Aged
18-25
(2007)
Aged
18-25
(2008)
Aged
26+
(2007)
Aged
26+
(2008)
*Low precision; no estimate reported.
a Difference between estimate and 2008 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2008 estimate is statistically significant at the 0.01 level.
1 Includes other-specify drug responses that are not asked about explicitly in the Tranquilizers module but fall into this category.
2 Includes Klonopin® or clonazepam, Xanax®, alprazolam, Ativan® or lorazepam, Valium® or diazepam, Librium®, Limbitrol®, Rohypnol®, Serax®, and Tranxene®.
3 Includes Equanil®, meprobamate, and Miltown®.
4 Includes Flexeril® and Soma®.
Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2007 and 2008.
Klonopin® or Clonazepam 3,694 3,945 164 137 1,234 1,187 2,296 2,620
Xanax®, Alprazolam, Ativan®, or Lorazepam 11,416b 12,710 496 507 3,022 2,977 7,899b 9,225
Valium® or Diazepam 13,172 14,023 314a 250 2,252 2,103 10,606 11,670
Atarax® 214 283 18 15 43 45 152 223
BuSpar® 544 679 16 26 151 144 377 508
Equanil® 86 38 5 9 12 14 69 15
Flexeril® 2,438 2,461 56 42 568 538 1,813 1,881
Librium® 662 818 18 20 42 42 602 755
Limbitrol® 99 51 9 10 13 10 77 30
Meprobamate 107 77 9 11 13 17 85 49
Miltown® 53 117 6 6 5 7 42 104
Rohypnol® 276 297 22 25 71 82 184 190
Serax® 63 113 6 8 26 22 32 83
Soma® 2,709 2,833 106 99 956 933 1,647 1,800
Tranxene® 108 195 10 6 36 24 62 165
Vistaril® 301 298 7 14 57 42 237 242
SELECTED GROUPS OF DRUGS1                
Benzodiazepines2 18,934 20,147 670 633 3,883 3,806 14,382a 15,709
Meprobamate Products3 236 183 18 21 27 32 192 130
Muscle Relaxants4 4,274 4,414 139 136 1,241 1,222 2,894 3,055
90331
Table 1.90B – Nonmedical Use of Specific Tranquilizers in Lifetime, by Age Group: Percentages, 2007 and 2008
Tranquilizer Total
(2007)
Total
(2008)
Aged
12-17
(2007)
Aged
12-17
(2008)
Aged
18-25
(2007)
Aged
18-25
(2008)
Aged
26+
(2007)
Aged
26+
(2008)
*Low precision; no estimate reported.
a Difference between estimate and 2008 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2008 estimate is statistically significant at the 0.01 level.
1 Includes other-specify drug responses that are not asked about explicitly in the Tranquilizers module but fall into this category.
2 Includes Klonopin® or clonazepam, Xanax®, alprazolam, Ativan® or lorazepam, Valium® or diazepam, Librium®, Limbitrol®, Rohypnol®, Serax®, and Tranxene®.
3 Includes Equanil®, meprobamate, and Miltown®.
4 Includes Flexeril® and Soma®.
Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2007 and 2008.
Klonopin® or Clonazepam 1.5 1.6 0.6 0.6 3.8 3.6 1.2 1.4
Xanax®, Alprazolam, Ativan®, or Lorazepam 4.6a 5.1 2.0 2.0 9.2 9.0 4.2b 4.8
Valium® or Diazepam 5.3 5.6 1.2 1.0 6.9 6.4 5.6 6.1
Atarax® 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1
BuSpar® 0.2 0.3 0.1 0.1 0.5 0.4 0.2 0.3
Equanil® 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Flexeril® 1.0 1.0 0.2 0.2 1.7 1.6 1.0 1.0
Librium® 0.3 0.3 0.1 0.1 0.1 0.1 0.3 0.4
Limbitrol® 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Meprobamate 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0
Miltown® 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1
Rohypnol® 0.1 0.1 0.1 0.1 0.2 0.2 0.1 0.1
Serax® 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0
Soma® 1.1 1.1 0.4 0.4 2.9 2.8 0.9 0.9
Tranxene® 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.1
Vistaril® 0.1 0.1 0.0 0.1 0.2 0.1 0.1 0.1
SELECTED GROUPS OF DRUGS1                
Benzodiazepines2 7.6 8.1 2.7 2.5 11.9 11.6 7.6 8.2
Meprobamate Products3 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1
Muscle Relaxants4 1.7 1.8 0.5 0.5 3.8 3.7 1.5 1.6
90331
Table 1.91A – Nonmedical Use of Specific Stimulants in Lifetime, by Age Group: Numbers in Thousands, 2007 and 2008
Stimulant Total
(2007)
Total
(2008)
Aged
12-17
(2007)
Aged
12-17
(2008)
Aged
18-25
(2007)
Aged
18-25
(2008)
Aged
26+
(2007)
Aged
26+
(2008)
*Low precision; no estimate reported.
a Difference between estimate and 2008 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2008 estimate is statistically significant at the 0.01 level.
1 Also known as crank, crystal, ice, or speed. Estimates of Use of Methamphetamine, Desoxyn®, or Methedrine include data from methamphetamine items added in 2005 and 2006 and are not comparable with estimates presented in NSDUH reports prior to the 2007 National Findings report. See Section B.4.8 in Appendix B of the Results from the 2008 National Survey on Drug Use and Health: National Findings.
2 Respondents were asked about their use of prescription diet pills and were given the following as examples: amphetamines, Benzedrine®, Biphetamine®, Fastin®, or phentermine. However, respondents were not given an exhaustive list of examples of prescription diet pills.
3 Includes other-specify drug responses that are not asked about explicitly in the Stimulants module but fall into this category.
4 Includes prescription diet pills, Dexedrine®, dextroamphetamine, and Ionamin®.
5 Includes Mazanor® and Sanorex®.
6 Includes Ritalin®, other products containing methylphenidate, and products containing dexmethylphenidate.
Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2007 and 2008.
Methamphetamine, Desoxyn®, or Methedrine1 13,065 12,598 222 195 1,844b 1,544 10,999 10,859
Prescription Diet Pills2 7,640 7,533 176 180 660 694 6,804 6,659
Ritalin® or Methylphenidate 4,542 4,808 377 325 1,582 1,559 2,583 2,923
Cylert® 223 168 18 13 24 30 181 125
Dexedrine® 2,387 2,262 27 16 205 179 2,155 2,067
Dextroamphetamine 547 558 27 21 129 129 391 408
Didrex® 128 127 5a 16 22 8 101 103
Eskatrol® 115 150 7 11 11 8 98 132
Ionamin® 300 181 9 5 11 6 280 170
Mazanor® 36 49 9 11 13 2 14 35
Obedrin-LA® * * 2 8 * 4 * *
Plegine® 74 35 7 10 9 11 59 14
Preludin® 412 529 6 10 13 12 393 507
Sanorex® 151 99 10 13 26 24 115 62
Tenuate® 77 111 12 9 * 3 63 99
SELECTED GROUPS OF DRUGS3                
Amphetamine, Dextroamphetamine,
  and Phentermine Products4
9,686 9,283 287 255 1,296 1,345 8,103 7,683
Mazindol Products5 181 130 15 20 37 25 129 85
Methylphenidate or
  Dexmethylphenidate Products6
4,558 4,823 379 325 1,596 1,569 2,583 2,929
90331
Table 1.91B – Nonmedical Use of Specific Stimulants in Lifetime, by Age Group: Percentages, 2007 and 2008
Stimulant Total
(2007)
Total
(2008)
Aged
12-17
(2007)
Aged
12-17
(2008)
Aged
18-25
(2007)
Aged
18-25
(2008)
Aged
26+
(2007)
Aged
26+
(2008)
*Low precision; no estimate reported.
a Difference between estimate and 2008 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2008 estimate is statistically significant at the 0.01 level.
1 Also known as crank, crystal, ice, or speed. Estimates of Use of Methamphetamine, Desoxyn®, or Methedrine include data from methamphetamine items added in 2005 and 2006 and are not comparable with estimates presented in NSDUH reports prior to the 2007 National Findings report. See Section B.4.8 in Appendix B of the Results from the 2008 National Survey on Drug Use and Health: National Findings.
2 Respondents were asked about their use of prescription diet pills and were given the following as examples: amphetamines, Benzedrine®, Biphetamine®, Fastin®, or phentermine. However, respondents were not given an exhaustive list of examples of prescription diet pills.
3 Includes other-specify drug responses that are not asked about explicitly in the Stimulants module but fall into this category.
4 Includes prescription diet pills, Dexedrine®, dextroamphetamine, and Ionamin®.
5 Includes Mazanor® and Sanorex®.
6 Includes Ritalin®, other products containing methylphenidate, and products containing dexmethylphenidate.
Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2007 and 2008.
Methamphetamine, Desoxyn®, or Methedrine1 5.3 5.0 0.9 0.8 5.6b 4.7 5.8 5.7
Prescription Diet Pills2 3.1 3.0 0.7 0.7 2.0 2.1 3.6 3.5
Ritalin® or Methylphenidate 1.8 1.9 1.5 1.3 4.8 4.7 1.4 1.5
Cylert® 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1
Dexedrine® 1.0 0.9 0.1 0.1 0.6 0.5 1.1 1.1
Dextroamphetamine 0.2 0.2 0.1 0.1 0.4 0.4 0.2 0.2
Didrex® 0.1 0.1 0.0a 0.1 0.1 0.0 0.1 0.1
Eskatrol® 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1
Ionamin® 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.1
Mazanor® 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Obedrin-LA® * * 0.0 0.0 * 0.0 * *
Plegine® 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Preludin® 0.2 0.2 0.0 0.0 0.0 0.0 0.2 0.3
Sanorex® 0.1 0.0 0.0 0.1 0.1 0.1 0.1 0.0
Tenuate® 0.0 0.0 0.0 0.0 * 0.0 0.0 0.1
SELECTED GROUPS OF DRUGS3                
Amphetamine, Dextroamphetamine,
  and Phentermine Products4
3.9 3.7 1.1 1.0 4.0 4.1 4.3 4.0
Mazindol Products5 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0
Methylphenidate or
  Dexmethylphenidate Products6
1.8 1.9 1.5 1.3 4.9 4.8 1.4 1.5
90331
Table 1.92A – Nonmedical Use of Specific Sedatives in Lifetime, by Age Group: Numbers in Thousands, 2007 and 2008
Sedative Total
(2007)
Total
(2008)
Aged
12-17
(2007)
Aged
12-17
(2008)
Aged
18-25
(2007)
Aged
18-25
(2008)
Aged
26+
(2007)
Aged
26+
(2008)
*Low precision; no estimate reported.
a Difference between estimate and 2008 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2008 estimate is statistically significant at the 0.01 level.
1 Respondents were asked about their use of barbiturates and were given the following as examples: Nembutal®, pentobarbital, Seconal®, secobarbital, or butalbital. However, respondents were not given an exhaustive list of examples of barbiturates.
2 Includes other-specify drug responses that are not asked about explicitly in the Sedatives module but fall into this category.
3
Includes Restoril®, temazepam, Dalmane®, or Halcion®.
4 Includes barbiturates, Amytal®, Butisol®, phenobarbital, and Tuinal®.
Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2007 and 2008.
Methaqualone, Sopor®, or Quaalude® 5,919 5,794 48 30 159 149 5,712 5,615
Barbiturates1 2,607 2,854 29 29 116a 72 2,462 2,754
Restoril® or Temazepam 1,130 914 34 43 149 114 947 757
Amytal® 160 169 8 10 31 25 122 134
Butisol® 71 95 10 15 17 3 45 78
Chloral Hydrate 169 193 2 4 8 5 158 184
Dalmane® 316 264 15 26 23 9 278 230
Halcion® 523 506 6 16 24 19 493 471
Phenobarbital 887 1,214 17 18 57 70 813 1,126
Placidyl® 646 533 * 6 13 8 632 518
Tuinal® 728 1,019 5 5 7 5 716 1,009
SELECTED GROUPS OF DRUGS2                
Temazepam, Flurazepam, or Triazolam3 1,694 1,485 52 72 184 134 1,458 1,280
Any Barbiturates4 3,022 3,478 53 54 181 136 2,788 3,288
90331
Table 1.92B – Nonmedical Use of Specific Sedatives in Lifetime, by Age Group: Percentages, 2007 and 2008
Sedative Total
(2007)
Total
(2008)
Aged
12-17
(2007)
Aged
12-17
(2008)
Aged
18-25
(2007)
Aged
18-25
(2008)
Aged
26+
(2007)
Aged
26+
(2008)
*Low precision; no estimate reported.
a Difference between estimate and 2008 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2008 estimate is statistically significant at the 0.01 level.
1 Respondents were asked about their use of barbiturates and were given the following as examples: Nembutal®, pentobarbital, Seconal®, secobarbital, or butalbital. However, respondents were not given an exhaustive list of examples of barbiturates.
2 Includes other-specify drug responses that are not asked about explicitly in the Sedatives module but fall into this category.
3
Includes Restoril®, temazepam, Dalmane®, or Halcion®.
4 Includes barbiturates, Amytal®, Butisol®, phenobarbital, and Tuinal®.
Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2007 and 2008.
Methaqualone, Sopor®, or Quaalude® 2.4 2.3 0.2 0.1 0.5 0.5 3.0 2.9
Barbiturates1 1.1 1.1 0.1 0.1 0.4a 0.2 1.3 1.4
Restoril® or Temazepam 0.5 0.4 0.1 0.2 0.5 0.3 0.5 0.4
Amytal® 0.1 0.1 0.0 0.0 0.1 0.1 0.1 0.1
Butisol® 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0
Chloral Hydrate 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.1
Dalmane® 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1
Halcion® 0.2 0.2 0.0 0.1 0.1 0.1 0.3 0.2
Phenobarbital 0.4 0.5 0.1 0.1 0.2 0.2 0.4 0.6
Placidyl® 0.3 0.2 * 0.0 0.0 0.0 0.3 0.3
Tuinal® 0.3 0.4 0.0 0.0 0.0 0.0 0.4 0.5
SELECTED GROUPS OF DRUGS2                
Temazepam, Flurazepam, or Triazolam3 0.7 0.6 0.2 0.3 0.6 0.4 0.8 0.7
Any Barbiturates4 1.2 1.4 0.2 0.2 0.6 0.4 1.5 1.7

Go to Top of PageGo to the Table of Contents